text stringlengths 102 99.6k | url stringlengths 31 426 | crawl_date timestamp[us, tz=UTC]date 2022-04-01 00:29:49 2022-09-19 04:34:15 |
|---|---|---|
“Now we need them to deliver,” says Sec. Buttigieg as flight cancellations increase
WASHINGTON (Gray DC) - The hundreds of flight cancellations across the country as we head toward a busy holiday travel weekend is an issue that’s catching the attention from top government officials.
Department of Transportation Secretary Pete Buttigieg said it is time for the airline industry to deliver.
Buttigieg said, “passengers have high expectations from an industry that we have supported with tens of billions of dollars in taxpayer funding through the pandemic to keep it up and running so that it can serve passengers. Now we need them to deliver.”
Concerned about flight cancellation trends, Secretary Buttigieg said he has spoken directly with airlines.
He said, “Something I’ve asked them to do so that if you’re selling a ticket, you know you can back that up, that you have the staffing to do it.”
Rebecca Spicer, Senior Vice President with Airlines For America, a group that represents some of the largest U.S. airlines, said, “we do know that there are some challenges and airlines are working day-in and day-out to get things right. That’s why they are proactively making changes to their own schedules. They are taking flights off the schedule to create a little bit more wiggle room in the schedule and a little bit more flexibility.”
Spicer also said she can’t predict how many more flights could be canceled during the holiday weekend. She did say, however, that the industry is aggressively hiring new people.
Spicer said, “once we get people on board, it takes time to train them and make sure that they are fully on board it and ready to go. So hiring in the airline industry isn’t like just flipping a switch. It does take time.”
A tip Spicer shared if you are taking to the skies -- download your airlines’s app as soon as you buy a ticket. She said that is the most effective and efficient way for an airline to notify you about changes.
Copyright 2022 Gray DC. All rights reserved. | https://www.mysuncoast.com/2022/07/01/now-we-need-them-deliver-says-sec-buttigieg-flight-cancellations-increase/ | 2022-07-01T14:51:18Z |
Bob LuPone, who helped lead MCC Theater, has died at 76
NEW YORK (AP) — Bob LuPone, who as an actor earned a Tony Award nomination in the original run of “A Chorus Line” and played Tony Soprano’s family physician, and also helped found and lead the influential off-Broadway theater company MCC Theater for almost 40 years, has died. He was 76.
LuPone, brother of Broadway icon Patti LuPone, died Saturday following a three-year battle with pancreatic cancer, according to Matt Ross Public Relations.
“The MCC Theater community mourns the loss of our much loved and uniquely inspiring partner, colleague and dear friend, Bob LuPone, who lived fearlessly and with great curiosity, good humor, a boundless passion for connection, and a whole lot of heart. We will miss him deeply and always,” the theater company said in a statement.
LuPone’s first professional job was in 1966, in the ensemble of the Westbury Music Fair’s production of “The Pajama Game” starring Liza Minnelli. He made his Broadway debut in the 1968 production of Noel Coward’s “Sweet Potato” and later appeared in “Minnie’s Boys,” “The Rothschilds” and “The Magic Show.”
LuPone was initially cast as Al in “A Chorus Line,” but convinced creator and director Michael Bennett to let him play Zach after the original actor left. LuPone would earn a best featured actor Tony nomination for the role.
Born in 1946 in Brooklyn, New York, LuPone graduated from The Juilliard School with a bachelor’s degree in dance in 1968.
He was teaching an acting class at New York University when one of his students was Bernie Telsey. Together they would help form Manhattan Class Company in 1986 — known today as MCC Theater.
LuPone, Telsey along with third co-artistic director Will Cantler shaped MCC into a theatrical powerhouse, producing such Broadway-bound works as “Frozen,” “Reasons to be Pretty,” “Hand to God,” “School Girls; or the African Mean Girls Play,” “The Snow Geese,” “The Other Place” and the Pulitzer Prize- winning “Wit.”
While serving as co-artistic director of MCC, LuPone also worked as an actor, appearing in “A View from the Bridge,” “True West” and “A Thousand Clowns,” all on Broadway. He was in the Chicago premiere of Sam Shepard’s “The Tooth of Crime and on TV was in “The Sopranos” “Sex and the City,” Guiding Light,” and “All My Children,” for which he received a Daytime Emmy nomination.
He played Dr. Bruce Cusamano on “The Sopranos,” teasingly nicknamed “Cooze” by neighbor mobster Tony Soprano. In one memorable episode, Tony plays a joke by bringing Cooze a sealed box and asking him to hold on to it for a while, not telling his nervous neighbor that the package is filled with sand.
He also served as director of the master’s drama program at the New School for Drama from 2005 through 2011 and served as president of the board of directors of A.R.T/ New York.
LuPone is survived by his wife, Virginia; his son, Orlando; sister, Patti; and brother, William.
___
Mark Kennedy is at http://twitter.com/KennedyTwits
Copyright 2022 The Associated Press. All rights reserved. | https://www.wibw.com/2022/08/28/bob-lupone-who-helped-lead-mcc-theater-has-died-76/ | 2022-08-28T00:33:48Z |
NEW YORK, June 29, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRO, SNDL, SOFI, INTC, and AXSM.
To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link.
- MRO: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=MRO&prnumber=062920225
- SNDL: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=SNDL&prnumber=062920225
- SOFI: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=SOFI&prnumber=062920225
- INTC: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=INTC&prnumber=062920225
- AXSM: https://www.investorsobserver.com/lp/pr-stocks-lp-2/?symbol=AXSM&prnumber=062920225
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology. Each stock is evaluated based on short-term technical, long-term technical and fundamental factors. Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:
SOURCE InvestorsObserver | https://www.mysuncoast.com/prnewswire/2022/06/29/thinking-about-buying-stock-marathon-oil-sundial-growers-sofi-technologies-intel-corp-or-axsome-therapeutics/ | 2022-06-29T15:47:29Z |
Police have arrested a second suspect in connection to a mass shooting in downtown Sacramento, California, this weekend that left six people dead and a chaotic crime scene littered with more than 100 shell casings.
Smiley Martin, 27, who was taken into police custody Tuesday, was found at the scene of the shooting early Sunday with "serious injuries from gunfire" and taken to a local hospital, the Sacramento Police Department said in a news release. Police "quickly identified" him as a "person of interest" and kept him under police supervision at the hospital, the release said.
According to police, Smiley Martin is the brother of Dandrae Martin, another suspect arrested Monday in connection to the shooting, which also left 12 people wounded and was one of more than 120 mass shootings in the United States this year and one of at least 10 shooting incidents over the weekend.
Once Smiley Martin's medical care is complete, he will be booked at the Sacramento County Main Jail on charges of possession of a firearm by a prohibited person and possession of a machine gun, police said.
Dandrae Martin, 26, who was identified as a "related suspect," is scheduled to appear in court Tuesday after being booked on assault and illegal firearm possession charges, according to police. He was being held without bail, online jail records show. CNN has not been able to reach an attorney for him.
Sacramento County District Attorney Anne Marie Schubert noted in a statement posted online Monday that Dandrae Martin has not been charged with a homicide, adding she believed authorities would take more people into custody.
"The investigation is highly complex involving many witnesses, videos of numerous types and significant physical evidence," Schubert said. "This is an ongoing investigation and we anticipate more arrests in this case."
Multiple shooters were involved, police chief says
During an emotional vigil Monday night, members of the Sacramento community and officials expressed frustration with repeated instances of gun violence in the city and called for action to prevent more shootings.
"The last time we had a mass shooting we did the same thing," said one speaker who did not share his name but identified himself as a cousin of one of the victims. "Sat out here, held up our candles, talk about the police are here for us now, the public officials are here for us now."
"How are they here for us when we are sitting doing the same damn thing again? The same thing," he said. "So who's going to stop it?"
The shooting happened just after 2 a.m. in a bustling part of downtown, just a few blocks from the California State Capitol, Sacramento City Hall and the Golden 1 Center, where the city's NBA team plays home games.
A video posted on social media appears to show an altercation before the shooting, police said in a statement. "We are currently working to determine what, if any, relation these events have to the shooting," the statement said.
During the initial investigation, detectives found more than 100 shell casings and discovered at least three buildings and three cars that had been hit by bullets.
"There were a lot of shots fired that night, and hence the complexity of the investigation," police Chief Katherine Lester told CNN affiliate KCRA.
Lester has said there were multiple shooters and that a large fight preceded the gunfire. A stolen handgun was among the hundreds of pieces of evidence found at the scene, she said Sunday.
Police served search warrants at three homes and at least one handgun was recovered, Sacramento police said in a news release. Authorities said they have received more than 100 video or photo files on a tip portal.
Victims as young as 21
The Sacramento County Coroner's Office on Monday identified the six victims who died:
-- Johntaya Alexander, 21
-- Melinda Davis, 57
-- Sergio Harris, 38
-- Joshua Hoye-Lucchesi, 32
-- Yamile Martinez-Andrade, 21
-- Devazia Turner, 29
The tragedy has devastated the victims' families, confounded the community and angered those who are frustrated by yet another mass shooting.
"My son was a very vivacious young man," Harris' mother Pamela Harris told CNN affiliate KOVR. She said her son smiled all the time and never bothered anyone.
"And for this to happen, it's crazy," she said. "And I'm just to the point right now (where) I don't know what to do. I don't even think this is real."
Sacramento's second mass shooting in recent weeks
The incident was the second mass shooting in Sacramento in the past five weeks. On February 28, a man fatally shot three of his children and another man at a church. The gunman took his own life, authorities said.
Mayor Darrell Steinberg said solutions -- not well wishes -- are needed to help change the trajectory of gun violence in America.
"Thoughts and prayers are not enough," he said. "It is beyond time to have a sane conversation (about) guns in America. We have a sickness -- it's a sickness in our country, it's a sickness in our culture."
Sacramento will keep investing in programs focused on early intervention and violence prevention for young people, he said.
"In our city, we will take stock and we will do everything we can -- on the investment side, on the public safety side, on the gun side -- to protect the public," Steinberg said.
Gov. Gavin Newsom issued a statement saying the "scourge of gun violence continues to be a crisis in our country, and we must resolve to bring an end to this carnage."
And President Joe Biden described Sacramento as "another community devastated by gun violence," calling on Congress to act on gun control measures.
"In a single act in Sacramento, six individuals left dead and at least a dozen more injured," Biden said in a statement. "Families forever changed. Survivors left to heal wounds both visible and invisible."
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/news/police-arrest-second-suspect-in-sacramento-mass-shooting-that-left-6-dead/article_aa3a35be-24c5-5002-a828-42277ba53b6f.html | 2022-04-05T15:28:54Z |
The Bitcoin-multiplying fund for crypto-bullish investors is now open for trading
LAS VEGAS , May 18, 2022 /PRNewswire/ -- ICOA Inc. (OTC PINK: ICOA), a publicly-traded Nevada-based company that acquires exciting blockchain-driven ventures, has announced that The ICOA Fund is now live and available for subscription.
As a Bitcoin-denominated sub-fund of a VCC structure regulated under the Monetary Authority of Singapore (MAS), The ICOA Fund's principal strategy is to identify opportunities on the volatility surface, to exploit arbitrage opportunities in key derivatives markets, and to incorporate AI and quantitative methodologies to scale in on promising options.
It offers unparalleled safety features like insurance coverage and underwriting for public offering security insurance (POSI).
The fund's crypto assets are safeguarded through a hybrid infrastructure in custody with CGCX.io, the world's first fully-insured crypto exchange. The fund additionally utilizes a suite of security-focused tools and services provided by Copper.co. Underpinned by multi-award-winning custody, this partnership makes it possible for the fund to reliably and safely acquire, trade, and store cryptocurrencies.
All investors shall be accredited investors as defined by MAS, and shall undergo KYC/AML verification. Investment subscription contracts are also held in custody by regulated entities, and The ICOA Fund digital assets are held in storage secured by multi-signature verification.
The fund's philosophy is based on a maximum of 70% of investment going towards BTC yield generating strategies, and a maximum of 30% into Market Making and liquidity pools of carefully selected projects. The three core trading strategies employed are Covered Call, Negative Gamma, and Volatility Trading. More information on these can be found at https://icoa.fund/trading-strategy/.
ICOA CEO Hadria Wong comments on the launch, "The ICOA team is excited to release The ICOA Fund to the crypto community. By combining our networks, strengths, and visions, we know we are stronger than ever— and look forward to pouring that fortitude back into this exciting project."
Notes to editors:
For further information, please contact pr@icoa.tech
About ICOA
ICOA is a publicly-traded Nevada-based company operating in the fintech, blockchain, decentralized finance (DeFi), and cryptocurrency spaces through acquisitions.
SAFE HARBOR STATEMENT:
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Logo - https://mma.prnewswire.com/media/1821142/ICOA_Logo.jpg
View original content to download multimedia:
SOURCE ICOA Inc. | https://www.wibw.com/prnewswire/2022/05/18/icoa-fund-is-officially-live/ | 2022-05-18T20:18:14Z |
NEW YORK, Aug. 3, 2022 /PRNewswire/ -- J.C. Flowers & Co. LLC ("J.C. Flowers" or "the Firm"), a leading private investment firm dedicated to investing globally in the financial services industry, announced today it has completed fundraising for its fifth private equity fund, J.C. Flowers V L.P. (together with parallel vehicles, "JCF V"), with more than $1.1 billion in commitments.
Limited partners in JCF V represent a diverse group of corporate pension funds, sovereign wealth funds, insurance companies, foundations and endowments, and family offices. JCF V received strong support from existing longtime investors as well as highly respected new investors, with institutional investors located across Asia, Europe, Middle East, and North and South America.
"We are grateful for the support from both our existing and new limited partners which allowed us to surpass our target, especially given the backdrop of uncertainty over the last two years," said Chris Flowers, CEO of J.C. Flowers. "Our firm has built a deep bench of talented executives with significant financial services expertise, which has made us uniquely qualified to identify interesting investments through changing market conditions. We look forward to continuing to source, evaluate and invest in financial services opportunities worldwide where we can add significant value."
J.C. Flowers targets investments across all sub-sectors of the financial services industry, including banks, insurance and reinsurance, specialty and consumer finance, asset management and financial technology and securities firms. The firm has deep experience navigating the complexities of the global regulatory landscape, and has been approved for various investments in financial services companies in 18 jurisdictions. Teams in New York and London drive value in the firm's portfolio companies through operational transformation and balance sheet optimization.
To date, approximately 40% of JCF V has been invested, including announced platform investments in Ariel Re, Inigo Insurance, iLendingDirect, Insigneo Financial Group, LMAX Group, Tricor Insurance and Solomon Wealth.
Simpson Thacher & Bartlett LLP served as legal adviser for the Fund.
J.C. Flowers is a leading private investment firm dedicated to investing globally in the financial services industry. Founded in 1998, the firm has approximately $5 billion of assets under management. J.C. Flowers has offices in New York and London with an approximately 20-person investment staff who have a combined 300+ years of experience. Over its history, J.C. Flowers has invested more than $17 billion of capital in 62 portfolio companies in 18 countries across a range of industry subsectors including banking, insurance and reinsurance, securities firms, specialty finance, and services and asset management. For more information, please visit www.jcfco.com.
Media Contact:
Jennifer Hurson
Lambert
845-507-0571
jhurson@lambert.com
View original content to download multimedia:
SOURCE J.C. Flowers & Co. LLC | https://www.kxii.com/prnewswire/2022/08/03/jc-flowers-closes-fifth-private-equity-fund-with-more-than-11-billion-commitments/ | 2022-08-03T12:12:42Z |
Biden to plug manufacturing initiative at Ohio metal company
By AAMER MADHANI
Associated Press
WASHINGTON (AP) — President Joe Biden is set to announce that five major U.S. manufacturers have made commitments to boost their reliance on small and medium American firms for 3D printing. The White House says GE Aviation, Honeywell, Lockheed Martin, Raytheon and Siemens Energy have agreed to take part in the program. Biden will highlight the agreement during a visit to United Performance Metals in Hamilton, Ohio, on Friday. The program is being unveiled as Biden heads to the industrial Midwest to press Congress to approve a stalled competition and innovation bill that the Democratic president says is critical to bolstering domestic manufacturing and helping solve a semiconductor shortage. | https://localnews8.com/news/ap-national-business/2022/05/06/biden-to-plug-manufacturing-initiative-at-ohio-metal-company/ | 2022-05-06T11:48:32Z |
NEW YORK, May 20, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Lilium N.V. f/k/a Qell Acquisition Corp. (NASDAQ: LILM).
To receive updates on the lawsuit, fill out the form:
https://claimyourloss.com/securities/lilium-n-v-f-k-a-qell-acquisition-corp-loss-submission-form/?id=27461&from=4
The lawsuit seeks to recover losses for shareholders who purchased Lilium N.V. f/k/a Qell Acquisition Corp. between March 30, 2021 and March 14, 2022.
Shareholders interested in acting as a lead plaintiff representing the class of wronged shareholders have until June 17, 2022 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
According to a filed complaint, Lilium N.V. f/k/a Qell Acquisition Corp. issued materially false and/or misleading statements and/or failed to disclose that: (1) Lilium materially overstates the design and capabilities of the Lilium Jet, an electric vertical take-off-and-landing aircraft for use in a new type of high-speed air transport system for people and goods; (2) Lilium materially overstates the likelihood for the Lilium Jet's timely certification; (3) Lilium misrepresents its ability to obtain or create the necessary batteries for the Lilium Jet; (4) the special purpose acquisition company merger would not and did not generate enough cash to commercially launch the Lilium Jet; (5) Qell Acquisition Corp. did not engage in proper due diligence regarding its merger with Lilium GmbH; and (6) as a result, Defendants' public statements and statements to journalists were materially false and/or misleading at all relevant times.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original content:
SOURCE Jakubowitz Law | https://www.kxii.com/prnewswire/2022/05/20/lilm-shareholder-alert-jakubowitz-law-reminds-lilium-nv-fka-qell-acquisition-corp-shareholders-lead-plaintiff-deadline-june-17-2022/ | 2022-05-20T11:29:14Z |
DALLAS, June 30, 2022 /PRNewswire/ -- As previously announced, Vertical Capital Income Fund (NYSE: VCIF) paid a monthly distribution of $0.0721 per share to all shareholders of record as of June 17, 2022, pursuant to the Fund's managed distribution plan (the "Plan").
As a general matter, the amount of the Fund's distributable income depends on the aggregate gains and losses realized by the Fund during the entire year. Distributions may consist of net investment income, capital gains and return of capital but the character of these distributions cannot be determined until after the end of the Fund's fiscal year. However, under the Investment Company Act of 1940, as amended, and the terms of the Plan, the Fund may be required to indicate the source of each distribution to its shareholders. The following table sets forth the estimated sources of the current distribution, and the cumulative distributions paid during the 2022 fiscal year to date from the sources indicated in the table. All amounts are expressed on a per share basis and as a percentage of the distribution amount.
(1) You should not draw any conclusions about the Fund's investment performance from the amount of this distribution or from the terms of the Fund's Distribution Policy.
(2) The amounts and sources of distributions reported in this 19(a) Notice are only estimates and are not being provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during the remainder of its fiscal year and may be subject to changes based on tax regulations. The Fund will send you a Form 1099-DIV for the calendar year that will tell you how to report these distributions for federal income tax purposes.
(3) The Fund estimates that it has distributed more than its income and net realized capital gains; therefore, a portion of your distribution may be a return of capital. A return of capital may occur, for example, when some or all of the money that you invested in the Fund is paid back to you. A return of capital distribution does not necessarily reflect the Fund's investment performance and should not be confused with "yield" or "income."
The Plan will be subject to periodic review by the Board, and the Board may amend the terms of the Plan including amending the annual rate of payment or may terminate the Plan at any time without prior notice to the Fund's shareholders. The Fund's distribution rate may be affected by numerous factors, including changes in realized and projected market returns, Fund performance, and other factors. There can be no assurance that an unanticipated change in market conditions or other unforeseen factors will not result in a change in the Fund's distribution rate at a future time. The amendment or termination of the Plan could have an adverse effect on the market price of the Fund's shares. The public health crises caused by the COVID-19 outbreak may exacerbate other pre-existing political, social and economic risks to which the Fund is exposed. The duration of the COVID-19 outbreak and its effects cannot be determined with certainty. In order to comply with the requirements of Section 19 of the Investment Company Act of 1940, and an exemptive order received by the Fund from the Securities and Exchange Commission, the Fund will provide its shareholders of record on each distribution date with a 19(a) Notice and issue an accompanying press release disclosing the sources of its distribution payment when a distribution includes anything other than net investment income.
The amounts and sources of distributions reported in 19(a) Notices are only estimates and are not provided for tax reporting purposes. The actual amounts and sources of the amounts for tax reporting purposes will depend upon the Fund's investment experience during its full fiscal year and may be subject to changes based on tax regulations. The Fund will send shareholders a Form 1099-DIV for the calendar year that will tell them how to report these distributions for federal income tax purposes. Information on the Fund's 19(a) Notices, if any, can be found at www.vcif.us. The final determination of the source and tax characteristics of all distributions in 2022 will be made after the end of the year.
Shares of closed-end funds often trade at a discount from their net asset value. The market price of Fund shares may vary from net asset value based on factors affecting the supply and demand for shares, such as Fund distribution rates relative to similar investments, investors' expectations for future distribution changes, the clarity of the Fund's investment strategy and future return expectations, and investors' confidence in the underlying markets in which the Fund invests. Fund shares are subject to investment risk, including possible loss of principal invested. No Fund is a complete investment program and you may lose money investing in a Fund. An investment in the Fund may not be appropriate for all investors. Before investing, prospective investors should consider carefully the Fund's investment objective, risks, charges and expenses. For further details, please visit Vertical Capital Income Fund's website at vcif.us.
This release contains forward-looking statements relating to the business and financial outlook of Vertical Capital Income Fund that are based on the Fund's current expectations, estimates, forecasts and projections and are not guarantees of future performance. There is no assurance that the Fund will achieve its investment objective. Actual results may differ materially from those expressed in these forward-looking statements, and you should not place undue reliance on any such statements. A number of important factors could cause actual results to differ materially from the forward-looking statements contained in this release.
About Vertical Capital Income Fund
Vertical Capital Income Fund (VCIF) is an NYSE-listed closed-end fund that seeks monthly income by investing primarily in performing non-agency residential whole loans secured by real estate. As a secondary strategy the Fund aims to provide total return by acquiring performing residential loans at a discount to the unpaid principal balance (UPB). VCIF realizes capital gains as loans are paid off before maturity. For more information visit VCIF.us and connect with the Fund on Twitter.
About Oakline Advisors, LLC
Oakline Advisors, LLC is the adviser to Vertical Capital Income Fund. Founded in 2013, Oakline Advisors, LLC is an SEC-registered investment adviser that specializes in the residential whole loan market. It is a wholly owned subsidiary of Dallas, TX-based Behringer. Since its inception in 1989, Behringer, together with its affiliates, has raised equity of more than $6 billion in assets through public and private fund structures. For more information about Oakline and Behringer please visit their respective websites at oaklineadvisors.com and behringerinvestments.com.
Fund shares are identified by CUSIP 92535C104
View original content to download multimedia:
SOURCE Vertical Capital Income Fund | https://www.wibw.com/prnewswire/2022/06/30/vertical-capital-income-fund-vcif-announces-estimated-sources-june-2022-distribution/ | 2022-06-30T23:10:52Z |
-- Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA
-- Ascletis has filed multiple patent applications for ASC10 and its use globally. Compared with molnupiravir, ASC10 has a new and differentiated chemical structure
-- ASC10 is an oral double prodrug. After administration, both ASC10 and molnupiravir are rapidly and completely converted in vivo into the same active metabolite ASC10-A. Ascletis is actively communicating with regulatory authorities to explore the possibility of further accelerating the clinical development of ASC10
HANGZHOU, China and SHAOXING, China, Aug. 21, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application of ASC10, an oral inhibitor drug candidate targeting RNA-dependent RNA polymerase (RdRp) for COVID-19. Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. Food and Drug Administration (FDA).
ASC10 is an oral double prodrug which has a new and differentiated chemical structure from the single prodrug molnupiravir. After oral administration, both ASC10 and molnupiravir are rapidly and completely converted in vivo into the same active metabolite ASC10-A, also known as β-D-N4-hydroxycytidine (NHC). ASC10 was discovered and developed in-house. Ascletis has filed multiple patent applications for ASC10 and its use globally. ASC10 oral tablet formulation for the clinical study was developed with in-house proprietary technology of Ascletis.
By applying a double prodrug strategy, ASC10's permeability in Caco-2 cells (human colorectal adenocarcinoma cells) and active metabolite exposure in monkeys reached 3.2-fold and 2.1-fold of molnupiravir's, respectively. In the SARS-CoV-2 infected mouse models, ASC10 at 240 mg/kg twice daily led to a 4.0 log reduction in viral titer in lungs, equivalent to molnupiravir at 500 mg/kg twice daily[1]. Preclinical studies demonstrated that ASC10-A has potent cellular antiviral activity against Omicron variant (EC50 = 0.3 µM), Delta variant (EC50 = 0.5 µM) and wildtype virus (EC50 = 0.7 µM). It also suggested that there were no drug-drug interactions between ASC10 and other common medicines.
Ascletis is actively communicating with regulatory authorities to explore the possibility of further accelerating the clinical development of ASC10.
"The IND approvals of ASC10 from both China NMPA and U.S. FDA mark a great recognition to our in-house R&D capabilities. As the COVID-19 pandemic continues to cause huge social and economic implications globally, we will continue to advance the clinical development of our proprietary COVID-19 pipeline including ASC10 (RdRp inhibitor) and ASC11 (3CLpro inhibitor) to fight against the pandemic." said Dr. Jinzi J. Wu, Founder, Chairman and CEO of Ascletis.
[1] Wahl, et al., Nature. 2021 March ; 591(7850): 451 -457.
About Ascletis
Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange (1672.HK), covering the entire value chain from discovery and development to manufacturing and commercialization. Led by a management team with deep expertise and a proven track record, Ascletis focuses on three therapeutic areas with unmet medical needs from a global perspective: viral diseases, non-alcoholic steatohepatitis (NASH) and oncology. Through excellent execution, Ascletis rapidly advances its drug pipeline with an aim of leading in global competition. To date, Ascletis has three marketed products, i.e. ritonavir tablets, GANOVO® and ASCLEVIR®, and 20 drug candidates in its R&D pipeline. The most advanced drug candidates include ASC22 (CHB functional cure), ASC10 and ASC11(oral small molecules for COVID-19 treatment), ASC40 (recurrent glioblastoma), ASC42 (PBC, primary biliary cholangitis), and ASC40 (acne).
For more information, please visit www.ascletis.com.
View original content:
SOURCE Ascletis Pharma Inc. | https://www.mysuncoast.com/prnewswire/2022/08/22/ascletis-announces-ind-approval-oral-rdrp-inhibitor-asc10-covid-19-by-china-nmpa/ | 2022-08-22T00:31:12Z |
NANJING, China, May 6, 2022 /PRNewswire/ -- Tuniu Corporation (Nasdaq: TOUR) ("Tuniu" or the "Company"), a leading online leisure travel company in China, today provides an update on its status under the Holding Foreign Companies Accountable Act (the "HFCAA").
The Company is aware that it has been provisionally identified by the United States Securities and Exchange Commission (the "SEC") under the HFCAA as a Commission-Identified Issuer on May 4, 2022 U.S. Eastern Time. The Company understands that such identification may have resulted from its filing of the annual report on Form 20-F for the fiscal year ended December 31, 2021 with the SEC on April 29, 2022.
Tuniu understands the SEC made such identification pursuant to the HFCAA and its implementation rules issued thereunder, and this indicates that the SEC determines that the Company used a registered public accounting firm whose working paper cannot be inspected or investigated completely by the Public Company Accounting Oversight Board of the United States (the "PCAOB") to issue the audit opinion for its financial statements for the fiscal year ended December 31, 2021.
In accordance with the HFCAA, if the SEC determines that the Company filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit the shares or American depositary shares of the Company from being traded on a national securities exchange or in the over-the-counter trading market in the United States.
Tuniu has been actively exploring possible solutions. Tuniu will continue to comply with applicable laws and regulations in both China and the United States, and strive to maintain its listing status on Nasdaq to the extent it can.
About Tuniu
Tuniu (Nasdaq: TOUR) is a leading online leisure travel company in China that offers a large selection of packaged tours, including organized and self-guided tours, as well as travel-related services for leisure travelers through its website tuniu.com and mobile platform. Tuniu covers over 420 departing cities throughout China and all popular destinations worldwide. Tuniu provides one-stop leisure travel solutions and a compelling customer experience through its online platform and offline service network, including a dedicated team of professional customer service representatives, 24/7 call centers, extensive networks of offline retail stores and self-operated local tour operators. For more information, please visit http://ir.tuniu.com.
Safe Harbor Statement
This press release contains forward-looking statements made under the "safe harbor" provisions of Section 21E of the Securities Exchange Act of 1934, as amended, and the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates," "confident" and similar statements. Tuniu may also make written or oral forward-looking statements in its reports filed with or furnished to the U.S. Securities and Exchange Commission, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Any statements that are not historical facts, including statements about Tuniu's beliefs and expectations, are forward-looking statements that involve factors, risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Such factors and risks include, but are not limited to the following: Tuniu's goals and strategies; the growth of the online leisure travel market in China; the demand for Tuniu's products and services; its relationships with customers and travel suppliers; the Company's ability to offer competitive travel products and services; Tuniu's future business development, results of operations and financial condition; competition in the online travel industry in China; relevant government policies and regulations relating to the Company's structure, business and industry; the impact of the COVID-19 on Tuniu's business operations, the travel industry and the economy of China and elsewhere generally; and the general economic and business condition in China and elsewhere. Further information regarding these and other risks, uncertainties or factors is included in the Company's filings with the U.S. Securities and Exchange Commission. All information provided in this press release is current as of the date of the press release, and Tuniu does not undertake any obligation to update such information, except as required under applicable law.
View original content:
SOURCE Tuniu Corporation | https://www.wibw.com/prnewswire/2022/05/06/tuniu-provides-update-status-under-holding-foreign-companies-accountable-act/ | 2022-05-06T06:54:51Z |
Nevada's largest media company to stream 7 minutes of local news devoted to Hispanic residents of Las Vegas
LAS VEGAS, May 4, 2022 /PRNewswire/ -- The Las Vegas Review-Journal, Nevada's largest media company and No. 1 source for news, will debut "7@7 en español", a multiplatform video news program that's produced specifically for the Spanish-speaking audience in Southern Nevada.
"7@7 en español" will have similar graphics and production values to its sister program, the award-winning "7@7" newscast, launched nearly 18 months ago. Its content will be dedicated to the needs of Hispanic residents and provide the day's top stories, business and jobs news, health alerts, weather, sports, plus special events.
"7@7 en español" will be anchored on weekdays by Rosana Romero, a three-time Emmy-winning journalist who brings in-depth knowledge, covering the Southern Nevada Hispanic community for more than 15 years.
The streaming newscast will also feature content from "Las Vegas Review-Journal en español", the RJ's newly rebranded long-running print publication since 2004, formerly known as "El Tiempo". The Review-Journal has hired a dedicated team of Spanish-language journalists and production support to ensure "7@7 en español" is a success.
"We're strengthening our legacy español print product and expanding the RJ's digital footprint in the Hispanic community. This continued innovation collectively enables the Las Vegas Review-Journal and 'Review-Journal en español' to report culturally unique news," Review-Journal Publisher and Editor Keith Moyer said. "Our readers are as diverse as our team. The stories we cover and '7@7 en español' will reflect that."
"7@7 en español" will be produced from the Review-Journal's digital studios using the latest technology. Reporters will deliver content throughout the day from the scene or wherever they are via smartphone.
"Our goal is to move at the speed of the audience," Review-Journal Executive Director of Programming Jim Prather said. "Many times, users are watching multiple screens at work and home. We give them options on how and where to watch our newscasts, including their smartphone and the big screen. The audience wants a fast-paced format from a news team they can trust."
The Review-Journal and reviewjournal.com boast the largest news staff in the state, with more than 120 journalists in Las Vegas and bureaus in Carson City and Washington, D.C.
"7@7 en español" and related digital sites will extend the work of the Review-Journal's reporters and visual journalists, providing context on breaking news, enterprise stories and exclusive investigations in a fast-paced presentation to the Hispanic community.
The fast-paced "7@7 en español" format will be available on-demand, so viewers can watch or listen when their schedules allow. Viewing and audio platforms include mobile streaming, RJespanol.com, YouTube, Amazon Fire TV, Roku, Apple TV+, and Twitter.
About the Review-Journal
The Las Vegas Review-Journal has been Nevada's news leader since 1909. A state, regional, and national award-winning multiplatform news organization, the Review-Journal operates reviewjournal.com, a network of niche publications and community newspapers, e-newsletters, custom printing, a video production studio, and more to meet the specific needs of readers and advertisers alike.
Media Contact:
Wanda Blair
Vice President, Marketing/702.383.0223
wblair@reviewjournal.com
View original content to download multimedia:
SOURCE Las Vegas Review-Journal | https://www.wibw.com/prnewswire/2022/05/04/las-vegas-review-journal-continues-digital-innovation-with-77-en-espaol/ | 2022-05-04T19:59:57Z |
NEW YORK, May 24, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Mullen Automotive, Inc. f/k/a Net Element, Inc. (NASDAQ: MULN) alleging that the Company violated federal securities laws.
Class Period: June 15, 2020 to April 6, 2022
Lead Plaintiff Deadline: July 5, 2022
No obligation or cost to you.
Learn more about your recoverable losses in MULN:
https://www.kleinstocklaw.com/pslra-1/mullen-automotive-inc-f-k-a-net-element-inc-loss-submission-form?id=27570&from=4
Mullen Automotive, Inc. f/k/a Net Element, Inc. NEWS - MULN NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Mullen Automotive, Inc. f/k/a Net Element, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Mullen overstates its ability and timeline regarding production; (2) Mullen overstates its deals with business partners, including Qiantu; (3) Mullen overstates its battery technology and capabilities; (4) Mullen overstates its ability to sell its branded products; (5) Net Element did not conduct proper due diligence into Mullen Technologies; (6) the Dragonfly K50, a luxury sports car, was not (solely) delayed due to the COVID-19 pandemic; and (7) as a result, Defendants' public statements were materially false and/or misleading at all relevant times.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Mullen Automotive, Inc. f/k/a Net Element, Inc. you have until July 5, 2022 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased Mullen Automotive, Inc. f/k/a Net Element, Inc. securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the MULN lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/mullen-automotive-inc-f-k-a-net-element-inc-loss-submission-form?id=27570&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
View original content:
SOURCE The Klein Law Firm | https://www.mysuncoast.com/prnewswire/2022/05/24/muln-alert-klein-law-firm-announces-lead-plaintiff-deadline-july-5-2022-class-action-filed-behalf-mullen-automotive-inc-fka-net-element-inc-shareholders/ | 2022-05-24T11:11:22Z |
NEW YORK, May 10, 2022 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Embark Technology, Inc. f/k/a Northern Genesis Acquisition Corp. II (NASDAQ: EMBK, EMBKW, NGAB, NGAB.U, NGAB.WS) between January 12, 2021 and January 5, 2022, inclusive (the "Class Period"), of the important May 31, 2022 lead plaintiff deadline.
SO WHAT: If you purchased Embark securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Embark class action, go to https://rosenlegal.com/submit-form/?case_id=4934 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 31, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Embark had performed inadequate due diligence into Embark Trucks Inc. ("Legacy Embark"); (2) Legacy Embark and the Company, following the November 2021 merger of Legacy Embark and Northern Genesis Acquisition Corp. II (the "Business Combination"), held no patents and an insignificant number of test trucks; (3) accordingly, Embark had overstated its operational and technological capabilities; (4) as a result of all the foregoing, Embark had overstated the business and financial prospects of the Company post-Business Combination; and (5) as a result, defendants' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Embark class action, go to https://rosenlegal.com/submit-form/?case_id=4934 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:
SOURCE Rosen Law Firm, P.A. | https://www.mysuncoast.com/prnewswire/2022/05/10/rosen-leading-law-firm-encourages-embark-technology-inc-fka-northern-genesis-acquisition-corp-ii-investors-secure-counsel-before-important-deadline-securities-class-action-embk-embkw-ngab-ngabu-ngabws/ | 2022-05-11T03:35:40Z |
Police: Fatal shooting at shopping plaza was targeted, community on edge
By Crystal Bui and Miles Montgomery
Click here for updates on this story
ATLANTA (WGCL) — After a shooting claimed the life of 27-year-old Wyman Boyd Jr. on Saturday night, a community is shaken. It was the third shooting in southwest Atlanta in less than two days.
Police responded to reports of a shooting at the 3700 block of Carmia Drive near Camp Creek Parkway around 8:30 p.m. Saturday night. Upon arrival, they found who was not alert, not conscious, or breathing. He was pronounced deceased by Atlanta Fire Rescue.
“Preliminary information shows this was not a random shooting and targeted in fact,” says Atlanta Police Lt. Germain Dearlove.
Now, police say that this isn’t the first time a shooting occurred in the same shopping plaza.
The Georgia Bureau of Investigations says back in 2018, police followed a driver inside a stolen Black Nissan to the parking lot outside the Publix; after a confrontation ensued, police say the driver identified as Devin Nolley, was later shot by officers after slamming into police cruisers trying to escape.
Some residents say they’ve been aware of shootings nearby and are concerned with a lack of security. For other shoppers running errands, the fatal shooting Saturday night comes as a surprise.
“I’m amazed honestly. I never knew somebody got shot here. I thought it was a safe place,” said Chase Johnson. “I will still come here at night, but I’ll just be more aware of my surroundings.”
Atlanta Police have said they don’t want the public to be worried and they’re searching for the suspect.
“We are working out leads and the footage recovered,” Lt. Dearlove said.
The shooting remains under investigation.
Please note: This content carries a strict local market embargo. If you share the same market as the contributor of this article, you may not use it on any platform. | https://localnews8.com/news/2022/05/30/police-fatal-shooting-at-shopping-plaza-was-targeted-community-on-edge/ | 2022-05-30T16:08:26Z |
WASHINGTON, June 30, 2022 /PRNewswire/ -- Mary T. Boyle was sworn in as a Commissioner for the Consumer Product Safety Commission today. Boyle was nominated by President Joseph R. Biden in July, 2021.
Boyle has served in leadership roles at the CPSC for more than a decade, including as General Counsel. Most recently she served as the agency's Executive Director. Throughout her tenure, she has spearheaded key initiatives to protect consumers from hazardous and unsafe products, including the agency's safety efforts on safe sleep and high-powered magnets. In addition, over the years, Boyle has been instrumental in advancing the agency's enforcement efforts.
Before joining the Commission staff, Boyle developed affordable housing programs for the city of Gaithersburg, Md., worked in private practice at a major international law firm, and served on Capitol Hill as a staff member for the late Congressman Stephen J. Solarz and for the Asia and Pacific Subcommittee of the House Foreign Affairs Committee.
"Mary's depth of knowledge, insight and commitment to public safety will serve her well in her new role and will be a tremendous asset to the Commission as we work to keep consumers safe from hazardous products," said CPSC Chair Alexander Hoehn-Saric. "I am grateful the Commission will continue to benefit from Mary's expertise and I look forward working with her, and with the rest of our colleagues, to improve consumer product safety for all Americans."
Boyle has spent more than a decade at CPSC in senior positions across the agency, most recently as Executive Director, and was a career member of the Senior Executive Service prior to her confirmation as Commissioner. Her work has covered a broad range of issues, including policy, administration, legal advice, budgets, product recalls, civil penalty negotiations, and development of rules and regulations.
As Executive Director, Boyle had responsibility for the programmatic, operational, and administrative functions of the agency. She developed the agency's budgets and operating plans, managed its regulatory portfolio, and supervised agency efforts to identify and reduce hazards to consumers. Her responsibilities also included compliance enforcement, import surveillance, and international programs and she worked both with the small business ombudsman and the consumer ombudsman to improve the agency's outreach to citizens.
Prior to being named Executive Director, Boyle served as the agency's General Counsel, the chief legal officer of the agency. Her work included legal analysis and review of proposed product safety standards, substantial product hazard determinations, and administrative litigation. In addition, in conjunction with the Department of Justice, she was responsible for all Federal court actions to which the Commission was a party.
Boyle received her B.A. in English from Georgetown University in 1985 and her law degree from the University of Virginia in 1991. She is a member of the District of Columbia and Maryland Bars.
Boyle was born and raised in Brooklyn, New York. She now lives with her husband in Bethesda, Maryland. They have three adult children.
About the U.S. CPSC
The U.S. Consumer Product Safety Commission (CPSC) is charged with protecting the public from unreasonable risk of injury or death associated with the use of thousands of types of consumer products. Deaths, injuries, and property damage from consumer product-related incidents cost the nation more than $1 trillion annually. CPSC's work to ensure the safety of consumer products has contributed to a decline in the rate of injuries associated with consumer products over the past 50 years.
Federal law prohibits any person from selling products subject to a Commission ordered recall or a voluntary recall undertaken in consultation with the CPSC.
For lifesaving information:
- Visit CPSC.gov.
- Sign up to receive our e-mail alerts.
- Follow us on Facebook, Instagram @USCPSC and Twitter @USCPSC.
- Report a dangerous product or a product-related injury on www.SaferProducts.gov.
- Call CPSC's Hotline at 800-638-2772 (TTY 301-595-7054).
- Contact a media specialist.
Release Number: 22-179
View original content to download multimedia:
SOURCE U.S. Consumer Product Safety Commission | https://www.kxii.com/prnewswire/2022/06/30/mary-t-boyle-sworn-cpsc-commissioner/ | 2022-06-30T20:16:05Z |
LONDON, June 9, 2022 /PRNewswire/ -- According to a new M&A report launched today by global law firm Eversheds Sutherland – Putting the pieces into place: The next drivers of strategic M&A – 70% of global business leaders view the "triarchy" of talent, technology, and trade as core to their future M&A business strategy.
- Talent: 72% of business leaders see talent retention and acquisition as important in their organizations' business strategy over the next year. Three in five (62%) also believe the "Great Resignation" is acting as a catalyst for M&A as the battle for talent continues.
- Technology continues to drive organizations' business strategies, with almost 80% of business leaders seeking to improve their cyber security and three-quarters seeking digital transformation. M&A is seen as a rapid way to absorb new technology and expertise, with 74% saying M&A was important in bridging technology gaps.
- Trade: Impacted by supply chain disruption and trade sanctions, 68% of business leaders say that increasing supply chain resilience will be a strategic M&A priority over the next year. 72% of business leaders also see increasing supply chain resilience as important to their organization's business strategy over the next year.
The global Eversheds Sutherland study is based on opinion research conducted in early 2022 amongst 1,200 business leaders and across 16 markets around the world. Respondants from a wide range of sectors provided both a detailed and expansive global view. In April 2022, a supplementary piece of research amongst 75 business leaders provided insight into how the ongoing invasion of Ukraine is impacting M&A activity.
Eric Knai, Partner and Head of International M&A at Eversheds Sutherland, says: "We are delighted to launch our report Putting the pieces into place: The next drivers of strategic M&A to the market. After a turbulent few years in the wider business landscape, and the conflict in Ukraine, the rapidly changing economy has prompted leaders to reflect on how to best position their organizations for the future. Our research revealed that the majority of business leaders see talent, technology and trade as the main factors impacting the M&A landscape."
Robert Copps, Partner and head of US M&A at Eversheds Sutherland, says: "A number of factors are impacting the M&A landscape, including the invasion of Ukraine, inflation and rising energy prices, rising interest rates, stock market turbulence and the ongoing effects of the global pandemic. Notwithstanding these challenges, the study shows that organizations continue to face the same urgent strategic gaps that need to be bridged in order to grow and that they will continue to seek to bridge those gaps through M&A."
About Eversheds Sutherland
As a global top 10 law practice, Eversheds Sutherland provides legal services to a global client base ranging from small and mid-sized businesses to the largest multinationals, acting for 61 of the FTSE 100, 70 of the Fortune 100 and 128 of the Fortune 200.
With more than 3,000 lawyers, Eversheds Sutherland operates in more than 70 offices in over 30 jurisdictions across Africa, Asia, Europe, the Middle East and the United States. In addition, a network of more than 200 related law firms, including formalized alliances in Latin America, Asia Pacific and Africa, provide support around the globe.
View original content:
SOURCE Eversheds Sutherland | https://www.mysuncoast.com/prnewswire/2022/06/09/talent-tech-trade-revealed-key-drivers-mergers-acquisitions-new-research-eversheds-sutherland-shows/ | 2022-06-09T09:33:29Z |
NEW YORK, Aug. 31, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Weber Inc..
Shareholders who purchased shares of WEBR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.
CLASS PERIOD: This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Weber Class A common stock pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company's August 2021 initial public offering.
ALLEGATIONS: The complaint alleges that during the class period, Defendants issued materially false and/or misleading statements and/or failed to disclose that: (1) Weber was reasonably likely to implement price increases; (2) as a result, consumer demand for Weber's products was reasonably likely to decrease; (3) due to the resulting inventory buildup, Weber was reasonably likely to run promotions to "enhance retail sell through"; (4) the foregoing would adversely impact Weber's financial results; and (5) as a result of the foregoing, defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
DEADLINE: September 27, 2022 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/weber-inc-loss-submission-form/?id=31254&from=4
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of WEBR during the timeframe listed above, you will be enrolled in a portfolio monitoring software to provide you with status updates throughout the lifecycle of the case. The deadline to seek to be a lead plaintiff is September 27, 2022. There is no cost or obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is nationally recognized class action law firm, and our mission is to protect the rights of all investors who have suffered as a result of deceit, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a company lead to artificial inflation of the company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
View original content:
SOURCE The Gross Law Firm | https://www.wibw.com/prnewswire/2022/08/31/shareholder-alert-gross-law-firm-notifies-shareholders-weber-inc-class-action-lawsuit-lead-plaintiff-deadline-september-27-2022-nyse-webr/ | 2022-08-31T10:20:11Z |
- 56th annual award presented to engineers Luca De Angelis, Luca Pierrettori, Taylor Prohaska and Simone Pusca
- Award sponsored by BorgWarner and presented by the Indiana Section of the Society of Automotive Engineers International
- Technology provides two-way over-the-air communication to each car, team, race control and track flag system
AUBURN HILLS, Mich., May 20, 2022 /PRNewswire/ -- Today, the 56th annual Louis Schwitzer Award was presented to EM Motorsport engineers Luca De Angelis, Luca Pierrettori and Simone Pusca, as well as NTT INDYCAR® SERIES engineer Taylor Prohaska for their creative thinking and engineering innovation in bringing the EM Marshalling System to life. This technology has been adopted by INDYCAR and is making a significant impact by providing new, two-way over-the-air communication to each car, team, race control and track flag system. The award, along with a $10,000 prize, was given to De Angelis, Pierrettori, Prohaska and Pusca today at Indianapolis Motor Speedway by BorgWarner and the Indiana Section of the Society of Automotive Engineers (SAE) International.
The Louis Schwitzer Award celebrates the engineers behind developing new, innovative concepts aimed toward increasing competitive potential. Presented to engineers by engineers, the award focuses on cutting-edge technology with applications related to the engine, powertrain, profile, chassis or safety that meet the NTT INDYCAR SERIES specifications. Ultimately, judges recognize inventions that advance performance, safety or efficiency in motorsports.
"At BorgWarner, it's important that we not only honor the racers competing to win the Borg-Warner Trophy®, but also those who have worked tirelessly to bring new, cutting-edge technology to the racetrack and recognize the crucial role engineers play in driving the innovative future of motorsports," said Frédéric Lissalde, President and CEO, BorgWarner Inc. "As a proud sponsor of the Louis Schwitzer Award, we congratulate these four talented engineers for their engineering achievements and contributions to the racing industry. As the official turbocharger partner of the NTT INDYCAR SERIES, BorgWarner has a vested interest in witnessing the evolution of this Series' technology and commend the hard work and engineering excellence that powers it."
The EM Marshalling System provides key information to increase the quantity and quality of data for safety, performance and future applications. For example, the system improves the visibility of cars on the track for race control. Additionally, the flag types have been animated to better illuminate track conditions to drivers.
Along with celebrating engineering excellence, this award commemorates the spirit of Louis Schwitzer, the winner of the first auto race at Indianapolis Motor Speedway in 1909 and designer of the "Marmon Yellow Jacket" engine that powered the Marmon Wasp to victory during the first Indianapolis 500 in 1911. Schwitzer went on to lead the Indianapolis Motor Speedway technical committee and founded the Schwitzer Corporation in 1918, which was acquired by BorgWarner in 1999 to expand the company's line of engine cooling systems, turbochargers and more.
BorgWarner's historical legacy with the Indianapolis 500 runs deep featuring the Borg-Warner Trophy as the main attraction. Each year since 1936, the winner of the big race has had the honor of having their face sculpted and forever engraved onto the iconic trophy, as well as receiving a miniature version of the award known as the "Baby Borg", as a personal keepsake. BorgWarner's heritage continues with its EFR™ (Engineered for Racing) turbochargers boosting the engines of every racecar participating in the Indianapolis 500. The turbochargers are built for reliability, featuring Gamma-Ti (titanium aluminide) turbine wheels, stainless steel turbine housings and ceramic ball bearings.
About BorgWarner
For more than 130 years, BorgWarner has been a transformative global product leader bringing successful mobility innovation to market. Today, we're accelerating the world's transition to eMobility — to help build a cleaner, healthier, safer future for all.
The Borg-Warner Trophy, BorgWarner Championship Driver's Trophy, and BorgWarner Championship Team Owner's Trophy are trademarks of BorgWarner Inc
Forward-Looking Statements: This press release may contain forward-looking statements as contemplated by the 1995 Private Securities Litigation Reform Act that are based on management's current outlook, expectations, estimates and projections. Words such as "anticipates," "believes," "continues," "could," "designed," "effect," "estimates," "evaluates," "expects," "forecasts," "goal," "guidance," "initiative," "intends," "may," "outlook," "plans," "potential," "predicts," "project," "pursue," "seek," "should," "target," "when," "will," "would," and variations of such words and similar expressions are intended to identify such forward-looking statements. Further, all statements, other than statements of historical fact contained or incorporated by reference in this press release that we expect or anticipate will or may occur in the future regarding our financial position, business strategy and measures to implement that strategy, including changes to operations, competitive strengths, goals, expansion and growth of our business and operations, plans, references to future success and other such matters, are forward-looking statements. Accounting estimates, such as those described under the heading "Critical Accounting Policies and Estimates" in Item 7 of our most recently-filed Annual Report on Form 10-K ("Form 10-K"), are inherently forward-looking. All forward-looking statements are based on assumptions and analyses made by us in light of our experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate under the circumstances. Forward-looking statements are not guarantees of performance, and the Company's actual results may differ materially from those expressed, projected or implied in or by the forward-looking statements.
You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Forward-looking statements are subject to risks and uncertainties, many of which are difficult to predict and generally beyond our control, that could cause actual results to differ materially from those expressed, projected or implied in or by the forward-looking statements. These risks and uncertainties, among others, include: supply disruptions impacting us or our customers, such as the current shortage of semiconductor chips that has impacted original equipment manufacturer ("OEM") customers and their suppliers, including us; commodities availability and pricing; competitive challenges from existing and new competitors including OEM customers; the challenges associated with rapidly-changing technologies, particularly as relates to electric vehicles, and our ability to innovate in response; uncertainties regarding the extent and duration of impacts of matters associated with the COVID-19 pandemic, including additional production disruptions; the difficulty in forecasting demand for electric vehicles and our electric vehicles revenue growth; potential disruptions in the global economy caused by Russia's invasion of Ukraine; the ability to identify targets and consummate acquisitions on acceptable terms; failure to realize the expected benefits of acquisitions on a timely basis including our recent acquisitions of AKASOL AG and Santroll's light vehicle eMotor business and our 2020 acquisition of Delphi Technologies PLC; the ability to identify appropriate combustion portfolio businesses for disposition and consummate planned dispositions on acceptable terms; the failure to promptly and effectively integrate acquired businesses; the potential for unknown or inestimable liabilities relating to the acquired businesses; our dependence on automotive and truck production, both of which are highly cyclical and subject to disruptions; our reliance on major OEM customers; fluctuations in interest rates and foreign currency exchange rates; our dependence on information systems; the uncertainty of the global economic environment; the outcome of existing or any future legal proceedings, including litigation with respect to various claims; future changes in laws and regulations, including, by way of example, taxes and tariffs, in the countries in which we operate; impacts from any potential future acquisition or disposition transactions; and the other risks noted in reports that we file with the Securities and Exchange Commission, including Item 1A, "Risk Factors" in our most recently-filed Form 10-K and/or Quarterly Report on Form 10-Q. We do not undertake any obligation to update or announce publicly any updates to or revisions to any of the forward-looking statements in this press release to reflect any change in our expectations or any change in events, conditions, circumstances, or assumptions underlying the statements.
View original content to download multimedia:
SOURCE BorgWarner | https://www.kxii.com/prnewswire/2022/05/20/2022-louis-schwitzer-award-celebrates-engineers-behind-ntt-indycar-series-em-marshalling-system-innovation/ | 2022-05-20T17:32:52Z |
NEW YORK, Aug. 4, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Teladoc Health, Inc. ("Teladoc" or the "Company") (NYSE: TDOC) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Teladoc investors who were adversely affected by alleged securities fraud between October 28, 2021 and April 27, 2022. Follow the link below to get more information and be contacted by a member of our team:
TDOC investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) increased competition, among other factors, was negatively impacting Teladoc's BetterHelp and chronic care businesses; (ii) accordingly, the growth of those businesses was less sustainable than Defendants had led investors to believe; (iii) as a result, Teladoc's revenue and adjusted EBITDA projections for FY 2022 were unrealistic; (iv) as a result of all the foregoing, Teladoc would be forced to recognize a significant non-cash goodwill impairment charge; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Teladoc during the relevant time frame, you have until August 5, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:
SOURCE Levi & Korsinsky, LLP | https://www.kxii.com/prnewswire/2022/08/04/tdoc-lawsuit-alert-levi-amp-korsinsky-notifies-teladoc-health-inc-investors-class-action-lawsuit-upcoming-deadline/ | 2022-08-04T11:08:52Z |
BOSTON (AP) — A group of Christian, Hindu, Buddhist and Jewish leaders is asking Starbucks to stop charging extra for vegan milk alternatives, saying the practice amounts to a tax on people who have embraced plant-based lifestyles.
In a statement issued Friday, an interfaith coalition led by Nevada-based Hindu activist Rajan Zed pressed the coffee chain to end the surcharges it called “unethical and unfair.”
“A coffee company should not be in the business of taxing individuals who had chosen the plant-based lifestyle,” said Zed’s statement, which was also signed by Thomas W. Blake, an Episcopal priest; Greek Orthodox clergyman Stephen R. Karcher; Buddhist priest Matthew Fisher; and Jewish rabbi ElizaBeth Webb Beyer.
The religious leaders cited numerous reasons why some Starbucks customers prefer alternatives to dairy, including dietary restrictions, ethical issues, environmental concerns, lactose intolerance, milk allergies and animal welfare.
Those who want plant-based milk should not have to pay more, they said, calling on the Seattle-based company’s CEO, Howard Schultz, and board chair Mellody Hobson to immediately drop the surcharge.
Starbucks outlets in the United States typically charge 50 cents to a dollar more for drinks made with plant-based milks.
Starbucks doesn’t charge for a splash of nondairy milk, including soy milk, coconut milk, almond milk and oat milk, though it does levy a surcharge for customized beverages made largely with those substitutes, spokesperson Megan Adams told The Associated Press.
It is not the first time Starbucks’ surcharge has riled the public. On Tuesday, activist and actor James Cromwell glued his hand to the counter of a Starbucks franchise in New York City to protest the practice.
Cromwell, 81, later used a knife to scrape it off. Police said there were no arrests. | https://cw33.com/business/ap-business/interfaith-group-asks-starbucks-to-drop-vegan-milk-surcharge/ | 2022-05-14T17:37:21Z |
26 organizations recognized in Nintex's annual customer awards program, which celebrates public and private sector organizations in every industry and geography for their digital transformation success with the Nintex Process Platform
BELLEVUE, Wash., June 22, 2022 /PRNewswire/ -- Nintex, the global standard for process intelligence and automation, today announced the 26 winners of the 2022 Nintex Solution Innovation Awards, including this year's 2022 Nintex Champion – Quaker Houghton.
"Our community of customers and partners are a constant reminder of the inspiring digital transformation success that organizations are achieving," said Nintex Chief Executive Officer Eric Johnson. "We congratulate the 2022 Solution Innovation Award winners and applaud them for their success in transforming the way people work with the Nintex Process Platform."
Receiving top honors as the 2022 Nintex Champion, Quaker Houghton is a global leader in industrial process fluids and operates in more than 25 countries with 4,200 employees. Since their precise and sophisticated manufacturing processes leave no room for error, the organization uses Nintex Forms and Nintex Workflow to automate the process of initiating lab requests and directing them appropriately.
- To learn more about Quaker Houghton's Nintex success visit: https://www.nintex.com/case-study/quaker-houghton/
2022 Nintex Solution Innovation Awards winners by award category are available online at https://www.nintex.com/using-nintex/customer-and-partner-awards/2022-nintex-solution-innovation-awards/ and include:
2022 Nintex Champion
- Quaker Houghton
Regional Transformation Leaders
- Americas: GM Financial
- Asia Pacific: Austral Construction
- Europe: Twinings
- Middle East & Africa: Ministry of Tourism of Saudi Arabia
Game Changing Solution-Specific Deployments
- Process Excellence with Nintex Promapp®: Thermo Fisher Scientific
- Operational Performance with Nintex DocGen®: Dubai South
- Breakthrough Use Cases with Nintex RPA: BGL Group
- Cloud-Based Success with Nintex Workflow Cloud: Newson Health
Industry Breakthroughs
- Americas: Capital Farm Credit, Johnson & Johnson, and Draeger
- Asia Pacific: IQumulate, Harrison Group and Yancoal Australia
- Europe: Fidelity International and DuPont De Nemours
- Middle East & Africa: Wema Bank and Al Naboodah Group
Public Sector Excellence
- Americas: Delaware Department of Transportation (Division of Motor Vehicles)
- Asia Pacific: AgriFutures
- Middle East & Africa: Saudi Arabia Ministry of Communications and Information Technology
Education & Non-Profit Success
- Education, Americas: Auburn University
- Education, Asia Pacific: Busy Bees Asia
- Education, EMEA: Khalifa University
- Non-Profit: National Association for the Advancement of Colored People (NAACP)
The Nintex Solution Innovation award winners were selected by a panel of judges based on nominations submitted directly by Nintex customers and partners.
To learn how more organizations are achieving digital transformation and improving the way people work with the Nintex Process Platform, visit https://www.nintex.com/why-nintex/case-studies/.
Media Contact
Laetitia Smith
Nintex
laetitia.smith@nintex.com
cell: +64 21 154 7114
About Nintex
Nintex is the global standard for process intelligence and automation. Today more than 10,000 public and private sector organizations across 90 countries turn to the Nintex Process Platform to accelerate progress on their digital transformation journeys by quickly and easily managing, automating and optimizing business processes. Learn more by visiting www.nintex.com and experience how Nintex and its global partner network are shaping the future of Intelligent Process Automation (IPA).
Product or service names mentioned herein may be the trademarks of their respective owners.
View original content to download multimedia:
SOURCE Nintex | https://www.mysuncoast.com/prnewswire/2022/06/22/process-intelligence-automation-success-honored-with-2022-nintex-solution-innovation-awards/ | 2022-06-22T15:31:40Z |
AUSTIN, Texas (AP) — Texas Gov. Greg Abbott on Thursday again said he was initially misled about the police response to the Uvalde school massacre, calling newly leaked video of officers hesitating for more than an hour “shocking” and not what he had been told when he originally lauded officers for a swift and brave confrontation.
“None of the information in that video was shared with me on that day,” Abbott told reporters in Houston when asked about his reaction to the video published this week. “And so it was shocking.”
Multiple inaccurate and conflicting statements given by officials since the May 24 tragedy at Robb Elementary School have compounded the grief and anger over a gunman killing 19 children and two teachers. Seven weeks later, there remains an incomplete account of why heavily armed police officers waited so long to take action and who was in charge.
A nearly 80-minute school surveillance video published this week by the Austin American-Statesman put in full view the bewildering inaction by law enforcement as the massacre unfolded. Abbott said Thursday it was “disgusting to see what happened.”
A day after the attack, Abbott had commended police, saying at the time that officers “showed amazing courage by running toward gunfire” and that it was “a fact that because of their quick response” lives were saved. Two days later, Abbott said he had been misled during an initial briefing and was “livid.”
Abbott has not said who provided the misinformation. Renae Eze, an Abbott spokeswoman, said in an email Thursday that it came from a briefing in which “different accounts were spun” by a room of law enforcement and public officials. His office has not provided names.
At a Uvalde City Council meeting in June, Mayor Don McLaughlin said the briefing that preceded Abbott’s inaccurate remarks was given by Victor Escalon, a regional commander with the Texas Department of Public Safety. McLaughlin has been increasingly critical of state police since the shooting, accusing DPS leaders of minimizing the involvement of their own troopers and deflecting blame on local officers.
The department’s officials do not dispute that Escalon led the briefing but said it was based on information provided by local law enforcement. Agency spokesman Travis Considine said those in the room included McLaughlin, Uvalde School District police Chief Pete Arredondo and officials from Uvalde police, the local sheriff’s department and the Border Patrol. All “were present at the briefing and had the opportunity to clarify anything they deemed inaccurate,” Considine said in an email Thursday.
Considine said it was not until Texas Rangers, a division of the Department of Public Safety, began their investigation that discrepancies emerged.
An investigative committee led by Texas lawmakers is expected to release findings Sunday about the slow law enforcement response after interviewing more than 40 witnesses over the past several weeks. The U.S. Justice Department and Texas Rangers also have launched separate investigations that are ongoing.
“The families of the victims deserve to know what happened. And they will know what happened,” Abbott said.
____
Associated Press writer Jake Bleiberg in Dallas contributed to this report. | https://cw33.com/news/u-s-news/ap-us-headlines/governor-uvalde-video-shocking-account-of-police-response/ | 2022-07-15T19:02:30Z |
Leading employee experience platform receives the highest vendor Net Emotional Footprint score in the "Champion" category and is noted for its trustworthiness and unique features
AUSTIN, Texas, Aug. 3, 2022 /PRNewswire/ -- LumApps, a leading Employee Experience Platform, today announced that it has been named a Champion in the 2022 Digital Workplace Emotional Footprint Award from SoftwareReviews, a division of IT research and advisory firm Info-Tech Research Group.
LumApps took home first place, earning a score of 98 out of 100, with "trustworthy" and "unique features" receiving perfect marks from reviewers.
"This recognition highlights our ongoing commitment to meeting or exceeding our customers' expectations," said Josue Moens, VP of Customer Success at LumApps. "The importance of employee experience platforms continues to increase with the shift to remote and hybrid work. Comms, HR and IT leaders need innovative solutions to ensure their employees have the resources and information they need to be engaged and productive. This feedback validates our technology is making an impact on many important levels."
The Emotional Footprint report illustrates customers' experience with software vendors. The Net Emotional Footprint of a vendor is a result of aggregated emotional response ratings in the areas of service, negotiation, product impact, conflict resolution as well as strategy and innovation, creating a powerful indicator of overall user feeling toward a vendor and its product from the software users' point of view. Emotional Footprint Champions are selected based exclusively on feedback provided by their users via SoftwareReviews' comprehensive online survey. The survey measures user satisfaction across 27 elements of the provider relationship, resulting in the Net Emotional Footprint score. This score represents the overall user sentiment, a powerful indicator of the user feeling toward the provider and the product.
Visit SoftwareReviews to learn more about the Digital Workplace Emotional Footprint Awards. The full report can be found here.
For more on LumApps, visit: www.lumapps.com.
SoftwareReviews is the most in-depth source of buyer data and insights for the enterprise software market. By collecting customer experience data from IT and business professionals, the SoftwareReviews methodology produces detailed and authentic insights into the experience of evaluating and purchasing enterprise software.
LumApps is a cloud-native Employee Experience Platform launched in 2015. Integrated with Google Workspace and Microsoft 365 collaborative suites, LumApps intelligently connects employees to the information and business applications they need to be productive, engaged, and empowered. Whether in the office or in the field, on desktop or mobile app and in any language, LumApps enables knowledge management and best practices sharing across communities. LumApps also automates HR processes and orchestrates personalized journeys for key phases in the employee life cycle, such as onboarding, interviews with managers and more.
With over 300 employees in 7 offices on 3 continents, LumApps serves some of the biggest companies in the world, such as Airbus, Air Liquide, Electronic Arts, Galeries Lafayette, Japan Airlines, Publicis Sapient, Stellantis, The Economist, Valeo, and Veolia, and has over 4 million users worldwide.
Andrea LePain
eMedia Junction
andrea@emediajunction.com
617-275-8112
View original content to download multimedia:
SOURCE LumApps | https://www.wibw.com/prnewswire/2022/08/03/lumapps-lands-1st-place-softwarereviews-2022-digital-workplace-emotional-footprint-awards/ | 2022-08-03T15:59:29Z |
DALLAS, April 11, 2022 /PRNewswire/ -- Mohr Partners, Inc., a leading global full-service end-to-end corporate real estate services firm, is pleased to announce that Kevin Williams, a 15-year construction management veteran, has joined Mohr Partners in the Dallas office.
In his new role, Williams will be a senior member of the Mohr Partners Project & Development Management Services division, overseeing both ground-up development and tenant improvement projects for the occupier clients that utilize industrial, office, retail and healthcare real estate to support their businesses.
Williams will report to Craig Bull, a 30-year industry veteran, who oversees business development, client management and operations for Mohr Partners' project & development management services division, which has been one of the firms fasted growing service lines.
"I am pleased to have Kevin join my team as he and I both started in the design industry before transitioning to project management, which allows us to execute complicated design-build and build-to-suit projects" stated Craig Bull.
Kevin Williams commented, "I am excited to join Mohr Partners. The firm's full-service corporate real estate platform will allow me to leverage my experience and add value throughout the total occupier real estate life cycle."
About Mohr Partners, Inc.:
Mohr Partners, Inc. is a global corporate real estate advisor, providing corporate tenants with an integrated set of portfolio services including strategic planning, business intelligence, lease administration/accounting & FASB ASC 842 compliance, research and site selection, labor analytics, project and construction management, comprehensive demographics analysis, economic incentives negotiations and transaction management. Since 1986, Mohr has been managing real estate portfolios for corporations, and each year completes transactions for its clients in all 50 U.S. states, all provinces of Canada and locations around the world. Mohr seamlessly provides corporate real estate services globally through its strategic alliance partners in Canada, Mexico/Latin America, EMEA and Asia Pacific. For more information on Mohr, please visit www.mohrpartners.com.
View original content to download multimedia:
SOURCE Mohr Partners, Inc. | https://www.mysuncoast.com/prnewswire/2022/04/11/mohr-partners-expands-project-amp-development-management-services-with-recruitment-industry-veteran-kevin-williams/ | 2022-04-11T23:26:14Z |
NEW YORK (AP) — When the U.S. hit 1 million COVID-19 deaths on Monday, the news was driven by a government tally derived from death certificates.
But that’s not the only tally. And you may be wondering, where do these numbers come from? A look behind the data:
DEATH CERTIFICATES
Deaths certificates have long been considered the most comprehensive record of deaths and their causes. The Centers for Disease Control and Prevention systematically collects information from all 50 states to track fatalities from all causes, including cancer, drug overdoses and now COVID-19.
But early in the pandemic, officials recognized the COVID-19 data was sluggish and incomplete.
Testing was often unavailable. In some places — especially rural ones — coroners or medical examiners did not have the staff to ask about coronavirus symptoms when people died at home. Even when information was available, overworked doctors could be slow to do the death certificate paperwork.
DEATHS FROM CASE REPORTS
With information on death certificates slow to arrive, experts and news organizations began looking to other real-time sources of deaths.
They turned to state health department tallies derived from preliminary reports that were mainly of people diagnosed with COVID-19 who went to a hospital and died. Such data was more timely than death certificates, which can take weeks to fill out and process.
Johns Hopkins University became a leader in searching state health department websites and rapidly analyzing and posting those numbers.
OTHER COUNTS
Other organizations have their own counts, including NBC News, which two weeks ago reported that the U.S. had surpassed 1 million COVID-19 deaths, but did not explain in its story how it arrived at that figure.
Last week, federal officials issued statements about the nation hitting 1 million deaths, even though the U.S. government’s own data had yet to show it. Based on lags in the reporting of death certificate information, officials concluded it was likely the milestone had passed and that it was appropriate to remark on it.
HOW THE TALLIES HAVE CHANGED
As the pandemic dragged on, many states cut back on posting case and death numbers — some to just once a week.
“We’ve lost a lot of immediacy in our reporting.” Emily Pond, a Johns Hopkins research data analyst, said in an email.
At the same time, the numbers based on death certificates rose faster. One reason: Investigators have been going back and adding several thousand deaths in which COVID-19 was not named initially but was identified later after autopsies or other medical investigations, said Robert Anderson, who oversees death data for the CDC’s National Center for Health Statistics.
Most of those deaths happened early in the pandemic, when COVID-19 was still new and underdiagnosed. Anderson said many were relabeled last year, largely in response to a Federal Emergency Management Agency program that began providing funeral assistance for families who could produce a death certificate attributing a death to COVID-19.
As of Monday morning, the Johns Hopkins data portal counted 999,607 deaths. The CDC count based on death certificates was 1,000,292.
At least 900,000 of the death certificates included in the CDC tally list COVID-19 as the primary cause of death, the agency said. The others list it as a contributing cause.
Some experts believe even the current death certificate-based data is an undercount. But it’s the best available, said Andrew Stokes, a Boston University researcher.
“It’s kind of the final say,” he said.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. | https://cw33.com/health/ap-health/death-certificates-reveal-that-us-hit-grim-covid-milestone/ | 2022-05-17T14:27:37Z |
DALLAS, July 25, 2022 /PRNewswire/ -- CECO Environmental Corp. (Nasdaq: CECE), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced it will report its second quarter 2022 results on Monday, Aug. 8, 2022, premarket. The company will also host an earnings conference call starting at 8:30 a.m. Eastern Time (7:30 a.m. CT).
The Company's financial results will be posted on its website at http://www.cecoenviro.com. Please visit the Investor Relations portion of the website to listen to the call via webcast. The conference call may also be accessed by dialing 888-346-4547 (Toll-Free) within the U.S., or +1-412-317-5251 (Toll-Required) outside the U.S.
A replay of the conference call will be available on the Company's website for seven days. The replay may be accessed by dialing 877-344-7529 (Toll-Free) within the U.S., or +1-412-317-0088 (Toll-Required) outside the U.S. and entering access code 6087150.
CECO Environmental is a leading environmentally focused, diversified industrial company, serving a broad landscape of industrial air, industrial water and energy transition markets across the globe through its key business segments: Engineered Systems and Industrial Process Solutions. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean, and more efficient solutions that help protect people, the environment and industrial equipment. In regions around the world, CECO works to improve air quality, optimize the energy value chain, and provide custom solutions for applications including power generation, petrochemical processing, general industrial, refining, midstream oil and gas, electric vehicle production, polysilicon fabrication, battery recycling, beverage can, and water/wastewater treatment along with a wide range of other applications. CECO is listed on Nasdaq under the ticker symbol "CECE." Incorporated in 1966, CECO's global headquarters is in Dallas, Texas. For more information, please visit www.cecoenviro.com.
Matthew Eckl
Chief Financial Officer
888-990-6670
Steven Hooser or Gary Guyton
Three Part Advisors
214-872-2710
Investor.Relations@OneCECO.com
Kimberly Plaskett
Corporate Communications Director
kplaskett@OneCECO.com
View original content to download multimedia:
SOURCE CECO Environmental Corp. | https://www.kxii.com/prnewswire/2022/07/25/ceco-environmental-release-second-quarter-2022-earnings-host-conference-call-august-8/ | 2022-07-25T11:33:25Z |
Farm-gate opens wider as new Ever.Ag software sees the dairy farm
FRISCO, Texas, June 21, 2022 /PRNewswire/ -- Ever.Ag, a leading agtech provider dedicated to empowering supply chains to feed a growing world, has acquired Cainthus, a company that offers artificial intelligence- enabled cameras for analyzing dairy operations. The addition of Cainthus to the Ever.Ag portfolio will provide dairy farmers and their advisors new insights from passive data collection.
"As part of our agtech vision, we are excited to add virtual eyes on the farm, Cainthus, to our portfolio," said Ever.Ag CEO Scott Sexton. "We believe precision agriculture, now in the dairy barn, is the future. We are committed to growing, expanding, and embedding Cainthus technology into our software suite that spans the supply chain."
The acquisition of Cainthus delivers on Ever.Ag's mission and continues its decades-long tradition of partnering with the dairy industry from farm to fork. Additionally, as consumers become more focused on purchasing environmentally friendly and sustainably produced goods, the data it collects can validate responsible farming practices throughout the supply chain. The information from Cainthus is invaluable to upstream affiliates and downstream consumers.
"At Ever.Ag, we continue to invest in the dairy industry as we've done for several decades, and Cainthus offers multiple benefits for our producer clients," said Mike Borman, Ever.Ag Chief Product Officer. "We look forward to continuing to develop its cost-saving, quality-enhancing capabilities for farmers, cooperatives, processors, and their partners."
Following the Cainthus acquisition, Ever.Ag plans to enhance the offerings of its My Dairy Dashboard product and producer portals ― which integrates data from milk pickups, feed delivered, recorded cow events, milk schedules, and pay information. Cainthus will use the operational data to associate and visually validate herd performance in the barn.
Both Ever.Ag and Cainthus are leaders in data digitization for dairy farm operations and their animals. Ever.Ag solutions are designed, developed, and produced by a global team with a passion for agtech, client sustainability, and mutual prosperity.
"Mobile cow-side data entry revolutionized the industry a decade ago, but it only digitized work, it did not reduce it," said Ryne Braun, Segment Leader at Ever.Ag. "Cameras from Cainthus, mounted in your barns, provide passive collection of herd health and feed consumption data -- that's literally a gift from above. Cainthus is very innovative technology for farmers who are willing to "look up" to improve their operations."
The Ever.Ag team is comprised of over 500 agtech professionals from around the world. With headquarters in Texas, and satellite offices or hubs in Wisconsin, Illinois, Tennessee, Ireland, India, and Canada, Ever.Ag is well positioned to serve a global client base.
For more information, visit News.Ever.Ag/Cainthus.
About Ever.Ag
Ever.Ag offers innovative AgTech solutions and services that empower agriculture, food, and beverage supply chains to feed a growing world. The breadth of the portfolio is uniquely capable of supporting the complex needs of companies involved in dairy, livestock, crops, and agribusiness. With decades of experience and industry-leading innovations, our technology, risk management, and market intelligence provide our customers with the tools and insights they need to operate more efficiently, sustainably, and strategically across every stage of the supply chain. To learn more, visit News.Ever.Ag.
About Cainthus
Founded in 2016 and headquartered in Dublin, Ireland, with an office in California, Cainthus is a computer vision company that turns visual information into actionable insights for farmers. Its proprietary technology passively tracks key farm management practices that impact nutrition, health, behavior, environment and the mental well-being of livestock. This breakthrough predictive imaging technology provides the analytics and information needed to drive business decisions.
Media Contact:
Sarah Wallach
Sarah.Wallach@Ever.Ag
(720) 988-6579
View original content to download multimedia:
SOURCE Ever.Ag | https://www.kxii.com/prnewswire/2022/06/21/everag-accelerates-growth-broadens-on-farm-dairy-solutions-with-acquisition-cainthus/ | 2022-06-21T15:25:53Z |
NEW YORK, April 29, 2022 /PRNewswire/ -- LA Swimwear Production is announcing that they are now accepting new clients looking to start a swimwear brand, or swimwear brands looking for a full service manufacturing supplier with fabric and trims included as well as retailers and brands looking for private label pre designed pieces that they can put their label and brand name in.
Los Angeles based swimwear manufacturing company LA Swimwear Production is a one stop shop for new swimwear brands and swimwear retailers to produce a private label or custom brand. LA Swimwear Production is available to work with emerging brands to thrive domestically and sustainability. LA Swimwear Production 360 brand creation approach by offering product development (swimwear design), manufacturing, warehousing and distribution. LA Swimwear Production is able to offer 100 private label swimwear pieces that swimwear brands can choose from and put them label on or use their cut and sew services.
Choosing sustainability above all LA Swimwear Production offers eco sustainable fabric with all cut and sew abilities. By bringing fabric production, ink sublimation, printing of fabric under one company, with cut and sew and private label. LA Swimwear Production has all the components of what a brand needs in one place, with one company. Eliminating waste and decreasing shipping and import and export cost for customers.
LA Swimwear Production is accepting client's all over the global. You do not have to live in Los Angeles CA area. They have a 100% virtual project management system and each client is assigned a Project Manager who will assist them with updates and can do virtual meetings and fittings. For more information visit their site at www.laswimwearproduction.com to see all 200+ of their swimwear styles ready for private label and for more information on them.
View original content:
SOURCE Nesis Brand Group | https://www.wibw.com/prnewswire/2022/04/29/la-swimwear-production-full-service-swimwear-manufacture-los-angeles/ | 2022-04-30T11:12:47Z |
Global enabler of IoT products and solutions adds Irvine location to its regional offices in Illinois, Florida and North Carolina
IRVINE, Calif., June 14, 2022 /PRNewswire/ -- Telit, a global enabler of the Internet of Things (IoT), today announced a new global corporate headquarters in Southern California. Following the CEO's move to the U.S., the new headquarters is in the City of Irvine—Orange County's technology hub—and will support Telit's strategy to grow its connected devices and solutions business worldwide. The Irvine office will also serve key projects and customers in the region, widening its U.S. presence that currently includes offices in Illinois, Florida and North Carolina.
"These are exciting times for Telit," said Paolo Dal Pino, CEO, Telit. "Choosing a global headquarters in California is a move consistent with the objective of strengthening our market position as a leading western player in the IoT connected devices and solutions arena. Particularly now—with a 100% Western shareholder structure—it's a move that poises Telit for major growth and expansion in 2022 and beyond."
Today, Telit's headquarters, research and development centers, and sales and operations offices continue to expand globally, with 28 locations on six of the seven continents which include R&D centers in the U.S., Italy, Korea and India. As a driver enabling Industry 4.0. and digital transformation, Telit provides enterprises with best-in-class device management and connectivity solutions that are essential to technologies powering smart cities, transportation, manufacturing, automotive, retail, healthcare and beyond. Telit's IoT experts—renowned for pioneering a successful end-to-end system approach—ensure Telit modules, connectivity and platforms all work seamlessly together to scale IoT deployments today and in the future. In addition to implementing thousands of successful IoT solutions worldwide, Telit continues to invest in its technology roadmap to push the industry forward for years to come.
The Irvine location is now open and operating.
Telit simplifies onboarding of connected 'things' with a portfolio of enterprise-grade wireless communication and positioning modules; cellular MVNO connectivity plans and management services; edge and cloud software; and data orchestration, IoT and Industrial IoT platforms. With over two decades of pioneering IoT innovation experience, Telit delivers award-winning, secure, integrated IoT solutions for many of the world's largest enterprises, OEMs, system integrators and service providers, so they can connect and manage IoT at any scale.
For more information, follow us on YouTube, Twitter, LinkedIn and Facebook or visit www.Telit.com.
Copyright © 2022 Telit Communications LTD. All rights reserved. Telit, Telit OneEdge and all associated logos are trademarks of Telit Communications LTD and its affiliated companies in the United States and other countries. Other names used herein may be trademarks of their respective owners.
Leslie Hart
Telit
+1 919-415-1510
Leslie.Hart@Telit.com
Lora Wilson
Valerie Christopherson
GRC for Telit
+1 949-608-0276
telit@globalresultspr.com
View original content to download multimedia:
SOURCE Telit | https://www.mysuncoast.com/prnewswire/2022/06/14/telit-opens-new-corporate-headquarters-california-serve-rapidly-growing-market-key-customers/ | 2022-06-14T13:41:48Z |
Research Confirms Da Vinci Painted Earlier Version of Masterpiece
Preeminent Scientist and Art Historian Proves New Data Changing Perception of how Louvre Portrait is Viewed
ROME, June 29, 2022 /PRNewswire/ -- Leonardo da Vinci's portrait of Lisa del Giocondo 'Mona Lisa' is the most famous painting in the world. In his new book; Is the Louvre Mona Lisa Leonardo's second version? («L'Erma» di Bretschneider – Roma), an in-depth analysis of the original documents, the historical sources and analytical data, Scientist and Art Historian Professor Salvatore Lorusso provides the evidence which settles a long-standing controversial issue: that the artist painted two versions of his immortal masterpiece - the first in c.1503-06 of a young Lisa and the second, the Louvre Mona Lisa, from c.1513 on.
"Given the execution of the documented original portrait of Lisa can now be reliably dated, any question of whether it is the Louvre portrait must be considered in the context of the chronology and evolution of Leonardo's work," said Salvatore Lorusso. "Unquestionable evidence shows Leonardo painted two distinct Mona Lisa paintings with different characteristics at different times: the first, an unfinished version and the second, a more finished version, stylistically and structurally different from the first."
Lorusso's research takes a critical analysis of numerous publications by Leonardo experts, a small number of whom, despite the evidence, still maintain that the Louvre Mona Lisa was started c.1503 and worked on until near the end of Leonardo's life in 1519, which is now proven to be an impossibility.
The historical documents analyzed by Lorusso - many of which have only been discovered recently – show the Louvre Mona Lisa could not have been the original portrait of Lisa del Giocondo started in Florence c. 1503, but instead was likely executed by Leonardo in Rome c.1513-16. Lorusso support this information through an in-depth analysis of the scientific data collected by the Centre de Recherche et de Restauration des Musées de France (C2RMF). Lorusso's findings prove that the original portrait of Lisa is another version by the great Master, confirming Leonardo painted two Mona Lisas.
Salvatore Lorusso was formerly a full professor at the University of Bologna, the world's oldest university, which boasts eminent alumni such as Albrecht Durer, Erasmus, Copernicus, Petrarch, Thomas Becket, Umberto Eco and no less than five popes. With a deep interest in both art and science, Lorusso was among the founders of the first Faculty of Conservation of Cultural Heritage in Italy and is editor-in-chief of the historical-technical Journal "Conservation Science in Cultural Heritage" where the human sciences and experimental sciences meet the arts. His deep experience and scholarship in both science and art is demonstrated in over 440 publications in national and international journals and 24 independent volumes. His expertise constitutes an ideal blend of both science and art with respect to the complex determination of authenticity and attribution in the field of old masters having recently authored a major publication on exactly that topic. In the last few years, he has become a notable expert on Leonardo's paintings with specific attention to Mona Lisa and is the author of several works on the subject. His biography appears in the 2016 Marquis Edition of Who's Who in the World.
INFO
Media Contact: DiamondLinks, zoe@diamondlinks.com
Publisher: «L'Erma» di Bretschneider – Roma
View original content to download multimedia:
SOURCE Salvatore Lorusso | https://www.mysuncoast.com/prnewswire/2022/06/29/louvre-mona-lisa-is-second-version/ | 2022-06-29T14:11:48Z |
VANCOUVER, BC, June 27, 2022 /PRNewswire/ - Rock Tech Lithium Inc. (TSXV: RCK) (OTCQX: RCKTF) (FWB: RJIB) (WKN: A1XF0V) (the "Company" or "Rock Tech") is pleased to announce that the Company has signed a non-binding term sheet (the "Term Sheet") with Swiss-based commodity trading company Transamine SA ("Transamine"), which provides for cooperation and collaboration between the parties in sourcing and supplying lithium spodumene concentrate feedstock for Rock Tech's proposed European lithium hydroxide converters.
Pursuant to the Term Sheet, Rock Tech and Transamine have agreed to engage in substantive negotiations regarding a potential joint venture to jointly pursue the development of an integrated spodumene concentrate supply chain, which would advance the Company's diversified sourcing strategy for the supply of lithium products to the European electric vehicle market. The validity of the Term Sheet is initially limited until 31 August 2022 but may be extended upon mutual agreement by the parties.
According to Markus Brügmann, CEO of Rock Tech Lithium, "in order to support automobile customers in the coming years, during which an upsurge in electric vehicles is expected in Europe, securing the supply chain of lithium hydroxide for batteries is going to be critical. With their established expertise, Transamine would represent an ideal partner for Rock Tech in sourcing the raw material needed for our lithium hydroxide converters. In times of disruption, a partnership with Transamine would further help to secure a resilient supply chain for our operations."
Jean-Pierre Adamian, from Transamine, commented that: "Transamine is active worldwide for 70 years in non-ferrous ores and concentrates whereas spodumene required by the Rock Tech Converters' fits perfectly our existing trading activity. In view of also contributing to the low carbon footprint industry, we are happy to enter this JV with the first European compliant converter, which also aims to source recycled lithium sulphate from battery recycling (hydromet recycling of the black mass) which would replace part of the primary spodumene resource. Because the aim is also to obtain around half of the raw material required from recycling by 2030."
Founded in 1953, Transamine Trading SA is an independent and privately held commodities trading company specialising in non-ferrous raw materials. Transamine is headquartered in Geneva, Switzerland, and has offices throughout key markets including Australia, South Africa, India, the United States and China. Transamine is a full-service company providing worldwide raw material sourcing, marketing, finance and investment and specialises in all aspects of non-ferrous raw materials production and trade. Transamine maintains the highest standard of conduct to promote fundamental principles such as sustainability, environment and social responsibilities.
Rock Tech Lithium is a cleantech company with operations in Canada and Germany that aims to supply the automotive industry with high quality lithium hydroxide "made in Germany". As early as 2024, the Company intends to commission Europe's first lithium converter with a nameplate production capacity of 24,000 tonnes per year. This is equivalent to the volume needed to equip around 500,000 electric cars with lithium-ion batteries.
The Company has set itself the goal of creating the world's first closed loop for lithium, thus closing the raw material gap on the road to clean mobility. Rock Tech owns the Georgia Lake Project in Ontario, Canada and, as early as 2030, around 50 percent of the raw materials used are expected to come from the recycling of batteries
Rock Tech Lithium - The super fuel for the battery age
www.rocktechlithium.com
On behalf of the Board of Directors,
Dirk Harbecke
Chairman
The following cautionary statements are in addition to all other cautionary statements and disclaimers contained elsewhere in, or referenced by, this press release.
Certain information set forth in this press release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking information") within the meaning of applicable securities laws, which are based on Rock Tech's current expectations, estimates, and assumptions in light of its experience and is perception of historical trends. All statements other than statements of historical facts may constitute forward-looking information. Often, forward-looking information can be identified by the use of words or phrases such as "estimate", "project", "anticipate", "expect", "intend", "believe", "hope", "may" and similar expressions, as well as "will", "shall" and all other indications of future tense. All forward-looking information set forth in this press release is expressly qualified in its entirety by the cautionary statements referred to in this section.
In particular, this new release contains forward-looking information pertaining to: expectations regarding the relationship between, and future actions taken by, Rock Tech and Transamine, including with respect to the cooperation and collaboration between the parties, the occurrence or outcome of negotiations between the parties regarding a potential joint venture or the purposes or benefits thereof; statements regarding Rock Tech's proposed lithium hydroxide converters, including the features and locations thereof; statements regarding Rock Tech's future plans and expectations, including with respect to the Company's feedstock sourcing strategy and the impact of a joint venture with Transamine thereon; anticipated production of lithium hydroxide and related processing methods; statements and expectations regarding the electric vehicle industry; Rock Tech's opinions, beliefs and expectations regarding the Company's business strategy, development and exploration opportunities and projects; and plans and objectives of management for the Company's operations and properties.
Forward-looking information contained in this press release is based on certain assumptions, estimates, expectations, analysis and opinions of the Company and in certain cases, third party experts, that are believed by management of Rock Tech to be reasonable at the time they were made. Such assumptions, estimates and other factors include, among other things: the supply and demand for, deliveries of, and the level and volatility of prices of, feedstock and intermediate and final lithium products, expected growth, performance and business operations, future commodity prices and exchange rates, prospects, growth opportunities and financing available to the Company, general business and economic conditions, results of development and exploration, Rock Tech's ability to procure supplies and other equipment necessary for its business. The foregoing list is not exhaustive of all assumptions which may have been used in developing the forward-looking information. While Rock Tech considers these assumptions, estimates and factors to be reasonable based on information currently available, they may prove to be incorrect. Forward-looking information should not be read as a guarantee of future performance or results.
In addition, forward-looking information involves known and unknown risks and uncertainties and other factors, many of which are beyond Rock Tech's control, that may cause Rock Tech's actual events, results, performance and/or achievements to be materially different from that which is expressed or implied by such forward-looking information. Risks and uncertainties that may cause actual events, results, performance and/or achievements to vary materially include the Company's ability to access funding required to invest in available opportunities and projects (including the Company's proposed lithium hydroxide converters) and on satisfactory terms, the current and potential adverse impacts of the COVID-19 pandemic and recent geopolitical hostilities; the risk that Rock Tech will not be able to meet its financial obligations as they fall due, changes in commodity and other prices, Rock Tech's ability to attract and retain skilled staff and to secure feedstock from third party suppliers, unanticipated events and other difficulties related to construction, development and operation of the Company's proposed lithium hydroxide converters, the cost of compliance with current and future environmental and other laws and regulations, title defects, competition from existing and new competitors, changes in currency, exchange rates and market prices of Rock Tech's securities, Rock Tech's history of losses, impacts of climate change and other risks and uncertainties described from time to time in Rock Tech's public disclosure documents available on the Company's SEDAR profile at www.sedar.com, including those discussed under the heading "Risk Factors" in Rock Tech's most recently filed Management Discussion and Analysis and Annual Information Form, respectively. Such risks and uncertainties do not represent an exhaustive list of all risk factors that could cause actual events, results, performance and/or achievements to vary materially from the forward-looking information.
We cannot assure you that actual events, results, performance and/or achievements will be consistent with the forward-looking information and management's assumptions may prove to be incorrect. Forward-looking information reflects Rock Tech management's views as at the date the information is created. Except as may be required by law, Rock Tech undertakes no obligation and expressly disclaims any responsibility, obligation or undertaking to update or to revise any forward-looking information, whether as a result of new information, future events or otherwise, to reflect any change in Rock Tech's expectations or any change in events, conditions or circumstances on which any such information is based.
Given these uncertainties, readers are cautioned not to rely on the forward-looking information set forth in this press release.
View original content to download multimedia:
SOURCE Rock Tech Lithium Inc. | https://www.wibw.com/prnewswire/2022/06/27/rock-tech-lithium-transamine-cooperate-lithium-supply/ | 2022-06-27T07:45:28Z |
SAN DIEGO, July 20, 2022 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, will announce financial results for the second quarter of 2022 along with recent corporate updates on August 3, 2022. During a conference call at 4:30 p.m. ET / 1:30 p.m. PT on August 3, company executives will provide company updates and review financial results.
Investors and the general public are invited to listen to a live webcast of the call at the "Investors and Media" section on Mirati.com or by dialing the U.S. toll free +1 313-209-4906 or international +1 877-502-9276, confirmation code: 1791105. A replay of the call will be available approximately 2 hours after the event has ended at the same website.
Mirati Therapeutics, Inc. is a clinical-stage biotechnology company whose mission is to discover, design and deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. The company is relentlessly focused on bringing forward therapies that address areas of high unmet medical need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. Unified for patients, Mirati's vision is to unlock the science behind the promise of a life beyond cancer. For more information about Mirati, visit us at Mirati.com or follow us on Twitter, LinkedIn and Facebook.
This press release contains forward-looking statements regarding the business of Mirati Therapeutics, Inc. ("Mirati"). Any statement describing Mirati's goals, expectations, financial or other projections, intentions or beliefs, development plans and the commercial potential of Mirati's drug development pipeline, including without limitation adagrasib (selective KRASG12C inhibitor), sitravatinib (TAM receptor inhibitor), MRTX1719 (MTA cooperative PRMT5 inhibitor), MRTX1133 (selective KRASG12D inhibitor), and MRTX0902 (SOS1 inhibitor), is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to risks and uncertainties, particularly those challenges inherent in the process of discovering, developing and commercialization of new drug products that are safe and effective for use as human therapeutics, and in the endeavor of building a business around such drugs.
Mirati's forward-looking statements also involve assumptions that, if they never materialize or prove correct, could cause its results to differ materially from those expressed or implied by such forward-looking statements. Although Mirati's forward-looking statements reflect the good faith judgment of its management, these statements are based only on facts and factors currently known by Mirati. As a result, you are cautioned not to rely on these forward-looking statements. These and other risks concerning Mirati's programs are described in additional detail in Mirati's quarterly reports on Form 10-Q and annual reports on Form 10-K, which are on file with the U.S. Securities and Exchange Commission (the "SEC") available at the SEC's Internet site (www.sec.gov). Mirati assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by law.
Investor Relations: ir@mirati.com
Media Relations: media@mirati.com
View original content to download multimedia:
SOURCE Mirati Therapeutics, Inc. | https://www.kxii.com/prnewswire/2022/07/20/mirati-therapeutics-report-second-quarter-2022-financial-results-recent-corporate-updates/ | 2022-07-20T21:40:40Z |
Officials worry Southern California won’t have enough water to get through summer without unprecedented cuts
By Stephanie Elam, CNN
As Southern Californians brace for unprecedented water restrictions, officials worry some communities won’t have enough water to get through the summer — at least not without residents and businesses significantly cutting back on their usage.
The state’s top natural resources officer told CNN that California’s water emergency clearly shows the climate crisis in action.
“Some would consider this a wake-up call. I disagree,” Wade Crowfoot, California’s secretary for natural resources, told CNN. “The alarm’s already gone off.”
Scientists reported earlier this year that the West’s current megadrought is the worst in at least 1,200 years and that the human-caused climate crisis has made it 72% worse.
For the past two decades, weather in the West has been characterized by extended periods of drought with fleeting bursts of wintertime precipitation which have never been enough to overcome the region’s severe water shortage.
In California, snow typically builds up in the Sierra Nevada throughout the winter, storing precious water that gradually melts through the spring and early summer and replenishes reservoirs. In a normal year, snow melt would provide 30% of the state’s water, according to the Department of Water Resources.
But by April, at the end of this year’s wet season, California’s snowpack was only 4% of normal. By May there was no snow at all.
“Climate change is here and it’s been here across the American West,” Crowfoot told CNN. “Climate change is accelerating in alarming ways and faster than scientists predicted even 10 or 20 years ago and that means we have to move very quickly as governments, as water agencies, as communities.”
Metropolitan Water District of Southern California, a regional water wholesaler, sells water to 26 member agencies which then serve some 19 million people in six counties.
In light of the foreseen shortage, Metropolitan, for the first time in its nearly 100-year history, is mandating that restrictions be put in place for parts of Los Angeles, San Bernardino and Ventura counties that receive water through the State Water Project, which pipes water down from the Northern Sierra Nevada Mountains and the Sacramento-San Joaquin River Delta. They have two options: they can either implement volumetric limitations, or demand customers reduce their outdoor watering to one day a week by June 1.
At the same time, the water district is asking all Southern Californians to cut their usage by 35%.
“The action has to happen now because we can’t wait until the middle of the summer,” Adel Hagekhalil, the general manager of the Metropolitan Water District of Southern California, told CNN. “It’ll be too late, and I don’t want anybody to turn on the faucet and not have water.”
Targeting outdoor watering could have a large impact on water conservation, officials say. If not enough water is saved, Metropolitan Water District says it is prepared to ban all outdoor watering on September 1.
“If you look at water usage right now, 30 to 70% of the water that is consumed in the home or in a business or an institution is mainly in the landscaping outdoors,” Hagekhalil said. “We need to right now conserve every drop, re-prioritize how we use water to make sure it’s only for basic health services, our livelihood, our indoor usage — and not watering our lawn.”
The Metropolitan Water District also gets 25% of its water from the Colorado River, where the West’s megadrought is starkly visible. The river system supplies water to some 40 million people across seven states and Mexico, and its two major reservoirs — the country’s largest — are draining rapidly.
The federal government announced Tuesday it is taking unprecedented, emergency steps to help boost water levels at Lake Powell, and buy the surrounding communities more time to plan for the very real possibility the reservoir, the country’s second-largest, will soon run out of water.
At Lake Mead, the waterline has dropped so low in the lake that it has exposed a water intake valve that had been in service since 1971. The Southern Nevada Water Authority activating a newer, low-lake pumping station to still be able to access water for its customers.
“But (the pumping station) coming online is also a symbol of how serious the situation is on the Colorado River right now,” said Colby Pellegrino, deputy general manager of resources for Southern Nevada Water Authority. “Reservoir levels are lower than they’ve ever been in both Lake Powell and Lake Mead since the time that they filled.”
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/news/national-world/cnn-national/2022/05/04/officials-worry-southern-california-wont-have-enough-water-to-get-through-summer-without-unprecedented-cuts/ | 2022-05-04T22:44:45Z |
Serum TTR reductions were sustained at all doses tested with follow-up now reaching 12 months in the 0.1 and 0.3 mg/kg and six months in the 0.7 and 1.0 mg/kg cohorts
Pharmacokinetic modeling and simulation indicated that an 80 mg fixed dose provides similar exposure to the 1.0 mg/kg dose, where treatment with NTLA-2001 resulted in 93% mean and 98% maximum serum TTR reduction by day 28
Intellia to host investor event to discuss updated data from Phase 1 study of NTLA-2001, the first-ever systemically administered in vivo CRISPR investigational therapy today, Friday, June 24, at 8:00 a.m. ET
CAMBRIDGE, Mass. and TARRYTOWN, N.Y., June 24, 2022 /PRNewswire/ -- Intellia Therapeutics, Inc. (NASDAQ: NTLA) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced additional positive interim data from an ongoing Phase 1 study of their lead investigational in vivo genome editing candidate, NTLA-2001, which is being developed as a single-dose treatment for transthyretin (ATTR) amyloidosis. The data were presented in an oral presentation at the European Association for the Study of the Liver (EASL) International Liver Congress™ 2022, taking place June 22 – 26 in London.
The presentation today included extended follow-up data from 15 patients with hereditary ATTR amyloidosis with polyneuropathy (ATTRv-PN) treated across four single-ascending dose cohorts in Part 1 of the study. Results demonstrated sustained durability of serum transthyretin (TTR) reduction through the last measured timepoint in the ongoing observation. These data support NTLA-2001's continued development as a potential one-time treatment to permanently inactivate the TTR gene and reduce the disease-causing protein. At the highest dose evaluated, treatment with NTLA-2001 at 1.0 mg/kg resulted in a 93% mean and 98% maximum serum TTR reduction by day 28 across the six patients treated. With longer-term follow-up data now available, these deep reductions continue to be sustained through six months, with an observed mean reduction of 93%. Additionally, three patients in the 1.0 mg/kg cohort have reached nine months in the follow-up period with no evidence of a loss in TTR reduction after a single dose. In the 0.7 mg/kg dose cohort, the 86% mean serum TTR reduction observed at day 28 also remained durable through six months. Further, in the 0.1 and 0.3 mg/kg cohorts, patients have now reached 12 months of follow-up, and a durable response to treatment continues to be observed. Notably, patients in the 0.3 mg/kg cohort sustained an 89% mean serum TTR reduction at 12 months.
At all four dose levels, NTLA-2001 was generally well tolerated through the follow-up period (median follow-up of 10 months). The majority of adverse events were mild in severity with 73% (n = 11) of patients reporting a maximal adverse event severity of Grade 1. There was a single possibly related serious adverse event of vomiting (Grade 3) reported in a patient with concomitant medical history of gastroparesis in the 1.0 mg/kg dose group. The most frequent adverse events included headache, infusion-related reactions, back pain, rash and nausea. All infusion-related reactions were considered mild, resolving without clinical sequelae.
The safety and activity profile of NTLA-2001 observed in Part 1 indicates that NTLA-2001 has a favorable therapeutic window. These data combined with pharmacokinetic modeling and simulation data support the utilization of a fixed dose of 80 mg in Part 2, which is anticipated to yield similar exposures to the 1.0 mg/kg dose. Dosing is ongoing in Part 2, the single-dose expansion cohort of the polyneuropathy arm.
"Based on the interim data shared today, we believe NTLA-2001's potential to be a transformational treatment for patients with ATTR amyloidosis is becoming clearer. The safety, depth of serum TTR reduction and durability profile demonstrated thus far highlights its potential for halting and reversing the disease after a single dose," said Intellia President and Chief Executive Officer John Leonard, M.D. "These data further underscore the power of genomic medicines and bolster the probability of success across our broader in vivo genome editing platform. We look forward to progressing the clinical development of the first-ever systemically administered in vivo CRISPR investigational therapy."
"We're pleased to share updated data that enhance the safety and durability profile of NTLA-2001, increasing our confidence in its potential as a one-time, systemically delivered and long-lasting CRISPR-based therapy," said George D. Yancopoulos, Ph.D., M.D., President and Chief Scientific Officer of Regeneron. "Single-dose in vivo gene editing could one day help patients with a variety of hard-to-treat genetic diseases, making it one of the most exciting medical breakthroughs on the horizon today."
The Phase 1 study, run by Intellia as the program's development and commercialization lead as part of a multi-target collaboration with Regeneron, is evaluating NTLA-2001 in patients with either ATTRv-PN or ATTR amyloidosis with cardiomyopathy (ATTR-CM). The cardiomyopathy arm, evaluating NTLA-2001 across patients classified with New York Heart Association (NYHA) Class I – III heart failure, is ongoing. The companies plan to present the first interim data from the cardiomyopathy arm in the second half of 2022. Enrollment across both ATTRv-PN and ATTR-CM patient populations is expected to complete in 2022.
Intellia Therapeutics Investor Event and Webcast Information
Intellia will host a live webcast today, Friday, June 24, 2022, at 8:00 a.m. ET, to review the presented data. To join the webcast, please visit this link, or the Events and Presentations page of the Investors & Media section of the company's website at www.intelliatx.com. A replay of the webcast will be available on Intellia's website for at least 30 days following the call.
About NTLA-2001
Based on Nobel Prize-winning CRISPR/Cas9 technology, NTLA-2001 could potentially be the first single-dose treatment for ATTR amyloidosis. NTLA-2001 is the first investigational CRISPR therapy candidate to be administered systemically, or through a vein, to edit genes inside the human body. Intellia's proprietary non-viral platform deploys lipid nanoparticles to deliver to the liver a two-part genome editing system: guide RNA specific to the disease-causing gene and messenger RNA that encodes the Cas9 enzyme, which carries out the precision editing. Robust preclinical data, showing deep and long-lasting transthyretin (TTR) reduction following in vivo inactivation of the target gene, supports NTLA-2001's potential as a single-administration therapeutic. Intellia leads development and commercialization of NTLA-2001 as part of a multi-target discovery, development and commercialization collaboration with Regeneron. The global Phase 1 trial is an open-label, multi-center, two-part study of NTLA-2001 in adults with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN) or transthyretin amyloidosis with cardiomyopathy (ATTR-CM). Visit clinicaltrials.gov (NCT04601051) for more details.
About Transthyretin (ATTR) Amyloidosis
Transthyretin amyloidosis, or ATTR amyloidosis, is a rare, progressive and fatal disease. Hereditary ATTR (ATTRv) amyloidosis occurs when a person is born with mutations in the TTR gene, which causes the liver to produce structurally abnormal transthyretin (TTR) protein with a propensity to misfold. These damaged proteins build up as amyloid in the body, causing serious complications in multiple tissues, including the heart, nerves and digestive system. ATTRv amyloidosis predominantly manifests as polyneuropathy (ATTRv-PN), which can lead to nerve damage, or cardiomyopathy (ATTRv-CM), which can lead to heart failure. Some individuals without the genetic mutation produce non-mutated, or wild-type TTR proteins that become unstable over time, misfolding and aggregating in disease-causing amyloid deposits. This condition, called wild-type ATTR (ATTRwt) amyloidosis, primarily affects the heart. There are an estimated 50,000 people worldwide living with ATTRv amyloidosis and between 200,000 and 500,000 people with ATTRwt amyloidosis.
About Regeneron
Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to nine FDA-approved treatments and numerous product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases and rare diseases.
Regeneron is accelerating and improving the traditional drug development process through our proprietary VelociSuite® technologies, such as VelocImmune®, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies, and through ambitious research initiatives such as the Regeneron Genetics Center, which is conducting one of the largest genetics sequencing efforts in the world.
For additional information about the company, please visit www.regeneron.com or follow @Regeneron on Twitter.
About Intellia Therapeutics
Intellia Therapeutics, a leading clinical-stage genome editing company, is developing novel, potentially curative therapeutics leveraging CRISPR-based technologies. To fully realize the transformative potential of CRISPR-based technologies, Intellia is pursuing two primary approaches. The company's in vivo programs use intravenously administered CRISPR as the therapy, in which proprietary delivery technology enables highly precise editing of disease-causing genes directly within specific target tissues. Intellia's ex vivo programs use CRISPR to create the therapy by using engineered human cells to treat cancer and autoimmune diseases. Intellia's deep scientific, technical and clinical development experience, along with its robust intellectual property portfolio, have enabled the company to take a leadership role in harnessing the full potential of genome editing to create new classes of genetic medicine. Learn more at intelliatx.com. Follow us on Twitter @intelliatx.
Regeneron Forward-Looking Statements and Use of Digital Media
This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, the impact of SARS-CoV-2 (the virus that has caused the COVID-19 pandemic) on Regeneron's business and its employees, collaborators, and suppliers and other third parties on which Regeneron relies, Regeneron's and its collaborators' ability to continue to conduct research and clinical programs, Regeneron's ability to manage its supply chain, net product sales of products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Products"), and the global economy; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and product candidates being developed by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Product Candidates") and research and clinical programs now underway or planned, such as NTLA-2001 (a product candidate being developed for transthyretin (ATTR) amyloidosis under a multi-target discovery, development, and commercialization collaboration between Regeneron and Intellia Therapeutics, Inc.); the extent to which the results from the research and development programs conducted by Regeneron and/or its collaborators or licensees (including the Phase 1 clinical study evaluating NTLA-2001 discussed in this press release) may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; the potential of the CRISPR/Cas9 gene-editing technology discussed in this press release for in vivo therapeutic development; uncertainty of the utilization, market acceptance, and commercial success of Regeneron's Products and Regeneron's Product Candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary), including the Phase 1 clinical study evaluating NTLA-2001 discussed in this press release, on any of the foregoing or any potential regulatory approval of Regeneron's Products and Regeneron's Product Candidates (such as NTLA-2001); the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's Product Candidates and new indications for Regeneron's Products; the ability of Regeneron's collaborators, licensees, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron and/or its collaborators to manufacture and manage supply chains for multiple products and product candidates; safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates in patients, including serious complications or side effects in connection with the use of Regeneron's Products and Regeneron's Product Candidates (such as NTLA-2001) in clinical trials; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and Regeneron's Product Candidates; ongoing regulatory obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy; the availability and extent of reimbursement of Regeneron's Products from third-party payers, including private payer healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payers and new policies and procedures adopted by such payers; competing drugs and product candidates that may be superior to, or more cost effective than, Regeneron's Products and Regeneron's Product Candidates; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance; the potential for any license, collaboration, or supply agreement, including Regeneron's agreements with Sanofi, Bayer, and Teva Pharmaceutical Industries Ltd. (or their respective affiliated companies, as applicable), as well as Regeneron's collaboration with Intellia Therapeutics, Inc. discussed in this press release, to be cancelled or terminated; and risks associated with intellectual property of other parties and pending or future litigation relating thereto (including without limitation the patent litigation and other related proceedings relating to EYLEA® (aflibercept) Injection, Dupixent® (dupilumab), Praluent® (alirocumab), and REGEN-COV® (casirivimab and imdevimab)), other litigation and other proceedings and government investigations relating to the Company and/or its operations, the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron's business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended December 31, 2021 and its Form 10-Q for the quarterly period ended March 31, 2022. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.
Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website (https://newsroom.regeneron.com/) and its Twitter feed (https://twitter.com/regeneron).
Intellia Forward-Looking Statements
This press release contains "forward-looking statements" of Intellia Therapeutics, Inc. ("Intellia", "we" or "our") within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, express or implied statements regarding Intellia's beliefs and expectations regarding the safety, efficacy and advancement of our clinical program for NTLA-2001 for the treatment of ATTR amyloidosis, including the potential for NTLA-2001 to be a transformative treatment for people with ATTR amyloidosis; the expected timing of data releases, regulatory filings, and the initiation and completion of clinical trials, including completion of enrollment across both ATTRv-PN and ATTR-CM patient populations in 2022; our ability to successfully secure additional clinical studies authorizations, such as investigational new drug applications ("IND") and clinical trial applications ("CTA"); our belief that NTLA-2001 can be approved as a single-dose therapy; our plans to present data at upcoming scientific conferences, including the presentation of interim data from the cardiomyopathy arm in the second half of 2022; the advancement, expansion, acceleration and success of our CRISPR/Cas9 technology and in vivo pipeline to develop breakthrough genome editing treatments for people living with severe diseases; ability to demonstrate our platform's modularity and replicate or apply results achieved in preclinical studies, including those in our ATTR program, in any future studies, including human clinical trials for NTLA-2002 for the treatment of hereditary angioedema; our ability to optimize the impact of our collaborations on our development programs, including but not limited to our collaboration with Regeneron Pharmaceuticals, Inc. ("Regeneron"); statements regarding the timing of regulatory filings and clinical trial execution, including dosing of patients, regarding our development programs; and potential commercial opportunities, including value and market, for our product candidates.
Any forward-looking statements in this press release are based on management's current expectations and beliefs of future events, and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by such forward-looking statements. These risks and uncertainties include, but are not limited to: risks related to our ability to protect and maintain our intellectual property position; risks related to our relationship with third parties, including our licensors and licensees; risks related to the ability of our licensors to protect and maintain their intellectual property position; uncertainties related to regulatory agencies' evaluation of regulatory filings and other information related to our product candidates; uncertainties related to the authorization, initiation and conduct of studies and other development requirements for our product candidates; the risk that any one or more of our product candidates, including those that are co-developed, will not be successfully developed and commercialized; the risk that the results of preclinical studies or clinical studies will not be predictive of future results in connection with future studies; and the risk that our collaborations with Regeneron or our other collaborations will not continue or will not be successful. For a discussion of these and other risks and uncertainties, and other important factors, any of which could cause Intellia's actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in Intellia's most recent annual report on Form 10-K and quarterly report on Form 10-Q, as well as discussions of potential risks, uncertainties, and other important factors in Intellia's other filings with the Securities and Exchange Commission ("SEC"). All information in this press release is as of the date of the release, and Intellia undertakes no duty to update this information unless required by law.
View original content:
SOURCE Regeneron Pharmaceuticals, Inc. | https://www.mysuncoast.com/prnewswire/2022/06/24/intellia-regeneron-present-updated-interim-data-phase-1-study-crispr-based-ntla-2001-treatment-transthyretin-attr-amyloidosis-demonstrating-that-deep-serum-ttr-reductions-remained-durable-after-single-dose/ | 2022-06-24T11:46:27Z |
RIVIERA MAYA, Mexico, Aug. 2, 2022 /PRNewswire/ -- Mario Anzoategui joins the Fairmont Mayakoba team of heartists as the new Director of Engineering & Capital Projects.
In his new role, he will drive the operation and improvement of the maintenance of property assets in an efficient and ecologically responsible manner, and to start his new role with a great milestone; he will launch the so wanted new beach club.
Mario focused his career on the service industry and developed in ultra-luxury brands. Continually seeks to innovate and be at the forefront of the market. Having opened and successfully developed reverse osmosis projects, bottling plants, and various energy-saving projects.
With more than 20 years of experience in the hotel industry, Mario started his career as a Maintenance Supervisor at Pueblo Bonito in 1999. Ever since, he has thrived in several properties as a Navy Chief at El Cid Resorts in the Riviera Maya. In addition, he has worked at companies such as Pueblo Bonito Emerald Bay, Villa del Palmar, One and Only Palmilla, and AM Resorts in Curazao.
Mario, a Marine by profession, graduated from the Nautical School of Mazatlán as a Naval Mechanical Engineer. In his free time, he enjoys barbecuing with family and friends, taking a motorcycle ride with his wife, golfing, and discovering new small towns.
About Fairmont Mayakoba, Riviera Maya
Nestled in the heart of the Riviera Maya, Mexico, the 401-room Fairmont Mayakoba is a AAA Five Diamond resort set on 45 acres, within a private luxury community. Surrounded by a lush mangrove forest intersected by water canals, the property offers over 46,000 sq. ft. of indoor and outdoor meeting space, an energizing Willow Stream Spa featuring 20 treatment rooms, and El Camaleón Golf Course, host to the only official PGA TOUR event in Mexico. A dedication to a green philosophy has earned Fairmont Mayakoba the Rainforest Alliance verification among other eco-accolades. For reservations contact your Travel Agent or Meeting Planner, call 1(800) 540 6088 or email myk.reservations@fairmont.com, or visit fairmont.com/Mayakoba or follow Fairmont Mayakoba on Twitter, Facebook, LinkedIn, and Instagram.
About Accor
Accor is a world leading hospitality Group consisting of more than 5,100 properties and 10,000 food and beverage venues throughout 110 countries. The Group has one of the industry's most diverse and fully-integrated hospitality ecosystems encompassing luxury and premium brands, midscale and economy offerings, unique lifestyle concepts, entertainment and nightlife venues, restaurants & bars, branded private residences, shared accommodation properties, concierge services, co-working spaces, and more. Accor also boasts an unrivalled portfolio of distinctive brands and approximately 260,000 team members worldwide. Over 68 million members benefit from the company's comprehensive loyalty program ALL - Accor Live Limitless - a daily lifestyle companion that provides access to a wide variety of rewards, services, and experiences. Through its Planet 21 – Acting Here, Accor Solidarity, RiiSE, and ALL Heartist Fund initiatives, The Group is focused on driving positive actions through business ethics, responsible tourism, environmental sustainability, community engagement, diversity, and inclusivity. Founded in 1967, Accor SA is headquartered in France, and publicly listed on the Euronext Paris Stock Exchange (ISIN code: FR0000120404), and on the OTC Market (Ticker: ACCYY) in the United States. For more information visit group.accor.com or follow Accor on Twitter, Facebook, LinkedIn, and Instagram.
View original content to download multimedia:
SOURCE Fairmont Mayakoba | https://www.kxii.com/prnewswire/2022/08/02/mario-anzoategui-new-director-engineering-amp-capital-projects-fairmont-mayakoba/ | 2022-08-02T17:57:15Z |
This time last year, the brand new, stunningly effective Covid-19 vaccines were rolling out across the country, injecting a strong note of optimism into the United States' once fumbling pandemic response.
Millions of people were lining up daily to get their shots. Instead of the steady drumbeat of cases, hospitalizations and deaths, we were tracking a new number: the percentage of Americans who had been vaccinated. This number, we believed, was our best chance to beat the virus.
The US was caught up in a fever dream of reaching herd immunity, a threshold we might cross where vulnerable individuals -- including those too young to be vaccinated or those who didn't respond well to the vaccines -- might be protected anyway because, as a community, we would weave an invisible safety net around them.
With herd immunity, if someone does get infected by a virus, they are surrounded by enough people who are shielded against infection that the virus has nowhere to go. It fails to spread.
As a country, we had reached this point against some formidable viruses, such as rubella and measles. We thought we could get there with Covid-19. We were probably wrong.
"The concept of classical herd immunity may not apply to Covid-19," Dr. Anthony Fauci, director of the National Institutes of Allergy and Infectious Diseases, said in an interview with CNN.
And that "means we're not going to be without SARS-CoV-2 in the population for a considerable period of time," said Fauci, who recently co-authored a paper on herd immunity for the Journal of Infectious Diseases.
How we beat measles
Fauci points to measles as an ideal case study in herd immunity.
Like the virus that causes Covid-19, the measles virus spreads through the air. It is so contagious that if one person has it, 9 out of 10 people around them will catch it if they are not immune to it, according to the CDC. Some experts have estimated that the Omicron viruses are as contagious as the measles.
The US eliminated transmission of measles and has successfully kept the virus from circulating in this country because of three things: an extremely effective vaccine; a virus that doesn't change, or mutate, in significant ways over time; and a successful childhood vaccination campaign.
The measles vaccine is 97% effective at preventing the disease, according to the CDC. Once a person is vaccinated, studies have determined that protection lasts virtually their whole lives.
Many states in the US had once reached an ambitious public health goal of getting more than 90% of their children vaccinated against the disease by the time they started kindergarten.
This high level of vaccination coverage, the durability and effectiveness of the vaccine, and the relative stability of the virus have helped the United States prevent major outbreaks of the disease for more than 20 years.
Still, herd immunity has to extend beyond the borders of the United States. Each year, a certain number of cases arise when travelers bring it into the country, but it has never regained a foothold here and continued to circulate, because we have community-level protection against it.
Elimination of the virus isn't infallible. In the United States, herd immunity against measles is wearing thin in many parts of the US -- and indeed around the world -- because of vaccine hesitancy.
The World Health Organization warned in 2019 that measles could become endemic again around the world as more people refuse their shots.
Corralling Covid
Covid-19, unfortunately, isn't playing by those same rules.
"Bad news number one," said Fauci, is that the coronavirus that causes Covid-19 changes a lot and in significant ways.
"We've already experienced over a period of two years that we've had five separate variants Alpha, Beta, Delta, Omicron. And now BA.2 from Omicron one," he said.
"Bad news number two is that there's a lack of a wide acceptance of safe and effective vaccines," Fauci said. Put simply, not enough people have been vaccinated.
The more contagious the virus, the more people have to be vaccinated to stop it from ripping through a community, according to Dr. Adam Kucharski, co-director of the Center for Epidemic Preparedness and Response at the London School of Hygiene and Tropical Medicine. In a July 2021 Twitter thread and in a recent interview with CNN, Kucharski explained how expectations around herd immunity have to shift as viruses become more contagious.
Kucharski estimated that for a virus as contagious as the Delta variant, 98% of the population would need to be vaccinated if the vaccines we have could prevent 85% of transmission of the virus.
If the vaccines didn't prevent transmission to that extent, he said, then herd immunity probably wouldn't be possible with the vaccines we currently have.
In a May 2021 paper on the same theme published in the journal Eurosurveillance, Kucharski and his co-authors explain that much of herd immunity also depends on how well the vaccines prevent transmission -- the act of an infected person passing the virus to someone else.
Vaccines that prevent transmission are said to convey sterilizing immunity. The measles vaccine creates sterilizing immunity. The Covid-19 vaccines do not. While vaccination reduces the chances that you might pass Covid-19 to someone else, contact tracing studies have shown it still happens.
If not enough people get vaccinated -- which has to be virtually the entire population for highly contagious variants -- or the vaccines we have don't stop nearly all transmission, we may not be able to reach herd immunity for Covid-19 until most people have developed immunity after getting the infection, Kucharski wrote in the article.
There are other factors to take into account, too, such as the durability of immunity over time.
"Not only is vaccine induced immunity not lifelong, but infection induced immunity is not lifelong," Fauci said, which means we're going to need repeated exposures to either vaccines or infection to keep our defenses up to speed.
Holding out hope
Some are not ready to completely give up on the idea, however.
Barry Bloom is an emeritus professor of public health at Harvard University. He says one way to get there would be to make better vaccines.
Companies are working on vaccines that would target more stable regions of the virus, including the stem of the spike protein, that doesn't appear to mutate as much. That might create more durable immunity that could stand up to to the shape-shifting of the viruses' variants.
There are also promising nasal spray vaccines that may help develop antibodies in nose and throat. The hope is that these vaccines may generate immunity in the tissues its most needed to create the kind of sterilizing immunity that prevents transmission.
If not a vaccine in a nasal spray, Bloom says, why not put monoclonal antibodies in a spray you could take daily before leaving home to prevent transmission of the virus?
"And the question is are they good enough to wipe it [the virus] out before they're asymptomatically transmitted? Or is it a constant game that we're going to have to live with?" Bloom said in an interview with CNN.
Or, Bloom says, maybe the best we can expect is an assist from evolution. He says the virus is changing to become more contagious over time, but not necessarily to cause more serious disease. Ultimately, killing a person doesn't do the virus much good. It needs hosts. It would be much better for the virus to evolve to become as contagious as it can be, but maybe with less propensity for causing severe disease.
Bloom thinks this is probably what happened to the coronaviruses that now cause common colds. He thinks they probably once started as fierce predators but evolved over time to just be pests.
That way, they get to live on, but so do we.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://www.albanyherald.com/features/health/is-herd-immunity-for-covid-19-still-possible/article_242d2dc5-0c44-5e12-a17a-ee05f1ff3a41.html | 2022-04-15T17:25:31Z |
Appeals court to consider paving way for Purdue Pharma deal
By GEOFF MULVIHILL
Associated Press
A federal appeals panel is considering whether to allow a legal move that would pave the way for a settlement between OxyContin maker Purdue Pharma and governments across the U.S. The deal would allow the company to exit bankruptcy and require members of the Sackler family who own it to contribute billions of dollars to help combat the opioid crisis in the U.S. At issue at a hearing Friday before the 2nd U.S. Circuit Court of Appeals in New York is whether a bankruptcy judge has the authority to grant members of the Sackler family protection from civil lawsuits over the toll of opioids. | https://localnews8.com/news/2022/04/29/appeals-court-to-consider-paving-way-for-purdue-pharma-deal/ | 2022-04-29T11:57:11Z |
DECADES OF PATERNALISM AND HIGH MORTALITY DIALYSIS CHALLENGED
KIDNEY PATIENT CONSUMERS DEMAND CARE CHOICE AND ACCESS
WASHINGTON, Aug. 26, 2022 /PRNewswire/ -- The American Association of Kidney Patients (AAKP), the largest independent kidney patient organization in the USA, and its strategic partners at The George Washington University (GW) School of Medicine & Health Sciences (SMHS) hosted their 4th Annual Global Summit on Kidney Innovations entitled "Global Kidney Patient Voice™ - The Key to Accelerating Innovations," on August 23-24, 2022. Since 2019, the Summit has grown its reach to nearly 90 countries and audiences in the tens of thousands and is now the largest patient-led innovations summit in the world. For 2022, the Summit engaged new participants from Nepal, Bosnia and Herzegovina, Iraq, and Kazakhstan. The 2022 event included 15 sessions and over a combined 60 patient expert, government, medical, and industry speakers. All 2022 Global Summit presentations will be available OnDemand through the AAKP website and AAKP YouTube Channel and will continue to reach additional viewers across the world to increase the AAKP and GW SMHS reach exponentially of this year's Global Summit content.
The 2022 Summit showcased the massive worldwide shift in patient expectations, advocacy, science, innovation, and public policy related to kidney diseases and treatments. Kidney disease medicine and treatments are undergoing the greatest transformations in decades as patients organize to impact policy and accelerate research as new companies and investors enter the field. Status quo kidney care, especially in-center dialysis, is a legacy of the last century defined by extremely high burdens, including patient disability and mortality, loss of work and dependency on unemployment assistance, and steep costs to taxpayers and societies. COVID-19 has exacerbated existing disease burdens for patients and remains a serious threat to the kidney patient population globally. Kidney patients are extremely vulnerable to COVID-19 due to the multiple chronic conditions they manage, compromised immune systems, and, for kidney transplant recipients, immune suppression therapies that limit the effectiveness of COVID-19 vaccines and therapeutics.
The Summit is a key component of AAKP's Decade of the Kidney™ initiative, launched in 2019 to organize patients internationally to become more involved in kidney research, clinical trials, industry-led innovations and public policy, and to deliver new life-saving treatments within the lifetime of most patients. AAKP is linking and coordinating patient consumers and patient advocacy organizations across the globe to elevate kidney disease as a health, policy, economic, and workforce priority. AAKP and allied professional organizations support innovations and care choices aimed at earlier disease detection and safer and more patient-centered treatments that prevent or slow disease progression. AAKP and its allies advocate for pre-emptive organ transplants, home dialysis, artificial implantable and wearable organs, and xenotransplants.
In the past several years, the U.S. Food and Drug Administration and regulatory bodies across the globe have approved new, safe therapies that improve kidney patient quality of life while reducing disease burdens.
AAKP trains and mobilizes patients to overcome barriers to care choice and access, especially government policies and provider and insurance company practices that intentionally thwart patient care choice and access to timely treatments and new innovations. In the U.S., AAKP recently launched its Patient Voice Patient Choice™ initiative to hold elected leaders, the Centers for Medicare and Medicaid Services (CMS), and health insurance companies fully accountable for decisions that interfere with patient choice and access (www.patientvoicepatientchoice.org). AAKP is working with patients across the globe to establish similar accountability initiatives within their own countries.
Dr. Barbara L. Bass, Vice President for Health Affairs, Dean of the GW SMHS, and CEO of the George Washington Medical Faculty Associates, opened this year's Global Summit. The first session featured AAKP International Ambassadors representing Nepal, India, Germany, Australia, and Canada who are working within their own nations to elevate patient insights and patient engagements in public policy, clinical trials, and medical innovations. Patients moderated all sessions and were joined by international experts including: Dr. Raymond Vanholder, MD, PhD, Professor of Medicine, University of Ghent and Clinical Head of the Nephrology Division of the Ghent University Hospital, Belgium, and President, European Kidney Health Alliance (BELGIUM); Dr. Murray Sheldon, MD, Associate Director of Technology and Innovation, U.S. Food and Drug Administration (FDA), Center for Devices and Radiologic Health (CDRH) (USA); Dr. Michael T. Osterholm, PhD, MD, Regents Professor and McKnight Presidential Endowed Chair in Public Health and Director of the Center for Infectious Disease Research and Policy, University of Minnesota (USA); Jack Fisher, Technical Officer, Global Coordination Mechanism on Non-Communicable Diseases, Global Non-Communicable Disease Platform, Deputy Director General's Office, World Health Organization, Geneva (SWITZERLAND); Dr. Manikkam Suthanthiran, MD, Stanton Griffis Distinguished Professorship in Medicine, Professorships in Biochemistry and Surgery in Medicine, Cornell University Medical College, Founding Chairman of the Department of Transplantation Medicine, and Chief of Nephrology and Hypertension at New York-Presbyterian/Weill Cornell Medical Center, Co-Chair, Executive Transplantation Council of the Multi-Organ Program of Columbia and Cornell, New York-Presbyterian Hospital (USA); Dr. Robert A. Star, MD, Director, Division of Kidney, Urologic, and Hematologic Diseases, Section Chief, Renal Diagnostics and Therapeutics Unit, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (USA); Dr. Benno Kitsche, MD, Specialist in Internal Medicine, Nephrology, and Hypertension, DHL, Chairman, Board for the further development and promotion of home dialysis, KfH Board of Trustees for Dialysis and Kidney Transplant (GERMANY); Melissa Flathmann, Consumer Reviewer Administrator, Peer Review and Science Management, Congressionally Directed Medical Research Program, U.S. Department of Defense (USA); Ann M. Dodelin, MA, Consumer Reviewer Administrator, Sr., Peer Review and Science Management, Congressionally Directed Medical Research Program, U.S. Department of Defense (USA); Dr. Fokko Wieringa, PhD, (2021 KidneyX Artificial Kidney Prize Winner), Principal Scientist, IMEC, The Netherlands, Dutch Kidney Foundation, Member, Kidney Health Initiative (NETHERLANDS).
AAKP President Richard Knight, a 16-year kidney transplant recipient, stated, "Kidney disease is a devastating disease that is rapidly expanding and negatively impacting patients, families, and economies throughout the world. Future innovations in kidney medicine depend upon greater patient engagement through fully inclusive clinical trials and research. As stated in my opening remarks, educating people about kidney disease prevention and their choice of treatments and new innovations is a humanitarian act." Knight serves on the NIH/NIDDK Advisory Council, is Co-Chair of the Strategic Plan Stakeholder Engagement Subgroup, and Co-Chair of the Community Engagement Committee for the Kidney Precision Medicine Project (KPMP).
Dr. Dominic Raj, Director of the Division of Kidney Diseases & Hypertension, The George Washington University School of Medicine and Health Sciences, and Co-Chair of the Global Summit, stated, "We have witnessed a resurgence in drug development for kidney disease over the last five years with a significant increase in drugs in the pipeline and clinical trials. The current movement in nephrology is driven by the increasing societal and economic burden imposed by CKD as well as scientific advances that have enabled the discovery of new drug targets."
Paul T. Conway, a 42-year kidney patient, Co-Chair of the Global Summit, and AAKP Chair of Policy and Global Affairs, stated, "AAKP is fortunate to have created a global platform to share patient insights, expand patient impact on innovation policies, and actively support courageous professionals and companies working to expand care choice and treatment innovations. Kidney patient consumers have the will and capacities to transcend status quo care, and we are executing that vision. But, as we celebrate our progress, we stand in full support of fellow kidney patients who live under regimes that reject universal human rights and are hostile to requests by patients to have a voice and choice in their own treatments and outcomes." Conway is a former Chief of Staff of the United States Department of Labor and serves on the Nephrology Specialty Board of the American Board of Internal Medicine (ABIM).
AAKP's Decade of the Kidney™ has garnered widespread international attention and support. In June of 2022, the European Kidney Health Alliance (EKHA) formally expanded its ongoing involvement in The Decade of the Kidney™ initiative by including it in the theme of their annual European Kidney Forum before the European Parliament in Brussels. AAKP leaders joined patients and elected officials from across the EU to discuss patient demands for greater innovations, including artificial organs and access. For the past year, AAKP has also been actively engaged with the World Health Organization (WHO) in a new engagement framework to elevate the lived experiences and sense of urgency shared by patients across the world within WHO deliberations and agenda setting.
AAKP and GW SMHS thanks its 2022 Global Summit sponsors: Gold Level, Novartis; Silver Level, Kibow Biotech; Bronze Level, Horizon Therapeutics and Travere Therapeutics; Patron Level, Mallinckrodt Pharmaceuticals; and Supporting Level, Talaris Therapeutics. Information on the 2023 Global Summit will be listed at https://aakp.org/programs-and-events/global-summit/ as it becomes available.
About the American Association of Kidney Patients (AAKP): Since 1969, AAKP has been a patient-led organization driving policy discussions on kidney patient consumer care choice and treatment innovation. In 2018, AAKP established the largest U.S. kidney voter registration program, KidneyVoters™. Over the past decade, AAKP patients have helped gain lifetime transplant drug coverage for kidney transplant recipients (2020); new patient-centered policies via the White House Executive Order on Advancing American Kidney Health (2019); new job protections for living organ donors from the U.S. Department of Labor (2018); and Congressional legislation allowing HIV-positive organ transplants for HIV-positive patients (2013). Follow AAKP on social media at @kidneypatient on Facebook, @kidneypatients on Twitter, and @kidneypatients on Instagram, and visit www.aakp.org for more information.
About the GW School of Medicine and Health Sciences: Founded in 1824, the GW School of Medicine and Health Sciences (SMHS) was the first medical school in the nation's capital and is the 11th oldest in the country. Working together in our nation's capital, with integrity and resolve, the GW SMHS is committed to improving the health and well-being of our local, national, and global communities. Visit their website at smhs.gwu.edu.
MEDIA CONTACT:
Jennifer Rate
Marketing & Communications Manager
jrate@aakp.org
(813) 400-2394
View original content to download multimedia:
SOURCE American Association of Kidney Patients | https://www.wibw.com/prnewswire/2022/08/26/global-kidney-summit-mobilizes-patients-care-innovation/ | 2022-08-26T12:21:54Z |
As pools and beaches open for Memorial Day, experts warn a nationwide lifeguard shortage could prove deadly
By Christina Maxouris, CNN
Across the US, millions of students are marking the end of another school year and preparing for summer festivities, and likely high on their list is getting some time under the sun.
But a nationwide lifeguard shortage will likely curb those plans for some, as cities around the country take measures to combat the lack of personnel, including keeping some pools and beaches closed.
Austin, Texas, will have fewer than half its city pools open by early June, officials there told CNN. The city has been able to hire just over 30% of the 750 lifeguards required to operate all the pools, according to a news release. Wisconsin’s Milwaukee County is keeping 10 pools closed for now, with officials telling CNN affiliate WISN they have hired about 56 lifeguards of the 300 they would need. Roughly half an hour away, Waukesha County leaders announced last week all of its park system beaches operate under Swim At Your Own Risk rules, and will not have lifeguards “due to the labor shortage.” Similar closure or reduced operation announcements in Indiana, Colorado, and parts of Pennsylvania.
Around a third to nearly half the nation’s more than 300,000 pools will likely be affected as the summer begins, according to an estimate from Bernard J. Fisher II, director of health and safety of the American Lifeguard Association.
“We definitely have a shortage,” Fisher said. “The worst I’ve ever seen.”
Dwindling interest in lifeguarding is not a new problem, according to some experts, but was exacerbated by the Covid-19 pandemic, when many pools and training sessions were shuttered and many of the young applicants who would normally apply are now choosing retail or restaurant jobs that offer higher pay. Having unmanned pools can be dangerous or even deadly, Fisher said.
But leaders in the field say this moment also offers an important opportunity to reshape the narrative around the job: how it’s perceived by the public, who can do it, how much it pays and why it is so important.
“We’ve got to keep up pay rates, we’ve got to keep up motivating these lifesavers and making sure that everybody understands that at the end of the day, there is no better job than being a sort of lifesaver,” Tom Gill, vice president of the United States Lifesaving Association, a nonprofit representing beach lifeguards and open water rescuers.
Where are all the lifeguards?
Long before Covid-19, the lifeguard profession was already battling a set of challenges: a low pay following the training costs required to sit on the chair, a limited working season, and a negative — or often indifferent — public perception.
Beach lifesavers usually go through different training to be able to work on the less predictable waterfront but are facing the same hiring struggles as pool lifeguards, Gill said.
“The average pay has always been bare minimum,” said Lieneke Keihl, who works as an instructor trainer with the American Red Cross based out of Dayton, Ohio. “(Young people) are opting for jobs that pay more money.”
To combat the shortage this year, cities across the country have upped their pay, waived training fees and are offering extra cash to bring more applicants through the door. The city of Boulder, Colorado, increased their lifeguard wages to about $15.25 per hour, up from an average of $12 roughly four years ago and $13 last year. The city is also reimbursing people for the training costs associated with the job, according to Jonathan Thornton, a spokesperson for the city.
Lifeguard training courses cost in the range of a few hundred dollars, depending on the level of certification, according to several websites of organizations offering training, including the Red Cross, the YMCA and the United States Lifesaving Association.
“The only reason why the employers have gotten away with the pay is due to the fact that we rely on the youth that doesn’t have to pay rent,” said Fisher, with the lifeguard association. “We’re going to have to raise the pay. We’re going to have to give incentives to get the numbers that we need.”
Phoenix, Arizona, officials announced earlier this year they’re offering a $2,500 bonus incentive for lifeguards, partly as a reimbursement for training costs. The base hourly wage there is roughly $14.02, officials said in a March news release. In Texas, Austin officials upped their pay to ranges of $16 to $19 an hour, and added roughly $1,250 in bonuses, along with paid sick leave and a free bus pass.
Austin had no trouble recruiting before Covid-19, hiring more lifeguards in 2019 than any other year, according to Jodi Jay, assistant director for the city’s Parks and Recreation department. But the pandemic “stopped us in our tracks,” forcing a training and hiring freeze which lasted for more than a year and the effects of which still linger, Jay said.
“When we started back up in March of 2021, we were limited on how many lifeguards we could have in a class and so that impeded our ability to get to (the needed) 750 last year,” Jay said. “So this will be our second summer that we’ve had trouble recruiting lifeguards but most recently we’ve just had a hard time getting people to return to work as we leave the pandemic.”
And there’s another pool of applicants many agencies have not been able to pull from, which usually helped boost numbers: foreign citizens.
“A number of our agencies depend on foreign workers at times, especially when you talk about filling those roles at the end of summer,” when many younger Americans return to school or start athletics again, Gill said.
Many of those workers were able to come to the US under J-1 visas, which approve people to come to the US to participate in work and study-based programs. But a Trump-era executive order temporarily banned visas including the J-1 during the pandemic. And officials battled massive backlogs of applications after President Joe Biden revoked the order last summer.
Nearly 4,000 drownings annually
The training and hiring freezes across the country also meant there were fewer swimming lessons conducted, so many young children are now coming into pools and beaches for the first time, experts say.
More than 3,900 American children die of drowning each year, for an average of 11 deaths each day, according to the US Centers for Disease Control and Prevention. There are roughly another 8,000 nonfatal drownings annually, which can cause brain damage and other serious outcomes, like long-term disabilities, according to the CDC.
Water Safety USA, a group of nonprofit and governmental organizations, like the US Coast Guard and the American Academy of Pediatrics, has said the most important drowning prevention strategies include learning how to swim and having supervision by people who can prevent, recognize and respond to someone who is drowning, such as lifeguards.
Thornton, with the city of Boulder, said because of the halt on lessons throughout the pandemic, his eight-year-old son hasn’t learned how to swim yet.
“He’s not the only one,” Thornton said. “So you’re going to have, maybe not a generation, but you’re going to have quite a few kids that have not learned to swim because of this, because you don’t have lifeguards, because you don’t have staff.”
And even the lifeguard shortage prompts some pools and beaches to close, some American children will still find places to swim over the summer, which likely would be unsupervised and dangerous, Fisher said.
“Kids will jump a fence, or they’ll go find a canal, a waterfront that’s unguarded, and they’ll go swimming,” Fisher said.
‘Superheroes wanted’
Despite the role’s importance, leaders in the field say lifeguards have usually been disregarded and not considered as public safety professionals, even though their services are literally lifesaving.
“The public perceives lifeguards to have a sort of do-nothing job,” Keihl, the instructor said. “They see them sitting in the chair, they see them twirling a whistle … they don’t see any rescues.”
“What the public forgets is, first of all, there’s quite a bit of training. There’s a minimum of 20-some hours every two years,” Keihl said. “(And) if a lifeguard is doing their job correctly, they don’t have to make any saves because they catch it before it happens.”
It is why this year in Boulder, city officials decided to recruit lifeguards by highlighting the most important part of the job: saving lives.
“We started a marketing campaign called ‘Superheroes Wanted.’ And we took pictures of our lifeguards wearing capes and masks,” Thornton said. “It just resonated with our community.”
Gill, with the national lifesaving association, said similar efforts are helping push the “do-nothing” narrative offstage. “People more and more recognize lifeguards as true first responders, a part of the public safety community, and the importance … of having those lifeguards out there, which is leading to better pay, more respect, better conditions.”
And the shortage this year offers is a good opportunity to rethink not only how these jobs are advertised and compensated, but also who departments are recruiting to fill the roles, experts say.
“I’m trying to promote, if at all possible, a whole different kind of audience for lifeguards,” Keihl said. “Let’s ask the retired folks, people that used to be on the swim team many years ago, who are just enjoying recreational swimming.”
“I just think we need to think outside that 15-year-old category,” Keihl added.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/news/national-world/cnn-national/2022/05/29/as-pools-and-beaches-open-for-memorial-day-experts-warn-a-nationwide-lifeguard-shortage-could-prove-deadly-2/ | 2022-05-29T11:06:57Z |
CHONGQING, China, Aug. 23, 2022 /PRNewswire/ -- The 2022 Smart China Expo is held in southwest China's Chongqing from August 22 to 24. Western China (Chongqing) Science City brought 112 exhibits from more than 60 enterprises, displaying 5 chips and many new products developed in the fields of integrated circuits and core components.
On the first day of the event, Western China (Chongqing) Science City signed contracts for key projects such as SAIC Artificial Intelligence Innovation Center and Chongqing Intelligent and Connected Automobile Innovation Center, with a total investment of over 30 billion yuan, involving fields like life and health, software and intelligent and connected automobiles.
In addition to leveraging the platform of the Smart China Expo, the Western China (Chongqing) Science City has continued to increase the introduction of talents, and promote the upgrading of the business environment through cutting red tapes and enriching services to help enterprises grow faster. The science city has rolled out a set of preferential policies to lure inbound inflow of talents, innovation, industry and finance across the world so as to create an innovation-empowered new engine in its development.
In recent years, Western China (Chongqing) Science City has centered on digital industrialization and industrial digitalization. It has rolled out the strategic action plan for innovation-driven development led by big data intelligence and accelerated the transformation of traditional industries into high-end, intelligent and green ones to turn scientific and technological innovation into the booster for industrial transformation and upgrading.
High-tech and emerging sectors are major features of the city's industrial layout, with a focus on building advanced manufacturing industry agglomeration, especially gathering steam on becoming a high ground in intelligent and connected new energy vehicles.
From January to July this year, the output value of digital economy in the core area of Western China (Chongqing) Science City reached 139.7 billion yuan, a year-on-year expansion of 12 percent. The number of high-tech enterprises climbed by 103, with a growth rate of 75 percent. The number of scientific research institutions rose by 48, and 78 enterprises carried out 138 intelligent transformations, and 8 intelligent factories and 20 digital workshops were built. The science city's automobile industry maintained rapid growth, with its output value increasing by 64.7 percent over one year ago.
According to the plan, the science city will basically form a coordinated development pattern of intelligent and connected new energy vehicle, intelligent transportation, intelligent facilities and smart city. A whole industry ecosystem featuring automobiles, roads, cloud computing, networks and maps will be in place initially. The intelligent and connected new energy automobile industry will be one of the top performers in China. Meanwhile, a demonstration base of intelligent and connected new energy vehicle industry high-quality development in western China will be built in the science city.
Image Attachments Links:
Link: http://asianetnews.net/view-attachment?attach-id=427907
Caption: As the new model of Chongqing's laboratories and the new force of national laboratories created by Western China (Chongqing) Science City, Jinfeng Laboratory has completed the expert review by the first batch of scientific research teams.
View original content to download multimedia:
SOURCE Western China (Chongqing) Science City | https://www.kxii.com/prnewswire/2022/08/23/empowered-by-digital-economy-western-china-chongqing-science-city-gains-fresh-growth-steam-industrial-development/ | 2022-08-23T15:14:51Z |
FREMONT, Calif., Aug. 24, 2022 /PRNewswire/ -- ASUS, a global technology leader renowned for continuously reimagining today's technologies for tomorrow, has collaborated with the world's first basketball developer, Spalding, to unveil the limited-edition ROG x Spalding basketball.
ROG and Spalding have a long history of providing athletes with high-performance equipment that allows them to perform and compete at their best, both on and off the court. Constructed of a hand-bonded synthetic composite, the ROG x Spalding basketball is built from the ground up with materials that meet exacting ROG standards. With its snakeskin-embossed surface, black finish, and pixelated markings, it makes an unforgettable style statement. An included ROG drawstring bag protects the ball as it is taken to and from the court, and its custom stand holds it securely when it is on display.
To celebrate the release of the ROG x Spalding basketball, ASUS will be teaming up with basketball superstar Seth Curry with a special livestream event.
Livestream with Seth Curry
Seth is passionate about bridging the gap between gaming and sports culture, so he's excited to see ROG and Spalding team up for our new basketball. "Gaming and sports culture has always been connected, with so many players gaming and bringing their setups on the road," Seth explained. "The competitiveness of sports culture also translates to gaming, especially in the online community." Learn more about Seth's passion for gaming and PC building here.
On August 27th, online fans can tune into a Call of Duty livestream with Seth Curry starting at 4PM PT/6PM CT/7PM ET on the ROG Twitch Channel. Watch the livestream closely to learn how to enter for a chance to win some major prizes in chat. Prizes include an ROG x Spalding basketball, a Seth Curry Brooklyn Nets Jersey, an ROG Maximus Z690 Hero motherboard, several ROG branded swag kits, and finally a premium gaming peripherals kit that includes an ROG Chakram Core mouse, an ROG Strix Flare II Animate keyboard and an ROG Delta S Animate headset.
ROG x Spalding basketball at PAX West 2022
The ROG x Spalding basketball will be displayed at the Seattle Convention Center, in Seattle, WA starting on September 2-5th. Stop by the ROG booth (#817) booth for a close look at the basketball, play on the latest ROG products and enter the daily raffle to win amazing prizes. Three lucky winners will have an opportunity to win a Seth Curry Brooklyn Nets jersey. Make sure to visit the booth to learn how to enter the giveaways.
To learn more about upcoming events with Seth Curry, visit www.asus.com/event/pcdiy/us/.
For more information about ASUS, visit www.asus.com/us.
About ASUS
ASUS is a global technology leader that provides the world's most innovative and intuitive devices, components, and solutions to deliver incredible experiences that enhance the lives of people everywhere. With its team of 5,000 in-house R&D experts, ASUS is world-renowned for continuously reimagining today's technologies for tomorrow, garners more than 11 awards every day for quality, innovation, and design, and is ranked among Fortune's World's Most Admired Companies.
View original content to download multimedia:
SOURCE ASUS Republic of Gamers | https://www.wibw.com/prnewswire/2022/08/24/asus-republic-gamers-teams-up-with-seth-curry-celebrate-release-rog-x-spalding-basketball/ | 2022-08-24T15:41:35Z |
The Company's retail presence grows to 51 locations in the Sunshine State and 137 nationwide
WAKEFIELD, Mass., July 29, 2022 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, announced today the opening of its Tampa Citrus Park dispensary, located at 10612 Sheldon Road, Tampa, FL 33626. Curaleaf Tampa Citrus Park expands the Company's retail presence to six locations in Hillsborough County and 51 across the Sunshine State.
Located on Sheldon Road near Citrus Park, the 4,023 square foot location features a drive-thru that offers patients on-the-go access to the dispensary's wide array of offerings. Patients can access a premium selection of vaporizers, edibles, and whole flower products, including BlueKudu Chocolate, Select Squeeze, Select X-Bites, Select Elite, Elite Live and Live Rosin vape cartridges, as well as other concentrates by Curaleaf.
"It is a pleasure to continue to expand access to medical cannabis in the Sunshine State, specifically Hillsborough County," said Matt Darin, CEO of Curaleaf. "Curaleaf Tampa Citrus Park is our ninth drive-thru in Florida, which enables our team to provide a more convenient and streamlined retail cannabis experience."
For more information on Curaleaf Tampa Citrus Park grand openings, along with product offerings and hours of operation, please visit https://curaleaf.com/locations#florida.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States, Curaleaf currently operates in 22 states with 137 dispensaries, 26 cultivation sites, and employs over 5,700 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.
This media advisory contains forward–looking statements and forward–looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward–looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as "plans", "expects" or, "proposed", "is expected", "intends", "anticipates", or "believes", or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. More particularly and without limitation, this news release contains forward–looking statements and information concerning the opening of Curaleaf Tampa Citrus Park. Such forward-looking statements and information reflect management's current beliefs and are based on assumptions made by and information currently available to the company with respect to the matter described in this new release. Forward-looking statements involve risks and uncertainties, which are based on current expectations as of the date of this release and subject to known and unknown risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Additional information about these assumptions and risks and uncertainties is contained under "Risk Factors and Uncertainties" in the Company's latest annual information form filed March 9, 2022, which is available under the Company's SEDAR profile at http://www.sedar.com, and in other filings that the Company has made and may make with applicable securities authorities in the future. Forward-looking statements contained herein are made only as to the date of this press release and we undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by law. We caution investors not to place considerable reliance on the forward-looking statements contained in this press release. The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
INVESTOR CONTACT
Curaleaf Holdings, Inc.
IR@curaleaf.com
MEDIA CONTACTS
Curaleaf Holdings, Inc.
Tracy Brady, SVP Corporate Communications
Media@curaleaf.com
View original content:
SOURCE Curaleaf Holdings, Inc. | https://www.mysuncoast.com/prnewswire/2022/07/29/curaleaf-celebrates-opening-tampa-citrus-park-dispensary/ | 2022-07-29T12:56:22Z |
This content is only available to subscribers.
The Memorial Day Flash Sale. Extended!
$9.99 for a Year
Your subscription supports:
Are you a subscriber with digital access?
Sign in to your accountAre you a subscriber without digital access?
Activate your digital accountAre you a subscriber without digital access?
Activate your digital accountThis content is only available to subscribers.
The Memorial Day Flash Sale. Extended!
$9.99 for a Year
Your subscription supports:
Are you a subscriber with digital access?
Sign in to your accountAre you a subscriber without digital access?
Activate your digital account | https://www.cantonrep.com/restricted/?return=https%3A%2F%2Fwww.cantonrep.com%2Fstory%2Flifestyle%2Fmagazine%2F2022%2F06%2F06%2Finnis-maggiores-ashley-johnson-honored-twenty-under-40-recipient-stark-county-young-professionals%2F9509618002%2F | 2022-06-06T13:23:55Z |
Two children are among the six people who died in a Montana pileup after a Friday evening dust storm caused blackout conditions on Interstate 90, a major route in both Montana and the Western U.S.
Montana Highway Patrol Sgt. Jay Nelson said investigators so far have found no other factors that contributed to the pileup that also sent eight other injured people to hospitals.
“Everything is indicative of an isolated extreme weather event,” Nelson said of the investigation, calling the crash among the worst he’d seen in 24 years with the state. “What could people do? It really was just panic.”
The pileup was just west of Hardin, with additional ambulances called in from Billings to help. The identities of the dead and conditions of the survivors are not yet being released.
The crash was reported around 4:30 p.m., as 21 vehicles, including six commercial semi-trucks, lost control in the dust storm that was fueled by gusts topping 60 mph (97 kph), authorities said.
Nelson said there was zero visibility for a mile-long stretch during a peak summer traffic hour for those commuting home from work or traveling for outdoor recreation.
It took more than six hours to fully reopen the road.
“We had a lot of debris and complete chaos,” Nelson said.
Gov. Greg Gianforte said on Twitter: “I’m deeply saddened by the news of a mass casualty crash near Hardin. Please join me in prayer to lift up the victims and their loved ones. We’re grateful to our first responders for their service.”
Montana Attorney General Austin Knudsen said in a statement that the Montana Highway Patrol, which he oversees, was investigating. “We will release more information as it becomes available and is appropriate out of respect of the lives lost and their loved ones.
A video from The Billings Gazette showed hundreds of tractor-trailers, campers and cars backed up for miles along the two eastbound lanes of the interstate.
Before the pileup, storms popped up in central southern Montana between 1 and 2 p.m. and slowly began moving east, said Nick Vertz, a National Weather Service meteorologist in Billings.
Those storms prompted a severe thunderstorm watch that covered Hardin and other parts of Montana from mid-afternoon until 9 p.m. Friday. Meteorologists forecasted the potential for isolated hail the size of a quarter, scattered gusts up to 75 mph (121 kph) and frequent lightning.
A so-called outflow — or a surge of wind that’s produced by storms — flew about 30 miles (48 kilometers) ahead of the storms, Vertz said.
Winds picked up quickly around the time of the crash, according to readings at nearby Big Horn County Airport. A 40 mph gust (64 kph) was recorded about 15 minutes before the crash was reported and in less than an hour another burst of wind hit 64 (103 kph).
The wind easily picked up dust — a product of recent temperatures into the 90s and triple digits over the last week — and reduced visibility to less than 1/4 mile (0.4 kilometers).
“If they looked up in the sky while they’re in Hardin, they probably didn’t see much of what you’d think of for a thunderstorm cloud, maybe not even much at all,” Vertz said. “It was just a surge of wind that kind of appeared out of nowhere.” | https://cw33.com/news/u-s-news/ap-us-headlines/6-people-die-after-storm-causes-montana-highway-pileup/ | 2022-07-17T03:21:30Z |
LOS ANGELES (AP) — Southern California’s gigantic water supplier took the unprecedented step Tuesday of requiring about 6 million people to cut their outdoor watering to one day a week as drought continues to plague the state.
The board of the Metropolitan Water District of Southern California declared a water shortage emergency and required the cities and water agencies it supplies to implement the cutback on June 1 and enforce it or face hefty fines.
“We don’t have enough water supplies right now to meet normal demand. The water is not there,” Metropolitan Water District spokesperson Rebecca Kimitch said. “This is unprecedented territory. We’ve never done anything like this before.”
The Metropolitan Water District uses water from the Colorado River and the State Water Project to supply 26 public water agencies that provide water to 19 million people, or 40% of the state’s population.
But record dry conditions have strained the system, lowering reservoir levels, and the State Water Project — which gets its water from the Sacramento-San Joaquin River Delta — has estimated it will only be able to deliver about 5% of its usual allocation this year.
January, February and March of this year were the driest three months in recorded state history in terms of rainfall and snowfall, Kimitch said.
The Metropolitan Water District said that the 2020 and 2021 water years had the least rainfall on record for two consecutive years. In addition, Lake Oroville, the State Water Project’s main reservoir, reached its lowest point last year since being filled in the 1970s.
California Gov. Gavin Newsom has asked people to voluntarily reduce their water consumption by 15%, but so far residents have been slow to meet that goal.
Several water districts have instituted water conservation measures. On Tuesday, the board of the East Bay Municipal Utility District voted to reduce water usage by 10% and cap daily usage for some 1.4 million customers in Contra Costa and Alameda counties, including Oakland and Berkeley. Households will be allowed to use 1,646 gallons (6,231 litres) per day — far above the average household usage of about 200 gallons (757 litres) daily — and the agency expected that only 1% to 2% of customers will exceed the limit, the San Francisco Chronicle reported.
The Metropolitan Water District restrictions apply to areas of Los Angeles, Ventura and San Bernardino counties that rely mostly on state water supplied through the district, including some parts of Los Angeles city. Mainly urban areas are impacted.
The MWD’s client water agencies must implement either the one-day-a-week outdoor use restriction or find other ways of making equivalent reductions in water demand, Kimitch said.
Although the water agencies support the water conservation move, it remains to be seen whether the public will do it, Kimitch said.
The Metropolitan Water District will monitor water use and if the restrictions don’t work, it could order an all-out ban on outdoor watering as soon as September, she said.
Meanwhile, state lawmakers have taken the first step toward lowering the standard for how much water people use in their homes.
California’s current standard for residential indoor water use is 55 gallons (208 liters) per person per day. The rule doesn’t apply to customers, meaning regulators don’t write tickets to people for using more water than they are allowed. Instead, the state requires water agencies to meet that standard across all of its customers.
But the state Senate overwhelmingly voted last week to lower the standard to 47 gallons (178 liters) per person per day starting in 2025 and 42 gallons (159 liters) per person per day beginning in 2030.
The bill has not yet passed the Assembly, meaning it is still likely months away from becoming law.
The U.S. West is in the middle of a severe drought just a few years after record rain and snowfall filled reservoirs to capacity. Scientists say this boom-and-bust cycle is driven by climate change that will be marked by longer, more severe droughts. A study from earlier this year found the U.S. West was in the middle of a megadrought that is now the driest in at least 1,200 years. | https://cw33.com/news/u-s-news/ap-u-s-headlines/millions-must-cut-water-use-in-drought-stricken-california-2/ | 2022-04-27T19:01:46Z |
Elon Musk says he has $46.5B in financing ready to buy Twitter
(AP) - Elon Musk says he has lined up $46.5 billion in financing to buy Twitter, putting pressure on the company’s board to negotiate a deal.
Last week, Musk announced an offer to buy the social media platform for $54.20 per share, or about $43 billion. At the time, he did not say how he would finance the acquisition.
The Tesla CEO said Thursday in documents filed with U.S. securities regulators that the money would come from Morgan Stanley and other banks, some of it secured by his huge stake in the electric car maker.
Twitter has yet to formally respond to Musk’s offer, but the company has enacted an anti-takeover measure known as a poison pill that could make a takeover attempt prohibitively expensive.
The company said in a statement Thursday that it received Musk’s updated proposal and “new information on potential financing” and said its board is “committed to conducting a careful, comprehensive and deliberate review.”
Musk, who owns about 9% of Twitter shares, indicated that he’s exploring what’s known as a tender offer in which Musk would try to get other shareholders to pledge their stock to him at a certain price on a certain date, bypassing the board. If enough shareholders agree, Musk could use that as leverage to get the board to drop its “poison pill” defense against his offer of $54.20 per share.
But Musk hasn’t decided yet whether to do that.
The poison pill could significantly raise the costs of a takeover. If someone acquires a 15% stake in the company, it would trigger a huge payout to shareholders that could bankrupt Twitter.
Other banks involved in Musk’s financing include Barclays, Bank of America, Societe Generale, Mizuho Bank, BNP Paribas and MUFG. Morgan Stanley is one of Twitter’s biggest shareholders, behind Vanguard Group and Musk.
Musk’s documents say that $13 billion in financing came from Morgan Stanley and the other banks. As much as $12.5 billion would be loans secured by Musk’s Tesla stock, and he also committed $21 billion in direct or indirect equity, although he didn’t disclose the source of those funds. The filing says that the equity commitment could be reduced by contributions from others or additional debt taken on.
Musk is the world’s wealthiest person, according to Forbes, with a nearly $279 billion fortune. But much of his money is tied up in Tesla stock — he owns about 17% of the company, according to FactSet, which is valued at more than $1 trillion — and SpaceX, his privately held space company. It’s unclear how much cash Musk has.
Tesla allows executive officers to use shares as collateral for loans, but limits the borrowing to 25% of the value of the pledged shares. Musk owns 172.6 million shares worth $176.47 billion. Just over 51% of his stake already is pledged as collateral, according to a Tesla proxy statement. That means Musk could use the remaining stake to borrow about $21.5 billion.
Musk’s latest move shows him “ratcheting up the seriousness of purpose” by lining up prominent banks that could finance his bid, said Donna Hitscherich, a finance professor at Columbia University.
“These are the usual suspects if you’d get financing,” she said. “But certainly it’s pointing to the direction that he could make good on his thoughts were he to proceed in launching the tender offer.”
Shares of Twitter rose slightly to $47.04 in Thursday trading after the financing became public. The shares are trading $7.16 below Musk’s offer.
“The market is waiting for this to come to a head” and for competing bidders to come forward, said Olaf Groth, a business professor at the University of California, Berkeley.
The revelation of Musk’s prominent financial backers was “mildly surprising” to Groth because “a lot of his wealth is tied to Tesla performance and Tesla has been on the volatile side of stock performance.” On the other hand, Tesla reported strong quarterly results this week and Musk is “viewed as coming through on things. That may be part of it,” Groth said.
Musk “is seeking to negotiate a definitive agreement for the acquisition of Twitter ... and is prepared to begin such negotiations immediately,” the documents say.
Musk in recent weeks has voiced a number of proposed policy changes at Twitter, from relaxing its content restrictions — such as the rules that suspended former President Donald Trump’s account — to ridding the platform of its problems with fake and automated accounts.
“If our twitter bid succeeds, we will defeat the spam bots or die trying!” he tweeted Thursday.
Once competing bids surface, Twitter’s board can look not just at the financial terms but what specific plans Musk or his competitors have for reshaping the social media business. That’s when Musk’s ideas – many of which he’s tied to free speech principles – could come into play.
“That could be ground for rejecting the offer,” Groth said of the business plans. “Some of that will be (about) money and some of that will be a beauty contest. Some of the board members will also talk about what’s in the public interest.”
____
Tali Arbel contributed from Phoenix. Krisher reported from Detroit. O’Brien reported from Providence, Rhode Island.
Copyright 2022 The Associated Press. All rights reserved. | https://www.mysuncoast.com/2022/04/21/elon-musk-says-hes-ready-buy-twitter-with-465-billion-financing/ | 2022-04-21T21:31:02Z |
DALLAS (KDAF) — Having top-tier players on your favorite NFL team’s roster is a must in this day and age as it has been all throughout the history of the NFL. The New England Patriots didn’t win all of those Super Bowls recently because Tom Brady and his offenses were full of scrubs.
Remember the days of Troy Aikman and Emmitt Smith, Cowboys fans? Elite offensive lines, great wide receivers, and good enough defenses won a couple of Super Bowls in the 90s. Now, the Cowboys still have some solid players on the o-line, good running back(s), one good wide receiver, a stellar QB, and one heck of a defense.
The NFL Network has released the bottom half of the top 100 players in the NFL and three Cowboys saw their names on the list:
- No. 95 CeeDee Lamb
- No. 92 Tyron Smith
- No. 68 Zack Martin
Lamb was unranked in 2021, Smith was also unranked while Martin rose from being ranked No. 85 in the previous year. It’s safe to say that a quarterback, linebacker, and maybe some more defensive and offensive players could make the top half of the NFL’s top 100 players of 2022.
The rest of the top 100 list will be released later in the month ahead of the beginning of the 2022 NFL season. | https://cw33.com/sports/several-dallas-cowboys-players-listed-among-bottom-half-of-nfls-top-100-players-of-2022/ | 2022-08-16T21:18:58Z |
UK man in court over threat to ‘kill queen’ with crossbow
LONDON (AP) — A man who got into the grounds of Windsor Castle armed with a crossbow told police he wanted to “kill the queen,” prosecutors said during a court hearing Wednesday.
Jaswant Singh Chail, 20, is charged under the Treason Act with intending to “injure the person of Her Majesty Queen Elizabeth II, or to alarm her Majesty.” He has also been charged with threats to kill and possession of an offensive weapon.
Chail was arrested at the royal residence west of London on Christmas Day 2021, when the queen was staying there.
Prosecutors allege the former supermarket worker from Southampton in southern England was wearing a hood and a mask and carrying a loaded crossbow with the safety catch off.
They say he told a police officer “I am here to kill the Queen,” before he was handcuffed and arrested.
Prosecutor Kathryn Selby said the Supersonic X-Bow weapon allegedly carried by Chail had the potential to cause “serious or fatal injuries.”
Prosecution lawyers maintain Chail wanted revenge on the British establishment for its treatment of Indians and sent a video to about 20 people claiming he was going to assassinate the queen.
To get close to the royal family, he had tried to join the British Army and the Ministry of Defense Police, prosecutors allege.
Chail appeared remotely for Wednesday’s hearing at London’s Westminster Magistrates’ Court from Broadmoor, a high-security psychiatric hospital.
He was not asked to enter a plea, and was ordered detained until his next court appearance on Sept. 14.
The allegations against him are not being treated as a “terrorism offense,” Selby said.
Charges under the Treason Act of 1842 are rare. In 1981, Marcus Sarjeant was charged under the act after firing blank shots at the queen as she rode on horseback in the Trooping the Color parade in London. He pleaded guilty and was sentenced to five years in prison.
The last person to be convicted under the separate and more serious Treason Act of 1351 was William Joyce, a World War II Nazi propaganda broadcaster known as Lord Haw-Haw. He was hanged for high treason in 1946.
Copyright 2022 The Associated Press. All rights reserved. | https://www.wibw.com/2022/08/17/uk-man-court-over-threat-kill-queen-with-crossbow/ | 2022-08-17T15:04:33Z |
YOKOHAMA, Japan, June 8, 2022 Kyodo JBN-AsiaNet/ -- Yokohama Hakkeijima Inc. has created a series of snow globes -"Microplastic Globe"- using plastic waste collected from the ocean as flakes. These snow globes are currently exhibited at the "Imagine the Future Ocean with Art" exhibition in Tokyo until July 18 to raise awareness of ocean plastic pollution.
YouTube:
https://youtu.be/5yQtNBMOgHo
https://youtu.be/UVnq4TUYrlc
Image1: https://kyodonewsprwire.jp/img/202206062130-O1-u47zoe8l
Image2: https://kyodonewsprwire.jp/img/202206062130-O2-u4nIXTBk
The problem of plastic waste is growing rapidly on a global scale. Millions of tons of plastic waste generated annually by industrial activities end up in the ocean, where they have a negative impact on the marine ecosystem. Yokohama Hakkeijima created the Microplastic Globe to bring attention to this serious issue.
Image3: https://kyodonewsprwire.jp/prwfile/release/M107210/202206062130/_prw_PI3lg_6r61IAY0.jpg
About Microplastic Globe -- Snow Globe of Future Sea
The flakes dancing inside the globes are made of plastic waste actually collected from the ocean, and can be viewed along with designs of five creatures that have already been reported to be affected by marine plastic debris.
Image4: https://kyodonewsprwire.jp/prwfile/release/M107210/202206062130/_prw_PI4fl_s313H4P2.jpg
After the product has served its purpose of raising awareness of the microplastic problem, they will be disposed appropriately under the supervision of experts.
Image5: https://kyodonewsprwire.jp/prwfile/release/M107210/202206062130/_prw_PI5fl_0TEfV0Sd.jpg
Background
Plastic waste is affecting the marine ecosystem in various ways. For example, regarding clownfish, one of the motifs of the Microplastic Globe, it has been reported that their habitat sea anemones are bleached because of microplastics in the ocean(*), suggesting a relationship with the global decline of clownfish. The Microplastic Globe was created to encourage people to think about what they can do to address this issue.
(*) A. Macali, A. Semenov, V. Venuti, V. Crupi, F. D'Amico, B. Rossi, I. Corsi& E. Bergami. "Episodic records of jellyfish ingestion of plastic items reveal a novel pathway for trophic transference of marine litter." Scientific Reports (2018).
About "Imagine the Future Ocean with Art" Exhibition
Sponsor: Yokohama Hakkeijima Inc.
Period: May 31, 2022 (Tuesday) - July 18, 2022 (Monday, holiday), 11:00-18:00
Closed on Mondays, and if Monday is a holiday, the next business day will be closed.
Venue: ITOCHU SDGs STUDIO (Itochu Garden B1F, 2-3-1 Kita-Aoyama, Minato-ku, Tokyo)
Admission: Free
*For more information, please visit the official website:
https://www.itochu.co.jp/ja/corporatebranding/sdgs/20220516.html
View original content:
SOURCE Yokohama Hakkeijima Inc. | https://www.mysuncoast.com/prnewswire/2022/06/08/world-oceans-day-japanese-aquarium-yokohama-hakkeijima-creates-snow-globes-using-microplastic-flakes-raise-issue-ocean-plastic-pollution-microplastic-globe-/ | 2022-06-08T07:33:25Z |
KEY HIGHLIGHTS
- Paradigm has been invited to present results from the mucopolysaccharidosis (MPS) program, with an oral presentation at the XVII International Conference on Lysosomal Diseases (ICLD 2023), to be held in Sydney, Australia, February 20-21, 2023.
- Dr Drago Bratkovic, Head of the Metabolic Clinic at the Adelaide Women's and Children's Hospital, will present the research entitled: Pentosan Polysulfate Sodium: A Potential Treatment to Improve Bone and Joint Manifestations of Mucopolysaccharidosis I.
- Three of the four subjects included in Paradigm's open-label phase 2 trial of pentosan polysulfate sodium (PPS) in MPS-I have completed the 48-week study, with a 6-month treatment extension available.
- Preliminary data from the MPS-I study were previously presented at the 14th International Congress of Inborn Errors of Metabolism in Sydney in 2021 and indicated favourable clinical responses and overall tolerance to PPS.
- In Paradigm's MPS-VI phase 2 trial based in Brazil, 50% of the planned number of subjects have been recruited to the 24-week study comparing PPS to placebo in a blinded, randomised and controlled trial.
- The Safety Monitoring Physician for the MPS-VI study confirmed successful evaluation of subjects aged 16 and above and the study is now scheduled to assess PPS in two younger cohorts (9 to 16 years, then following another safety review, 5 to 9 years).
- During the Bio International Partnering conference in June 2022, Paradigm saw significant interest in its rare disease clinical development program. Paradigm is currently exploring strategic partnerships to progress current and future clinical studies to further evaluate PPS as a treatment to address the critical unmet need in MPS patients.
NEW YORK, Aug. 12, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a late-stage drug development company, is pleased to announce that it is scheduled to present data from the open-label phase 2 study of pentosan polysulfate sodium (PPS) for mucopolysaccharidosis type I (MPS-I) as an oral presentation at the 2023 ICLD meeting. Paradigm is also pleased to provide an update on the ongoing multi-centre double-blind randomised phase 2 study comparing PPS to placebo in mucopolysaccharidosis type VI (MPS-VI) patients.
The mucopolysaccharidoses and related disorders belong to a group of more than 40 inherited lysosomal storage diseases. Lysosomes are the recycling centres of all cells that break down excess or worn-out cell parts with their digestive enzymes. Mucopolysaccharidoses disorders are due to errors with one of the enzymes that break down and recycle glycosaminoglycans (GAGs), previously known as mucopolysaccharides. As these waste products cannot be eliminated, they accumulate within the lysosomes of virtually every type of cell in the body, causing cells, tissues, and organs to function abnormally, leading to progressive damage. The heart, bones, joints, respiratory system, and central nervous system, including cognitive function, may eventually be affected. In most cases, symptoms are not apparent at birth, but emerge gradually as a result of defective lysosomal storage and resulting cell damage over time (1,2). Eleven different types of mucopolysaccharidosis have been described, where each is the result of a deficiency in one of the enzymes in the glycosaminoglycan degradation pathway.
Mucopolysaccharidosis type I is a relentlessly progressive and potentially fatal rare genetic disorder with a spectrum of disease. It is caused by reduction or absence in the amount of enzyme responsible for the catabolism (break down) of glycosaminoglycans, resulting in the progressive GAG accumulation in tissues. The disorder causes problems with neurological, skeletal, and cardiovascular development.
There is no cure and children born with the most severe form of MPS-I do not typically survive beyond 10 years of age without treatment. Current standard treatments include bone marrow transplant and enzyme replacement therapy to address the underlying cause of the disease.
Paradigm is partnering with the Adelaide Women and Children's Hospital in South Australia for a study evaluating PPS as an adjunctive therapy to enzyme replacement therapy and/or haematopoietic stem cell transplantation in an open-label, single-centre, phase 2 trial. The primary aim of the study is to evaluate safety and tolerability of PPS over an initial 48-week period, with a 6-month treatment extension available, in patients treated with the current standard of care. Secondary and exploratory objectives include examining the effects of PPS on pain, function, and quality of life, pharmacokinetics, biomarkers, and inflammatory processes.
Four patients with this rare disease have been enrolled, and three have completed the 48-week treatment regimen with no serious adverse events reported to date. Interim results presented at the 14th International Congress of Inborn Errors of Metabolism in Sydney (2021) indicated an overall trend toward providing meaningful improvements in pain, function, activities of daily living, and overall improvement in quality of life (3). PPS was well tolerated at weekly doses of 0.75 and 1.5 mg/kg for 47 weeks.
The data from the clinical trial participants treated to date is due to be presented at ICLD 2023 to be held in Sydney, Australia, February 20-21, 2023, by Dr Drago Bratkovic, Head of the Metabolic Clinic at the Adelaide Women and Children's hospital. The presentation of the research is titled: Pentosan Polysulfate Sodium: A Potential Treatment to Improve Bone and Joint Manifestations of Mucopolysaccharidosis I. The presentation will report on the safety and effect of pentosan polysulfate sodium in MPS-1 subjects along with clinical data including the clinical endpoints of pain, joint function, activities of daily living and biomarkers of disease.
Paradigm's Global Head of Safety and Head of the MPS program, Dr. Michael Imperiale, said, "Current MPS therapies are essential for MPS patients, however, they don't provide relief from the daily pain and discomfort caused by their disorders. We are very excited by the global recognition of Paradigm's clinical development in this rare disease and the opportunity to present the exciting work we are undertaking at the International Conference on Lysosomal Diseases early next year."
Mucopolysaccharidosis type VI, also known as Maroteaux-Lamy syndrome, is a rare autosomal recessive lysosomal storage disorder that affects between 0.36 and 1.30 of every 100,000 live births(4). It results in the development of multisystem clinical manifestations. Mucopolysaccharidosis type VI disorders range from very slowly to rapidly progressing, depending on the specific disease-causing mutation.
Current treatments for MPS VI patients include enzyme replacement therapy, however MPS-VI patients undergoing this therapy continue to report ongoing stiffness, pain, and inflammation. The current standards of care are not adequate in treating the pain associated with joint inflammation and musculoskeletal issues.
Brazil has one of the highest rates of MPS-VI and researchers there are evaluating the use of Paradigm's PPS to treat MPS-VI patients in a phase 2 study. The study is a randomised, double-blind, placebo-controlled study to evaluate the safety and tolerability of PPS in patients with MPS-VI. According to the study protocol, approximately 12 patients will be randomised 2:1 to receive PPS or placebo. Participants are dosed weekly for 24-weeks with the primary endpoint being safety. The secondary endpoints are improvements in pain and function. The study is the largest of its kind in the world and has attracted the interest of medical researchers and MPS patient advocacy groups globally.
To date, three adult subjects have been enrolled in the study and fifty-two weeks of cumulative data across the subjects have been assessed. Under the clinical protocol, a mandated safety review has been completed with no serious adverse events reported. This is a key milestone for the phase 2 study, which now allows the inclusion of subjects aged 9 to 16 years to assess the safety and tolerability of PPS among paediatric populations. An additional safety review will be completed once 3 patients in this age group have been enrolled and reach the specified timepoint.
A positive additional safety review will support the inclusion of subjects in the 5- to 9-year- old age group. These additional age groups are highly relevant to future potential therapeutic registration as the disease is detected and can manifest early in children and adolescents. Additionally, a 5-year extension program is being offered to subjects who, after completion of the trial, are deemed by their physician to benefit from ongoing treatment per local regulatory requirements.
Paradigm's CEO, Marco Polizzi, said, "Alongside our robust osteoarthritis clinical program, Paradigm is proud to work with specialists in the field of lysosomal storage diseases to potentially enable MPS sufferers to function more easily in their day-to-day activities. We are continuing discussions to progress the development of PPS for patients with MPS and believe that this data will contribute to planning and design for the registration of injectable PPS as an adjunctive therapeutic option for patients with MPS-I and MPS-VI."
Dr Donna Skerrett (Chief Medical Officer) and Dr Michael Imperiale (Global Head of Safety and Head of MPS) attended the BIO International partnering conference that was held in June in San Diego. Dr Skerrett delivered a presentation on Paradigm's clinical development program and with Dr Imperiale undertook many one-on-one meetings with potential partner companies. During the conference Paradigm saw significant interest in its rare disease clinical development program. Paradigm is currently exploring strategic partnerships to progress current and future clinical studies to further evaluate PPS as a treatment to address the critical unmet need of ongoing musculoskeletal symptoms in this rare patient population.
Paradigm Biopharmaceuticals LTD (ASX: PAR) is a late-stage drug development company whose mission is to develop and commercialise Pentosan Polysulfate Sodium for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. Paradigm is also exploring proof-of-concept studies for the use of PPS in respiratory and heart failure indications.
This Company announcement contains forward-looking statements, including statements regarding anticipated commencement dates or completions dates of preclinical or clinical trials, regulatory developments and regulatory approval. These forward-looking statements are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results to differ materially from those expressed in the statements contained in this presentation. Readers are cautioned not to put undue reliance on forward-looking statements.
- Kobayashi H. Recent trends in mucopolysaccharidosis research. J Hum Genet. 2019 Feb;64(2):127–37.
- Peters H, Ellaway C, Nicholls K, Reardon K, Szer J. Treatable lysosomal storage diseases in the advent of disease-specific therapy. Intern Med J. 2020 Nov;50 Suppl 4:5–27.
- ASX Release 23rd November 2021: Positive interim data from phase 2 rare disease trial presented at international medical congress.
- Muenzer J. Overview of the mucopolysaccharidoses. Rheumatology. 2011 Dec 1;50(suppl 5):v4–12.
Authorised for release by the Paradigm Board of Directors. To learn more please visit: https://paradigmbiopharma.com/
View original content to download multimedia:
SOURCE Paradigm Biopharmaceuticals | https://www.wibw.com/prnewswire/2022/08/12/mps-clinical-program-update-paradigm-present-international-conference-lysosomal-diseases/ | 2022-08-12T12:51:18Z |
Top-ranked logistics provider hiring aggressively; moving into new Dallas headquarters in 2022
DALLAS, May 17, 2022 /PRNewswire/ -- Founded in 1992, Worldwide Express began as a franchisor with the goal of providing unmatched shipping logistics services to the small and medium-sized business (SMB) community. In the three decades since, Worldwide Express, combined with its sister brands GlobalTranz and Unishippers, has become a top-ranked, full-service logistics provider and the second-largest privately held freight brokerage in North America, with customers spanning from SMBs to the Fortune 100.
This month, Worldwide Express marks 30 years in business and makes its debut as a primary sponsor in the NASCAR Cup Series. As part of a multi-year partnership with Trackhouse Racing, this week's NASCAR All-Star Race at Texas Motor Speedway will be the inaugural race for the WWEX Racing paint scheme on Ross Chastain's No. 1 Chevrolet Camaro. The scheme will make its debut on Daniel Suarez's No. 99 Chevrolet Camaro later this season in Michigan. For more information on the full WWEX Racing program, please visit www.wwexracing.com.
"From our beginnings as a startup operated from our co-founder David Kiger's spare bedroom, Worldwide Express has grown over the past 30 years into a leading, full-service logistics provider with an unrivaled growth engine, unmatched logistics solutions across direct and indirect channels, and world-class technology," said Tom Madine, Worldwide Express CEO. "Our foundation was built with a mindset that prioritized growth and delivering value to our customers, while maintaining market-leading relationships with our carrier partners. As we exceed $5 billion in revenue in 2022, we're deeply appreciative of our team and partners who have fueled the growth of the business and positioned us for the next 30 years, and beyond."
Rob Rose, Worldwide Express President, added: "Following our merger last year with GlobalTranz, we now provide an unparalleled offering of market-leading, multi-modal logistics solutions to customers ranging from SMBs up to some of the largest enterprises in the world. As our business has expanded, we have looked to establish value-added partnerships with carriers and other partners in and outside of the industry. Our NASCAR relationships with Trackhouse Racing and Niece Motorsports are great examples of collaborations that have delivered commercial benefits and increased national visibility for the three WWEX brands. Whether it's a celebration in Victory Lane or helping delivering goods from the shop to Main Street, our teams share a relentless drive to win, and we're excited to see where our NASCAR initiatives lead to next."
The combined Worldwide Express, GlobalTranz and Unishippers family of brands together form one of the top logistics providers in the country, offering market-leading solutions for parcel, less-than-truckload (LTL) and truckload shipping and managed transportation services delivered through proprietary technology. With the company's unique data assets and business intelligence capabilities, more than 115,000 shippers benefit from enhanced visibility and efficiency for their supply chains. The company will manage more than 35 million shipments in 2022 through its network of carrier partners, including over 65 leading LTL carriers and more than 85,000 truckload carriers.
Worldwide Express, GlobalTranz and Unishippers together employ more than 2,500 team members across 75 offices in the U.S., including 370 people in the Dallas-Fort Worth area. The companies have been consistently recognized across the country in various "Best Places to Work" surveys. Capping off its 30th anniversary year, Worldwide Express will be relocating its corporate headquarters to a new office location in Deep Ellum in Dallas at the end of 2022 and will be planning celebratory events throughout the year at many of its national locations. The company is hiring aggressively and looking for new, talented team members. To learn more about joining Worldwide Express, visit the company's Careers page at www.wwex.com/careers.
Worldwide Express, LLC is a full-service, non-asset-based logistics provider offering more than 115,000 customers access to industry-leading small package, truckload and less-than-truckload shipping solutions. With an annual systemwide revenue approaching $5 billion through a network of company-owned, franchise and agent locations, Worldwide Express, combined with its sister brands GlobalTranz and Unishippers, is the second-largest privately held freight brokerage in the country. As the largest non-retail UPS® Authorized Reseller in the US, the company is a local partner for the global supply chains for shippers of all sizes, from small- to medium-sized businesses to enterprise organizations. This, coupled with a selective portfolio of more than 65 LTL and tens of thousands of truckload carriers, provides clients with an unmatched range of options and flexibility to meet their shipping needs. To learn more, visit www.wwex.com.
View original content to download multimedia:
SOURCE Worldwide Express | https://www.kxii.com/prnewswire/2022/05/18/worldwide-express-celebrates-30th-anniversary-with-primary-sponsorship-debut-nascar-cup-series/ | 2022-05-18T03:01:20Z |
SAN JOSE, Calif., April 18, 2022 /PRNewswire/ -- Loan Factory, the nation's #1 mortgage broker is proud to announce a new logo that reflects their ongoing efforts to make the loan process faster, simpler, and more customer-friendly. This includes the development of an AI-powered loan processing system that will definitely reshape the US home mortgage industry. According to founder and CEO Thuan Nguyen, "The company wants the new logo to represent what we can do for our clients. We want the world to know that as a FinTech company, Loan Factory provides not only accessible technology, incredibly low rates and outstanding service, but also a lifetime partnership."
Mr. Nguyen further explains, "We are proud of how diligently everyone works at Loan Factory every day to improve our technology, processing methods, and customer service. For us, the most rewarding part of our job is seeing the customers happy. We want to help hundreds of thousands of people move into their new homes while also saving them thousands of dollars."
So, what's the meaning behind the new logo? It all boils down to their identity and the services they provide for their customers. The small black circle represents the buyer. The big orange circle represents the path it takes to complete the home buying process. There's a gap between the two circles, and that's where Loan Factory comes into the equation. Mr. Nguyen further explains, "When we help our clients purchase their home, they have the ability to enter into the realm of the bigger circle. Once they have embarked on this journey, our goal is to guide them throughout the entire process, from the time they contact us to the time the loan is closed, and well beyond."
Loan Factory has been helping clients achieve the dream of homeownership for over fifteen (15) years. In fact, Thuan Nguyen and his team have worked with nearly 26,000 happy clients, and have closed over $10.6 billion of loans since he first started the business.
If you are interested in learning more about Loan Factory and the mortgages that they offer to their clients across 42 states in the United States, please visit their website at https://www.loanfactory.com.
Phone: (800) 567-8869
Email: info@loanfactory.com
View original content to download multimedia:
SOURCE Loan Factory | https://www.wibw.com/prnewswire/2022/04/18/nations-1-mortgage-broker-announces-new-corporate-logo-designed-strengthen-their-image-position-themselves-fintech-company/ | 2022-04-18T18:23:33Z |
NEW YORK, Sept. 1, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Kiromic BioPharma, Inc. ("Kiromic" or the "Company") (NASDAQ: KRBP) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Kiromic investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of a class consisting of persons and entities that purchased or otherwise acquired: (a) Kiromic common stock issued in connection with the Company's public offering that closed on July 2, 2021 and/or (b) Kiromic common stock between June 25, 2021 and August 13, 2021, both dates inclusive. Follow the link below to get more information and be contacted by a member of our team:
KRBP investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The complaint alleges that the registration statement and prospectus issued in connection with the Company's public offering that closed on July 2, 2021 (the "Offering Documents") failed to disclose that the Food and Drug Administration ("FDA") had, prior to the filing of these documents, imposed a clinical hold on the Company's Investigational New Drug ("IND") applications for its two new drug candidates. Given that the offering closed on July 2, 2021, more than thirty (30) days after the Company submitted the IND applications for its two immunotherapy product candidates, investors were assured that no clinical hold had been issued and clinical trials would commence.
WHAT'S NEXT? If you suffered a loss in Kiromic during the relevant time frame, you have until October 4, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:
SOURCE Levi & Korsinsky, LLP | https://www.wibw.com/prnewswire/2022/09/01/krbp-lawsuit-alert-levi-amp-korsinsky-notifies-kiromic-biopharma-inc-investors-class-action-lawsuit-upcoming-deadline/ | 2022-09-01T10:41:18Z |
Kathleen Biggins, Founder & President, C-Change Conversations
PRINCETON, N.J., Aug. 16, 2022 /PRNewswire/ --
"It may not be perfect, but it is a big deal. With the signing of the 'Inflation Reduction Act of 2022' today, our country will devote the resources to move the needle to counter the causes and impacts related to climate change.
"For decades, Congress has been unable to enact significant climate legislation – other than tax credits for wind and solar – and now it has. This is a very big deal! Using more carrots than sticks, the new law will provide a much-needed boost for all energy – not just clean energy – during a period of high gas prices and uncertain energy supplies.
"As the founder of C-Change Conversations, a non-partisan organization providing science-based climate change information, which has been well received by moderate and conservative groups across the country, I see this legislation, the largest investment in U.S. history to fight climate change, as a welcome and promising step in furthering the conversation around mitigating the climate crisis we are facing.
"Clearly, there is work to be done. This legislation opens the door to bringing us closer to further progress."
For information on C-Change Conversations visit: https://c-changeconversations.org/
View original content to download multimedia:
SOURCE C-Change Conversations | https://www.mysuncoast.com/prnewswire/2022/08/16/statement-signing-inflation-reduction-act/ | 2022-08-16T23:58:42Z |
Thousands of former Marinello Schools of Beauty students will have fed loans forgiven
Kansas campuses were in Topeka, Manhattan, Wichita, and Overland Park
TOPEKA, Kan. (WIBW) - Students left in the lurch when Marinello Schools of Beauty closed will have their federal student loans discharged, according to the U.S. Department of Education.
The now-shuttered cosmetology school had locations in Topeka at 29th and Kansas and also in Manhattan, Wichita, and Overland Park. The century-old institution closed all 56 of its U.S. locations more than six years ago -- after the U.S. Department of Education cut off loans and grants. The agency accused the operators of preying on students, misleading them about the quality of their programs, and leaving them with unaffordable debt.
Some 28,000 loans totaling $238 million dollars will be forgiven. They belong to students who enrolled in the schools from 2009 until they closed in February of 2016. Some students were welcomed by other cosmetology schools in the area.
Copyright 2022 WIBW. All rights reserved. | https://www.wibw.com/2022/04/29/thousands-former-marinello-schools-beauty-students-will-have-fed-loans-forgiven/ | 2022-04-29T14:02:15Z |
NEW YORK, July 21, 2022 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by One Medical (NASDAQ: ONEM) and its board of directors concerning the proposed acquisition of the company by Amazon (NASDAQ: AMZN). Stockholders will receive $18.00 for each share of One Medical stock that they hold. The transaction is valued at approximately $3.9 billion.
If you are a stockholder of One Medical and are interested in obtaining additional information regarding this investigation, please visit us at: http://www.rowleylawpllc.com/investigation/onem/. You may also contact Shane Rowley, Esq. at Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at info@rowleylawpllc.com, or by telephone at 914-400-1920 or 844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class actions and derivative lawsuits in complex corporate litigation. For more information about the firm and its attorneys, please visit http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar outcome.
View original content:
SOURCE Rowley Law PLLC | https://www.mysuncoast.com/prnewswire/2022/07/21/alert-rowley-law-pllc-is-investigating-proposed-acquisition-one-medical/ | 2022-07-21T23:15:12Z |
NEW YORK, June 2, 2022 /PRNewswire/ --
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Oscar Health, Inc. (NYSE: OSCR) pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's March 2021 initial public offering ("IPO" or the "Offering"), of the important July 11, 2022 lead plaintiff deadline.
SO WHAT: If you purchased Oscar securities pursuant and/or traceable to the Registration Statement you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
WHAT TO DO NEXT: To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources or any meaningful peer recognition. Many of these firms do not actually handle securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm has achieved the largest ever securities class action settlement against a Chinese Company. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers.
DETAILS OF THE CASE: According to the lawsuit, the Registration Statement was materially false and misleading and omitted to state that: (1) Oscar was experiencing growing COVID-19 testing and treatment costs; (2) Oscar was experiencing growing net COVID-19 costs; (3) Oscar would be negatively impacted by an unfavorable prior year Risk Adjustment Data Validation (RADV) result relating to 2019 and 2020; (4) Oscar was on track to be negatively impacted by significant Special Enrollment Period (SEP) membership growth; and (5) as a result of the foregoing, defendants' positive statements about Oscar's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
To join the Oscar class action, go to https://rosenlegal.com/submit-form/?case_id=6200 or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.
No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Laurence Rosen, Esq.
Phillip Kim, Esq.
The Rosen Law Firm, P.A.
275 Madison Avenue, 40th Floor
New York, NY 10016
Tel: (212) 686-1060
Toll Free: (866) 767-3653
Fax: (212) 202-3827
lrosen@rosenlegal.com
pkim@rosenlegal.com
cases@rosenlegal.com
www.rosenlegal.com
View original content to download multimedia:
SOURCE Rosen Law Firm, P.A. | https://www.mysuncoast.com/prnewswire/2022/06/03/oscr-investor-news-rosen-trusted-top-ranked-investor-counsel-encourages-oscar-health-inc-investors-with-losses-excess-100k-secure-counsel-before-important-deadline-securities-class-action-oscr/ | 2022-06-03T00:54:44Z |
MULTAN, Pakistan (AP) — Pakistani rescuers Tuesday resumed a search for 29 people who went missing after a passenger boat carrying nearly 100 members of a wedding party capsized in the fast-flowing Indus river.
Twenty-one women and children were killed in the disaster a day earlier, a senior government official said.
Divers from Pakistan’s army were expected to join the rescue operation in Sadiqabad, a district in the eastern Punjab province, government official Saleem Assi said.
He said the bodies of 21 people had so far been recovered and handed over to their relatives.
Assi said at least 65 people, including the bridegroom, were rescued on Monday, but 29 people, including children, were still missing. The missing passengers are feared dead. Their relatives are still waiting hopefully along the riverbank to witness the rescue operation.
Assi said at least 90 people were on board the boat when the boat capsized.
Such accidents are common in Pakistan, where rickety wooden boats are often used to transport goods and people on rivers and lakes. Most operate without life jackets. | https://cw33.com/news/international/ap-international/pakistan-resumes-search-for-29-missing-after-boat-capsized/ | 2022-07-19T16:23:18Z |
BRUNSWICK, Ga. (AP) — A federal judge Wednesday postponed sentencing for the white men convicted of hate crimes in the killing of Ahmaud Arberyuntil Aug. 8.
U.S. District Court Judge Lisa Godbey Wood agreed to push sentencing hearings back one week after prosecutors cited a scheduling conflict. She scheduled the three defendants to be sentenced individually during hearings spaced two hours apart.
Father and son Greg and Travis McMichael and neighbor William “Roddie” Bryan each face possible life sentences after being convicted of hate crimes in February by a federal jury that concluded they chased and killed 25-year-old Arbery because he was Black.
All three defendants are already serving life in prison for the February 23, 2020, killing after being found guilty of murderin a Georgia state court last fall.
The McMichaels armed themselves and used a pickup truck to chase Arbery after spotting him running in their neighborhood just outside the port city of Brunswick. Bryan joined the pursuit in his own truck and recorded cellphone video of Travis McMichael blasting Arbery with a shotgun.
None of the three men were arrested until more than two months later, when the graphic video of Arbery’s shooting leaked online and the Georgia Bureau of Investigation took over the case from local police.
Prosecutors during the federal trial revealed more than two dozen text messages and social media posts in which Travis McMichael and Bryan repeatedly used racist slurs. Witnesses also testified to hearing racist comments spoken by both McMichaels.
Defense attorneys denied the McMichaels and Bryan targeted Arbery because of his race. They argued the men acted on an earnest, though mistaken, suspicion that Arbery had committed crimes in their neighborhood. | https://cw33.com/news/u-s-news/ap-u-s-headlines/arbery-killers-sentencing-for-hate-crimes-moved-to-august/ | 2022-04-21T04:20:43Z |
Shareholders with $500,000 losses or more are encouraged to contact the firm.
LOS ANGELES, June 3, 2022 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Axsome Therapeutics, Inc. ("Axsome" or the "Company") (NASDAQ: AXSM).
Class Period: December 30, 2019 – April 22, 2022
Lead Plaintiff Deadline: July 12, 2022
If you are a shareholder who suffered a loss, click here to participate.
The complaint filed alleges that, throughout the Class Period, Defendants failed to disclose to investors that: (1) Axsome's CMC practices were deficient with respect to AXS-07 and its manufacturing process; (2) as a result, Axsome was unlikely to submit the AXS-07 NDA on its initially represented timeline; (3) the foregoing CMC issues remained unresolved at the time that the FDA reviewed the AXS-07 NDA; (4) accordingly, the FDA was unlikely to approve the AXS-07 NDA; (5) as a result of all the foregoing, Axsome had overstated AXS-07's regulatory and commercial prospects; and (6) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Follow us for updates on Twitter: twitter.com/FRC_LAW.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contacts
The Law Offices of Frank R. Cruz, Los Angeles
Frank R. Cruz, 310-914-5007
fcruz@frankcruzlaw.com
www.frankcruzlaw.com
View original content to download multimedia:
SOURCE The Law Offices of Frank R. Cruz, Los Angeles | https://www.mysuncoast.com/prnewswire/2022/06/03/axsm-investors-have-opportunity-lead-axsome-therapeutics-inc-securities-fraud-lawsuit/ | 2022-06-03T17:40:21Z |
Complete data analysis confirms that the primary endpoint of improved clinical response and key secondary endpoints were met in a subprotocol under the platform ACCORD2 study where bemcentinib was added to standard of care therapy
BerGenBio to confirm the ACCORD2 data by progressing bemcentinib into EU-SolidAct, a pan-European platform COVID-19 study enrolling up to 500 patients
BERGEN, Norway, April 26, 2022 /PRNewswire/ -- BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL inhibitors for severe unmet medical needs, announced today that a complete data analysis of a randomized phase II study of bemcentinib in combination with standard of care (SoC) therapy, ACCORD2 (BGBIL019), in hospitalized COVID-19 patients confirms that the primary efficacy endpoint was met.
At the July 2021 European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) meeting, the Company previously presented preliminary data from the ACCORD2 study in combination with a second COVID-19 study (BGBC020) showing evidence of therapeutic benefit on meaningful clinical endpoints in a total of 177 patients. Today's announcement is the first time complete ACCORD2 data in a total of 61 treated patients has been separately reported.
Overall, 90% of patients treated with bemcentinib + SoC (26 of 29) experienced a clinical response by day 29 (median 7.0 days), as defined by either a two-point improvement in World Health Organization (WHO) category from baseline score, or discharge from hospital, whichever arose sooner. This compared to 69% (22 of 32 patients) with a clinical response to SoC treatment alone (median 9.5 days), showing statistical significance.
The data was generated under a sub-protocol of the platform ACCORD2 study (ACCORD2; EudraCT 2020-001736-95 - BGBIL019), a multi-center phase II randomized study designed to assess the efficacy and safety of candidate agents as add-on therapies to SoC for the treatment of COVID-19 in hospitalized patients.
Overall, 98% of patients received dexamethasone or an equivalent steroid in their SoC, and 18% received immunomodulatory treatment with tocilizumab. The antiviral remdesivir was used in 53% of those randomized to SoC alone, and in 21% of patients treated with bemcentinib.
In addition, key secondary endpoints saw statistically significant improvements for the bemcentinib + SoC arm compared to SoC alone, including avoidance of any deterioration by ≥1-point increase in WHO score (including death) and ventilator-free survival over 29 days. At day 29, 97% of bemcentinib + SoC treated patients were alive compared to 81% of SoC-alone.
Bemcentinib treatment was well tolerated in this patient population, with no clinically relevant safety signals in comparison to standard of care treatment.
These latest results underline bemcentinib's potential in COVID-19 and other severe respiratory infections. As previously announced, bemcentinib will be studied in the EU-SolidAct trial in up to 500 hospitalized COVID-19 patients.
Professor Tom Wilkinson MA Cantab MBBS PhD FRCP FERS, Professor of Respiratory Medicine and Chief Investigator on the ACCORD program commented: "With COVID-19 still driving hospital admissions globally it is key that new, more effective treatments are being developed. These results from the ACCORD2 program indicate that bemcentinib has demonstrated real promise as a new therapeutic option for hospitalized patients and it now warrants testing in larger studies. These results are a testament to the great collaboration between the NHS, NIHR, the MEU and our Southampton research teams with more exciting results to follow from the platform."
Martin Olin, Chief Executive Officer of BerGenBio, commented: "We are highly encouraged by the final data from our ACCORD2 study in hospitalized COVID-19 patients. The ability of bemcentinib to add a statistically significant benefit in clinical response over standard of care therapy is promising. We look forward to moving to the next step in the development of bemcentinib for COVID-19 through our participation in the EUSolidAct platform study, designed to enrol up to 500 hospitalized COVID-19 patients."
Contacts:
For BerGenBio: Martin Olin CEO, BerGenBio ASA
ir@bergenbio.com
Rune Skeie, CFO, BerGenBio ASA
rune.skeie@bergenbio.com
International Media Relations
Mary-Jane Elliott, Chris Welsh, Lucy Featherstone
Consilium Strategic Communications
bergenbio@consilium-comms.com
+44 20 3709 5700
About BerGenBio ASA
BerGenBio is a clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers. The company's proprietary lead candidate, bemcentinib, is a potentially first-in-class selective AXL inhibitor in a broad phase II clinical development programme focused on combination and single agent therapy in cancer and COVID-19. A first-in-class functional blocking anti-AXL antibody, tilvestamab, is undergoing phase I clinical testing.
BerGenBio is based in Bergen, Norway with a subsidiary in Oxford, UK. The company is listed on the Oslo Stock Exchange (ticker: BGBIO). For more information, visit www.bergenbio.com
About ACCORD2 study
Under the bemcentinib sub-protocol of the ACCORD2 study, patients were enrolled within a calendar day after being admitted to hospital. Eligible patients were categorized by the WHO 9-point clinical scale and ranged from patients who did not require supplementary oxygen (grade 3) to those requiring non-invasive ventilation or high-flow nasal oxygen, but not intubated (grade 5). In the bemcentinib sub-protocol 29 patients were randomized and received bemcentinib treatment in addition to SoC.
For further details: https://clinicaltrials.gov/ct2/show/NCT04890509
Forward looking statements
This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties, and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements. This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
View original content:
SOURCE BerGenBio ASA | https://www.wibw.com/prnewswire/2022/04/26/bergenbio-announces-complete-data-analysis-accord2-phase-ii-bemcentinib-study-hospitalized-covid-19-patients-primary-efficacy-endpoint-met/ | 2022-04-26T06:30:34Z |
LOS ANGELES, June 1, 2022 /PRNewswire/ -- The LA International Film Festival announces a range of networking events, parties and speed-pitching opportunities, in addition to showcasing emerging diverse talent, in the centre of the movie making industry.
Independent filmmakers getting back on their feet after a tough two years will benefit from an array of events at the LA International Film Festival (LAIFF) from 1–6 November 2022.
LAIFF will host in-person live events this year, after utilizing virtual formats during the Covid pandemic. Screening a number of feature films and a dynamic line-up of short films both in person and online, LAIFF will also host a program of networking events, as well as a speed-pitching mini-market connecting indie talent with industry experts.
The speed-pitching mini-market was launched in April at the LAIFF's sister festival, the London Independent Film Festival, and successfully matched selected projects together with industry experts in the same field, for new filmmakers to gain invaluable market knowledge.
The full schedule will be announced in due course.
LAIFF Director Natasha Marburger is confident that the program will allow anyone interested or working in the film industry to meet, mingle, and gain invaluable industry tips and advice at the same time as seeing award-winning new films.
"As filmmakers, we are always networking and looking for opportunities to celebrate as well as collaborate with fellow filmmakers. After the last two years, that's even more crucial than ever", says Natasha, who is also a producer with more than 10 years of experience in the film industry and has most recently produced BAFTA-winning Cathy Tyson's directorial debut short film LILIAN.
Dig IN Magazine is an official Press Partner of both Los Angeles International Film Festival and London Independent Film Festival.
Follow LAIFF online:
- Web – Los Angeles International Film Festival (laiff.org)
- Instagram – @losangelesiff
- YouTube - Los Angeles International Film Festival
About Dig IN Magazine
IN Close Entertainment, a creative and production agency founded by Cindy Maram, is the parent company of Dig IN Magazine.
View original content to download multimedia:
SOURCE IN Close Entertainment | https://www.kxii.com/prnewswire/2022/06/01/la-international-film-festival-host-hybrid-edition-speed-pitching-event-santa-monica-november-following-success-sister-festival-london-independent-film-festival/ | 2022-06-01T15:25:59Z |
NEW YORK, July 28, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Wells Fargo & Company ("Wells Fargo" or the "Company") (NYSE: WFC) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Wells Fargo investors who were adversely affected by alleged securities fraud. This lawsuit is on behalf of persons and entities that purchased or otherwise acquired Wells Fargo common stock between February 24, 2021 and June 9, 2022. Follow the link below to get more information and be contacted by a member of our team:
WFC investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) Wells Fargo had misrepresented its commitment to diversity in the Company's workplace; (ii) Wells Fargo conducted fake job interviews in order to meet its Diverse Search Requirement; (iii) the foregoing conduct subjected Wells Fargo to an increased risk of regulatory and/or governmental scrutiny and enforcement action, including criminal charges; (iv) all of the foregoing, once revealed, was likely to negatively impact Wells Fargo's reputation; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
WHAT'S NEXT? If you suffered a loss in Wells Fargo during the relevant time frame, you have until August 29, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate.
WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
Ed Korsinsky, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
View original content to download multimedia:
SOURCE Levi & Korsinsky, LLP | https://www.mysuncoast.com/prnewswire/2022/07/28/wfc-lawsuit-alert-levi-amp-korsinsky-notifies-wells-fargo-amp-company-investors-class-action-lawsuit-upcoming-deadline/ | 2022-07-28T11:08:34Z |
First responders save horse that fell through wooden bridge
SNOQAUALMIE, Wash. (Gray News) – Rescuers in Washington state saved a horse after it fell through a wooden bridge Monday.
The Washington State Animal Response Team said they responded to a call about a horse named Stewie who had fallen through a wooden bridge in Snoqualmie.
The animal response team was joined by local police and fire departments to assist with the rescue. Firefighters cut away more of the bridge to help Stewie down to the dry creek bed that was not far below.
Officials prepared a horse sling and tow truck to hoist Stewie up, but fortunately, it was not needed – Stewie was able to stand on his own.
Stewie stood to rest for a bit and then was coaxed up the trail. He was then loaded into a horse trailer and taken to a veterinary hospital for treatment.
Copyright 2022 Gray Media Group, Inc. All rights reserved. | https://www.wibw.com/2022/09/06/first-responders-save-horse-that-fell-through-wooden-bridge/ | 2022-09-06T15:21:34Z |
Actress and director Denise Dowse is hospitalized with viral meningitis, according to a post from her sister.
"I am requesting support and prayers be offered me and my sister, and my only immediate family @denisedowse," her sister wrote in an Instagram post made to Dowse's official account. "She is currently in the hospital in a coma brought on by a virulent form of meningitis. Her doctors do not know when she will come out of the coma as it was not medically induced."
"She is a vibrant actor and director that should have many years ahead of her. Thoughts, prayers and support are greatly appreciated," she added.
Her "90210" co-star, Ian Ziering wrote in the comments, "Sending prayers and hopes for better days ahead."
CNN has reached out to a representative for Dowse for comment.
Dowse is best known for her role as Mrs. Yvonne Teasley on "90210" from 1991 to 2000. Her credits also include roles on the CBS series "The Guardian" and in the HBO series "Insecure."
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/entertainment/denise-dowse-90210-actress-in-a-coma-due-to-meningitis/article_a5b97d22-b6f0-502e-b9aa-c8de6b92dbba.html | 2022-08-11T16:28:28Z |
‘It’s all legal’: Foreign college athletes cash in at home
By KEN MAGUIRE
AP Sports Writer
LONDON (AP) — Miami punter Lou Hedley is among thousands of international student athletes who can’t earn income from their name, image and likeness on U.S. soil. Some are trekking home to do it. Hedley had to fly 13,000 miles to western Australia to cash in on his name. Nebraska basketball player Jaz Shelley also made a trip home to Australia for so-called “NIL” deals. Foreign athletes at U.S. colleges are finding the NIL waters tricky to navigate, with mixed messages about what’s OK. | https://localnews8.com/news/ap-national-business/2022/05/29/its-all-legal-foreign-college-athletes-cash-in-at-home-2/ | 2022-05-30T06:58:48Z |
IRVINE, Calif., July 7, 2022 /PRNewswire/ -- Caylent, Inc (Caylent), a cloud native services company, announced today that it has achieved the AWS Premier Tier Services Partner status in the Amazon Web Services (AWS) Partner Network (APN).
Achieving AWS Premier Tier Services Partner status differentiates Caylent as an AWS Partner who has demonstrated expertise and notable success in helping customers design, architect, build, migrate, and manage their workloads on AWS.
"Caylent is proud to achieve AWS Premier Tier Partner status in the AWS Partner Network," said JP La Torre, CEO at Caylent. "The scale and maturity of AWS is second to none. As a pure play AWS Partner, securing this designation was an important milestone for Caylent and demonstrates that our team can help organizations achieve their technology goals on AWS no matter the size or complexity."
To earn AWS Premier Tier Services Partner status, partners must complete a rigorous approval process through accreditations and certifications, must demonstrate a long-term investment in their relationship with AWS, and must have extensive expertise in deploying customer solutions at scale on AWS. AWS Premier Tier Services Partners also must have a strong team of AWS trained and certified technical consultants and have deep expertise in project management and professional services.
Caylent, recipient of the prestigious AWS Rising Star Partner of the Year 2021 (SI) award, holds the AWS Migration Services Competency, AWS SaaS Competency, AWS DevOps Services Competency as well as the AWS Well-Architected Partner, AWS Public Sector Partner, and AWS Built on Control Tower Partner designations, showing significant investment in both its customer offering and services expertise on AWS. Caylent's AWS Certification count numbers over 220 which, coupled with an industry-leading customer satisfaction rating, further validates its commitment to fueling customer-centric cloud native service adoption on AWS.
As an all-in AWS Partner, Caylent is obsessed with accelerating time-to-value and its track record is backed by years of experience working with customers to solve even the most complex challenges. Caylent has developed an innovative "One-Organization" approach, ensuring seamless customer experience by delivering services across cloud architecture and engineering, data, security, and cloud native application development, as one cohesive and highly efficient service delivery organization. In addition, its portfolio of accelerators, Caylent Catalysts©, is geared towards fast-tracking solution implementations across common use cases such as AWS Control Tower, security & compliance, disaster recovery, and more.
"Having worked closely with the Caylent team, I've witnessed firsthand the value they bring to the AWS Partner community through their dedication to customer satisfaction, and I am thrilled to see them recognized with this designation." said Rima Olinger, AWS North America Partner Director at AWS." Our Premier Tier partners are the most experienced in the partner community and are recognized as leaders in their respective geographical, vertical, or horizontal markets."
"We are delighted to be recognized by AWS for this achievement," said David Close, VP of Alliances and Marketing at Caylent. "This is a huge validation of the role everyone at Caylent has played in accomplishing this goal. It is also a reflection of Caylent's commitment to bring out the best of people and technology and model the way in helping our clients use AWS to solve complex business challenges and take advantage of new market opportunities."
"Caylent has assisted us with two data center migrations to AWS as well as daily DevOps services. In both cases they have proven to be a reliable and trusted partner. The depth of resources they can draw on to create solutions has been impressive. They have seamlessly integrated into our teams and are a delight to work with." said John Genter, Vice President Security & Cloud Operations at Lightspeed Systems
Caylent is a cloud native services company that helps organizations bring the best out of their people and technology. We are living in a software-defined world where technology is at the core of every business. To thrive in this paradigm, organizations need to empower their people and processes through technology. Caylent is uniquely positioned to fuel that engine of innovation by bringing ambitious ideas to life for our customers. We work with customers to build, scale and optimize sophisticated cloud solutions using deep subject matter expertise to deliver world class outcomes through an agile co-delivery model.
Caylent's core practice areas include: Migration, Application Modernization, Data & Analytics, DevOps, Security & Compliance, and Cloud Native Application Development. Learn more at https://caylent.com/
View original content to download multimedia:
SOURCE Caylent | https://www.wibw.com/prnewswire/2022/07/07/caylent-achieves-aws-premier-tier-services-partner-status-aws-partner-network/ | 2022-07-07T15:37:33Z |
The most valuable NFT on Cardano, the race is on for the 17,420-carat emerald equine sculpture, providing proof of ownership of an exceedingly rare physical asset
SAN FRANCISCO, June 2, 2022 /PRNewswire/ -- ZAMARAD, an emerald equine sculpture, is in a class of its own in the world of blockchain-based assets.
The worth of this one-of-a-kind masterpiece of an equine's head with eyes ablaze is immediately and compellingly apparent. Carved from the side of a mountain in Bahia by Brazilian-based artist Florinaldo Souza dos Santos, it is sculpted entirely of emerald – one of the rarest of its kind unearthed in recent history – in a matrix specimen of biotite, shale and crystal.
With a weight of 132 pounds and a total of 17,420 carats, a stone of such magnitude and value required of its sculptor an all-consuming amount of patience to achieve such perfection. It took dos Santos six months to painstakingly carve every detail.
"One mistake and you could jeopardize the entire stone," he said.
The artisan's efforts are well worth it: ZAMARAD's majestic presence is commanding, its piercing eyes electrifying— a cultural symbol of courage and freedom, of unbridled spirit and strength.
The ideal showcase for such a rarity: the exclusive world of Blockchain technology. ZAMARAD enters the blockchain platform Cardano, with a high-stakes NFT digital proof of ownership.
Befitting of this unique physical asset, the emerald equine sculpture will be offered in a reverse auction: Starting at 100 million ADA, the price will be reduced by 10,000 ADA every 10 minutes, until it reaches a total of 40 million ADA to then reset itself at 100 million ADA.
Currently sitting in a private art collection in Dubai, ZAMARAD's origin, material, authenticity and provenance were scrupulously audited by multiple independent gemologists.
Full transparency – from official appraisals to escrow capability to documentation availability – ensures the integrity of the acquisition, with full control over the sculpture in both the digital and physical worlds. Fractionalization of the Zamarad NFT can offer the investor a savvy ROI option.
For the discerning art collector, NFT aficionado and investor, this once-in-a-lifetime race is the ultimate win.
Contacts:
Michele Bertolli
info@zamarad.io
+1 650.278.8905
https://zamarad.io
View original content to download multimedia:
SOURCE The Zamarad | https://www.mysuncoast.com/prnewswire/2022/06/02/zamarad-enters-coveted-winners-circle/ | 2022-06-02T12:58:22Z |
Man drowns after being swept away from pontoon boat on Crab Island, sheriff says
CRAB ISLAND, Fla. (Gray News) – A man drowned Sunday after he was swept away by currents on Crab Island.
According to the Okaloosa County Sheriff’s Office (OCSO), the victim’s body was recovered Monday. Officials did not give further information about the victim but described him as a “young man” with a family that lives out of the country.
The OCSO said the man was swept away from a rental pontoon boat during strong currents on the island. The victim and his friends were reportedly having boat issues, so several of them jumped in the water to try to fix the problem. That’s when the current swept the man away.
The other four people involved were rescued by the U.S. Coast Guard, the Florida Fish and Wildlife Conservation Commission, and the OCSO.
The OCSO reminded the public to be aware of strong currents and drop-offs on Crab Island, hazards that visitors may encounter at the popular tourist spot.
Copyright 2022 Gray Media Group, Inc. All rights reserved. | https://www.kxii.com/2022/05/30/man-drowns-after-being-swept-away-pontoon-boat-crab-island-sheriff-says/ | 2022-05-30T20:58:46Z |
LOUISVILLE, KY., June 8, 2022 /PRNewswire/ -- Paula Lambert, founder of the Mozzarella Company in Dallas, Texas, and Bev Shaffer, a Cleveland-based chef, recipe developer, author and culinary instructor, will be recognized with the Grande Dame Lifetime Achievement Award by Les Dames d'Escoffier International (LDEI).
The Grande Dame award recognizes extraordinary lifetime contributions within the food, beverage and hospitality industries. Every other year, recipients are determined by nominations and votes from LDEI's 2,400 members in 43 chapters around the world.
"LDEI's Grande Dame Award is one of the highest honors for a woman in food, beverage and hospitality," said LDEI President Deborah Mintcheff. "We are extremely proud to celebrate these two successful, inspirational women with the 2022 Grande Dame Award. Their accomplishments are nothing short of phenomenal."
Paula Lambert (Dallas Chapter) founded the Mozzarella Company in Dallas, Texas in 1982. She is an internationally renowned, award-winning artisanal cheesemaker, teacher, philanthropist and cookbook author. Among her many honors, Lambert was named one of the Top 50 Cheesemakers in America in 2021 by "Food & Wine" magazine, and is included in the James Beard Foundation's "Who's Who of Food & Beverage in America." Lambert is a sought-after cheese expert and speaker, having been featured on Food Network and multiple other media outlets. She is the author of two books on cheese: "The Cheese Lover's Cookbook and Guide" and "Cheese, Glorious Cheese."
Bev Shaffer (Cleveland Chapter) is a chef, instructor, recipe developer, author and entrepreneur. She opened "What's Cooking?," a kitchen store, cooking school and catering company in Cleveland in 1984. Subsequently, Shaffer led the Cooking School and Market Kitchen and Bakery at the Mustard Seed Market & Café, Ohio's largest retailer of natural and organic products. There, she authored the first of six cookbooks under her name. With her weekly food columns in the Cleveland Plain Dealer, Bev brought her expertise and inspiration to home cooks throughout the region. Bev also served as Corporate Chef and Manager of Recipe Development at Vitamix World Headquarters from 2011 – 2016. Bev also is known for her tireless support to find a cure for Alzheimer's Disease, to which her husband succumbed in 2021.
Both women will be honored on Oct. 22 at the LDEI Annual Conference in New York City.
Les Dames d'Escoffier International (LDEI) is an international organization of women leaders who create a supportive culture in their communities to achieve excellence in the fields of food, beverage and hospitality. The organization's 2,400 members in 43 chapters in the U.S., Canada, Mexico, the United Kingdom and France provide leadership, educational opportunities and philanthropy. LDEI chapters raised and donated more than $525,000 to community non-profits and philanthropic organizations in 2021. For more information, visit www.ldei.org and follow LDEI on Instagram and Twitter @lesdamesintl and Facebook Les Dames d'Escoffier Int'l.
View original content to download multimedia:
SOURCE Les Dames d'Escoffier International (LDEI) | https://www.kxii.com/prnewswire/2022/06/08/two-female-icons-food-world-receive-grande-dame-award-les-dames-descoffier-international/ | 2022-06-08T15:14:43Z |
ASHBURN, Va., June 3, 2022 /PRNewswire/ - DXC Technology (NYSE: DXC), a leading Fortune 500 global technology services company, will participate in the Baird Global Consumer, Technology, and Service Conference on Monday, June 6, 2022. John Sweeney, Vice President of Investor Relations, is scheduled to present at 10:15 AM EDT.
The presentation will be available on the "Events and Presentations" section of DXC's investor webpage at https://investors.dxc.com.
About DXC Technology
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private, and hybrid clouds. The world's largest companies and public sector organizations trust DXC to deploy services across the Enterprise Technology Stack to drive new levels of performance, competitiveness, and customer experience. Learn more about how we deliver excellence for our customers and colleagues at DXC.com.
Forward Looking Statements
All statements in this press release that do not directly and exclusively relate to historical facts constitute "forward-looking statements." These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. Furthermore, many of these risks and uncertainties are currently amplified by and may continue to be amplified by or may, in the future, be amplified by, the ongoing coronavirus disease 2019 ("COVID-19") pandemic and the impact of varying private and governmental responses that affect our customers, employees, vendors and the economies and communities where they operate. For a written description of these factors, see the section titled "Risk Factors" in DXC's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, and any updating information in subsequent SEC filings.
No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this presentation or to reflect the occurrence of unanticipated events, except as required by law.
View original content to download multimedia:
SOURCE DXC Technology Company | https://www.mysuncoast.com/prnewswire/2022/06/03/dxc-technology-participate-baird-global-consumer-technology-service-conference/ | 2022-06-03T13:07:26Z |
Newly Reopened Iconic Waikiki Venue Pays Tribute to the Golden Age of Hawaii Travel
HONOLULU, Sept. 15, 2022 /PRNewswire/ -- Halekulani Corporation today announced the reopening of one of Waikiki's most iconic and popular venues, House Without A Key, following a complete revitalization and enlargement. Located at Hawaii's most acclaimed hotel, Halekulani's House Without A Key has long been celebrated as a premier oceanfront destination for live Hawaiian entertainment, traditional hula performances and sunset cocktails. The indoor/outdoor restaurant has been completely transformed to complement the sweeping vistas of the Pacific Ocean, Diamond Head and the hotel's 135-year-old Kiawe Tree, while paying homage to Hawaii's golden age of travel. The announcement was made by Peter Shaindlin, Chief Operating Officer of Halekulani Corporation.
"House Without A Key's meticulous renovations will ensure and preserve our iconic traditions and relevance as we embark upon our second century of providing gracious hospitality, continuing to deliver legendary experiences for all who walk through our doors," said Mr. Shaindlin. "Halekulani Corporation and our ownership, Mitsui Fudosan, are committed to sustaining Halekulani's unmatched standards of excellence, as well as its distinguished and world-renowned reputation, for decades to come."
With a dramatic new entry experience adjacent to the sea, House Without A Key will feature a new shaded outdoor bar, Earl's, named in honor of the acclaimed 20th century novelist, Earl Derr Biggers, author of "House Without a Key." A rare first edition of the 1925 novel will be on display to welcome guests to one of the most famous and desirable settings in the world. Additional enhancements include a state-of-the-art exhibition-style glass kitchen and custom Marra Forni brick oven created in Italy exclusively for Halekulani.
Halekulani's Executive Chef Christian Testa and House Without A Key's Chef Jarrin Otake will oversee a completely re-imagined menu reminiscent of Hawaii's golden age of travel, featuring new dishes such as the House Without A Key Laulau, a deconstructed version of traditional laulau with the flavors of pork and butterfish, served on a bed of coconut stewed luau leaves and a side of fresh local poi. Additional menu items, both made using the new brick oven, include Char Siu Coconut Baby Back Ribs, with a hoisin and Chinese five spice honey glaze, and the Flat Bread "Skizza" Country Comfort, a fresh take on the classic Margherita pizza, island style. Newly conceived cocktails joining the hotel's signature Mai Tai include the Yellow Umbrella, with fresh Lilikoi Juice, Coconut Matcha Syrup, Tequila and Mezcal; Coconut Cake Martini, an ode to Halekulani's world-famous coconut cake; and Sweet Persea, a spirit-free avocado-based cocktail.
The newly reopened venue also offers a nod to the legendary Ernest Hemingway, who honeymooned at Halekulani in 1940 with his bride, acclaimed journalist Marsha Gellhorn. Hemingway – one of the many luminaries who frequented the restaurant – preferred a specific table near the ocean boasting a direct view of Diamond Head. This table will now be distinguished as 'Table 97,' available only by advance reservation. House Without A Key will also reintroduce the classic Daiquiri to the menu, Hemingway's favorite tropical libation.
Contemporary furnishings complement the setting from which to take in Hawaii's most spectacular seascapes and sunsets. Notable additions include new large-scale lounge furniture and a custom Charles Loomis Branch Sculpture designed using the hotel's iconic Kiawe Tree. Newly-refreshed landscaping incorporates vivid, colorful hues from flowering plants and foliage as well as indigenous and local Hawaiian species, including the King Kalakaua spider lily and extremely rare Dwarf Rainbow Plumeria.
House Without A Key's legendary musical entertainment will continue each night starting at 5:30 p.m., featuring live Hawaiian music paired with hula dancing from former Miss Hawaii and Miss Hawaii USA winners.
House Without A Key is accepting reservations for daily breakfast (7-10:30 a.m.), lunch (11:30 a.m.-5 p.m.), sunset cocktails and dinner (5-8:30 p.m.).
For more information, please visit www.halekulani.com.
About Halekulani Corporation
Halekulani Corporation owns and operates the globally acclaimed luxury resort Halekulani and the new luxury boutique hotel Halepuna Waikiki by Halekulani in Hawaii. Halekulani represents a luxury hospitality legacy of unique and iconic proportions and has been globally recognized with more than 500 awards. Halekulani is home to award-winning SpaHalekulani, House Without A Key, Lewers Lounge, Orchids and La Mer, Hawaii's longest, consecutively ranked AAA Five Diamond and Forbes Travel Guide 5-Star Restaurant. Following a multi-million-dollar transformation, Halepuna Waikiki by Halekulani debuted as the newest luxury boutique hotel in Waikiki. The hotel, which is situated near its iconic sister property Halekulani, was designed by acclaimed New York City-based firm Champalimaud providing hospitality hallmarks of the Halekulani brand such as innovative guest experiences and gracious service.
About Halekulani
Since its re-introduction in 1984 as one of the world's finest and most acclaimed independent luxury hotels, Halekulani has received more than 500 awards, most recently placing on Travel + Leisure's 2022 T+L 500 list of best hotels in the world as well as Travel + Leisure's 2022 World's Best Awards list of the best resorts in Hawaii. Freshly reopened following a comprehensive renewal project, Halekulani is home to La Mer, Hawaii's longest, consecutively ranked AAA Five Diamond and Forbes Travel Guide 5-Star Restaurant, Orchids, House Without A Key and the new Earl's Bar, L'Aperitif, Lewers Lounge, Cattleya Wine Bar, and SpaHalekulani. For over twenty years, Halekulani has maintained a strong commitment to arts and culture in the community through exclusive alliances with Oahu's most iconic cultural venues. Halekulani is operated by the Hotels and Resorts of Halekulani, a brand management division of the Honolulu-based Halekulani Corporation, which also oversees the Halepuna Waikiki by Halekulani. Halekulani is a member of The Leading Hotels of the World and is aligned with Tokyo's legendary Imperial Hotel. For further information, please visit www.halekulani.com.
View original content to download multimedia:
SOURCE Halekulani Corporation | https://www.wibw.com/prnewswire/2022/09/15/halekulanis-legendary-house-without-key-fully-reopens-following-extensive-revitalization-amp-expansion/ | 2022-09-15T15:16:37Z |
PITTSBURGH, May 31, 2022 /PRNewswire/ -- "I wanted to create a system to protect you and your pool against accidental falls, drownings and even debris," said an inventor, from Forest Park, Ga., "so I invented the DROWN GUARD. My design could help to save lives and it could rejuvenate your entire pool experience by making it safer and more enjoyable."
The invention provides a life-saving apparatus for swimming pools. In doing so, it helps to prevent drowning accidents in the pool or by falling into the pool. As a result, it enhances safety and it provides added peace of mind. The invention features an adjustable design that is easy to install and operate so it is ideal for the owners of swimming pools, hotels, public pools, etc. Additionally, it is producible in design variations and a prototype model is available upon request.
The original design was submitted to the Atlanta sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 20-ALL-1580, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
View original content to download multimedia:
SOURCE InventHelp | https://www.wibw.com/prnewswire/2022/05/31/inventhelp-inventor-develops-safety-system-swimming-pools-all-1580/ | 2022-05-31T17:01:31Z |
With increased investment in the company's developer-friendly, multi-cloud, fully-managed Postgres, Neon more than doubles funding to $54.3M.
SAN FRANCISCO, July 26, 2022 /PRNewswire/ -- Neon, Inc., the first open-source, fully-managed, multi-cloud Postgres as a service, has raised $30 million in its Series A-1 round. GGV Capital led an expert investment group that includes Khosla Ventures, General Catalyst, Founders Fund, and Elad Gil with support from a group of notable angels, including Nat Friedman, Ajeet Singh, Guillermo Rauch, Wes McKinney, Ryan Noon, and Søren Brammer Schmidt. Following a successful Series A round, Neon has now more than doubled its total funding to $54.3 million.
Neon, co-founded by Postgres hackers Heikki Linnakangas and Stas Kelvich, was incubated at Khosla Ventures by Nikita Shamgunov, who joined as CEO earlier this year. With this new funding, Neon will continue to build its engineering team, accelerate product expansion and overall growth as well as bootstrap a GTM team. The company is also focused on building developer relations with continued plans to prioritize developer experience. Neon offers a modern, robust platform that includes bottomless storage, and autoscaling, leading to substantial cost savings.
Neon's unique architecture separating storage and compute underpins features to improve the developer experience and save costs. Over 3,600 developers "starred" Neon on GitHub after its Technical Preview launch, with interest generating a front page listing on Hacker News.
"Modern applications are cloud-based, distributed, run at the edge, and perform at unparalleled speeds. At GGV Capital, we've been looking for a serverless Postgres-based backend solution that's tuned to the needs of modern application developers," said Glenn Solomon, Managing Partner at GGV Capital and Neon board member. "Nikita Shamgunov and the Neon team have built an incredible solution, empowering developers with the cloud-based backend database they need to complement their front-end projects. Given the strong developer traction, Neon's future is very bright."
Neon's scalable features contain costs, provide elasticity, offer bottomless storage, and easily integrate with Amazon S3. The company will further improve application development with its substantial roadmap, including features such as branching, which will enable developers to instantly branch their production database, saving time and resources.
"The Postgres community is already responding to what's possible with a modern, cloud-native architecture," said Neon CEO Nikita Shamgunov. "This additional investment ensures Neon is well-positioned to build and ship new features that will transform developer experience."
This impressive funding round validates investor confidence in Neon's mission, goals, and capabilities. As Neon continues its growth, the company will continue expanding features to further empower developers with a modern, serverless Postgres experience.
About Neon
Neon is an open-source, multi-cloud, fully-managed Postgres as a service backed by an impressive list of top-tier investors, including GGV Capital, Khosla Ventures, General Catalyst, and Founders Fund. By separating storage from compute, Neon offers autoscaling, one-click start, multi-cloud compatibility, and bottomless storage to give developers a simple, reliable, and powerful experience. With a generous free tier, developers can quickly start and efficiently scale at will. Learn more at neon.tech.
Contact: press@neon.tech
View original content to download multimedia:
SOURCE Neon | https://www.mysuncoast.com/prnewswire/2022/07/26/neon-secures-30-million-series-a-1-validating-investor-confidence-serverless-postgres-database-service/ | 2022-07-26T14:57:58Z |
Saturday roundup: Central Catholic girls golfer Kristen Belden is medalist at Stark Championships
AREA HIGH SCHOOL ROUNDUP
The reigning Division II cross country state champions had statement wins at Saturday’s Boardman Spartan Invitational.
The Marlington boys and Minerva girls won the Division II races in one of the Midwest’s largest meets. The Dukes rolled to a 112-point victory over runner-up Hawken. The Lions beat second-place Kenston by 18 points.
Colin Cernansky led a 1-2-3 finish for Marlington. His time of 16:18.0 secured his fourth win in five meets this season.
Nash Minor finished second in 16:20.5. Michael Nicholls was third in 16:20.9.
Hera Hoffee came in fourth in 19:32.0 to lead Minerva. Marlington’s Bella Graham was runner-up in 18:37.0.
Earlier in the day, East Canton’s Brylan Holland extended his winning streak. He captured his third straight victory in the Division III boys race in 16:24.3.
Lake’s Daniela Scheffler was runner-up in the Division I girls race in 19:06.5. Hoover’s Noah Johnson took fifth in the boys race in 16:08.5.
East Canton’s Audrey Wade was the area’s top finisher in the Division III girls race. She came in eighth in 20:24.4.
CARROLLTON WINS MEADOWBROOK TEAM TITLE
A 1-2 finish from Elizabeth Funkhouser and Maddie Burgett led Carrollton to the girls team title at the Meadowbrook Colt Carnival.
Funkhouser won the race in 20:55.3. Burgett finished in 20:58.7
Carrollton recorded a 62-point win over runner-up Meadowbrook.
FAIRLESS SECOND BEHIND HEARN, SLATZER
Andrew Hearn and Joseph Slatzer led the way for Fairless at West Holmes Nanny Goat Invite.
Hearn came in second in the boys race in 17:33. Slatzer was third in 18:26.
The Falcons finished second as a team.
GIRLS GOLF
STARK COUNTY CHAMPIONSHIPSCentral Catholic’s Kristen Belden won a playoff against Marlington’s Maria Warner to claim medalist honors at the Stark County Championships on Saturday. Belden and Warner both shot a 75 after 18 holes.
Lake won the team championship a score of 330. Kate Potashnik was third individually with a 78 to lead the Blue Streaks. Warner helped Marlington finish second as a team with a 341.
HIGH SCHOOL
GIRLS GOLF
Stark County Championships
Team standings: 1, Lake 330; 2, Marlington 341; 3, Jackson 365; 4, Massillon 378; 5, Louisville 389; 6, Central Catholic 390; 7, GlenOak 394; 8, Perry 409; 9, Canton South 418; 10, Lake Center Christian 426; 11, Northwest 463; 12, Minerva 493.
Medalist: Belden (CC) 75.
Individual results
Lake: Potashnik 78, Fedor 82, Nichols 82, Changet 88. Marlington: Warner 75, Mort 79, Kuhlmann 89, Nieman 98. Jackson: Murphy 88, Prodafikas 86, O’Connell 95, Grametbauer 96. Massillon: Findley 87, Hatheway 94, Hout 95, Findley 102. Louisville: Biery 87, Myers 95, Warner 100, Wallace 107. Central Catholic: Belden 75, Harold 86, Colucy 90, Rey 139. GlenOak: Schorsten 93, Hershberger 93, Watson 101, Ludwig 107. Perry: Gales 86, Jones 100, Ullum 102, Adams 121. Canton South: Kruger 85, Franks 100, Zellers 116, Foster 117. Lake Center: Starcher 90, Goodspeed 100, Varga 113, Collins 123. Northwest: Cliff 95, Caniglia 121, Ville 123, Bibbee 124. Minerva: Lukowski 105, Mitchell 123, Bartley 131, Mitchell 134.
GIRLS TENNIS
Jackson 5, Mount Notre Dame 0
Singles: P.Reese (J) d. Nofziger 6-0, 6-1; Altman (J) d. E.Assenmacher 7-5, 7-6; Utterback (J) d. Johnson 6-0, 6-1. Doubles: Shanmugam-Wright (J) d. Houck-Shydiak 6-0, 6-0; Rawal-Ahmed (J) d. Miller-Tam 6-3, 6-4.
BOYS SOCCER
Hoover 5, Solon 1
Goals: Nunziato (H) 2, VanNatta (H), McLeod (H), Streb (H). Assists: VanNatta (H), Schumacher (H), Jones (H). Shots: Hoover 20-8. Corner kicks: Hoover 6-0. Records: Hoover 6-1-2.
Alliance 6, Waterloo 1
Goals: Monette (A) 3, Simms (A) 2, Waterloo own goal. Assists: Blevins (S) 2, Simms (A), Monette (A). Saves: Heslop (A) 2.
Louisville 5, Tallmadge 2
Goals: Porter-Kovacic (L) 2, Burton (L), Young (L), Dillen (L). Assists: Swope (L) 2. Records: Louisville 7-1.
GIRLS SOCCER
Twinsburg 3, Jackson 0
Goals: Harris (T), Benach (T), Gilmer (T). Saves: Rozmajl (J) 5, Cellura (T) 3. Shots: Twinsburg 8-3. Corner kicks: Twinsburg 7-1. Halftime: Twinsburg 2-0. Records: Jackson 4-2-2, Twinsburg 9-0
VOLLEYBALL
Lake 25-25-13-22-15, Stow 18-22-25-25-9
Top servers: Hayes (L) 5 aces Kills leaders: Isroff (L) 17. Assists leaders: Hayes (L) 23. Defensive leaders: DeGeorge (L) 34 digs, Isroff (L) 7 blocks.
Jackson 25-25-25, Perry 18-11-15
Top servers: Weirch (P) 8 points. Kills leaders: Knop (P) 12. Assists leaders: Mohr (P) 22. Defensive leaders: Miller (P) 9 digs. Records: Perry 4-6, 3-2.
Central Catholic 25-25, Crestwood 10-7
Top servers: Heiser (CC) 2 aces, Neisel (CC) 2 aces. Kills leaders: Neisel (CC) 13. Assists leaders: Turner (CC) 18. Defensive leaders: Turner (CC) 8 digs, Heiser (CC) 5 blocks.
Norwayne 25-19-25, Central Catholic 19-25-22
Kills leaders: Neisel (CC) 17. Assists leaders: Turner (CC) 31. Defensive leaders: Neisel (CC) 21 digs, Heiser (CC) 3 blocks.
Central Catholic 25-25, Mogadore 8-19
Top servers: Turner (CC) 3 aces. Kills leaders: Heiser (CC) 15. Assists leaders: Turner (CC) 28. Defensive leaders: Clark (CC) 7 digs, Heiser (CC) 5 blocks.
Tallmadge 25-25-25, Louisville 21-15-17
Top servers: Jobe (L) 2 aces. Kills leaders: Haren (L) 5. Assists leaders: Burick (L) 31. Defensive leaders: Lanham (L) 20 digs.
Lake Center Christian 25-25-25, Rittman 20-21-21
Top servers: Wilson (LCC) 4 aces. Kills leaders: Zook (LCC) 9. Assists leaders: Levengood (LCC) 25. Defensive leaders: Barber (LCC) 22 digs, Eves (LCC) 2 blocks, Harrington (LCC) 2 blocks.
Sandy Valley 25-25-25, Alliance 15-18-21
Top servers: Delaney (SV) 12 points, 6 aces;Mullaly (A) 5 aces. Kills leaders: Tucci (SV) 15, Mullaly (A) 6, Haba (A) 6. Assists leaders: Ward (SV) 30,Reese (A) 17. Defensive leaders: Hatcher (A) 18 digs, Faiello (SV) 15 digs, Ward (SV) 5 blocks.
BOYS CROSS COUNTRY
Jackson HexSpacular
Team standings
1, Jackson 28; 2, Hudson 57; 3, GlenOak 58; 4, Wooster 92; 5, Louisville 145; 6, Canton South 184.
Top individual finishers
1, Young (GO) 15:25.54; 2, Ilg (J) 15:26.29; 3, LeVan (H) 15:53.92; 4, Keating (W) 16:13.48; 5, Prato (J) 16:26.31; 6, Ball (J) 16:31.30; 7, McNulty (J) 16:31.79; 8, Hull (J) 16:32.35; 9, Huzyak (J) 16:33.94; 10, Ginther (H) 16:35.72; 11, Sommers (GO) 16:37.50; 12, Lynch (GO) 16:39.30.
GIRLS CROSS COUNTRY
Jackson HexSpacular
Team standings
1, St. Joseph Academy 61; 2, Hudson 71; 3, Jackson 78; 4, GlenOak 78; 5, Wooster 83; 6, Louisville 161; 7, Canton South 189
Top individual finishers
1, Meyer (L) 19:05.55; 2, Blouch (SJA) 19:34.76; 3, Salem (GO) 19:41.90; 4, Rowell (SJA) 19:56.84; 5, Tzouloufis (GO) 20:03.55; 6, Will (H) 20:05.80; 7, Henderson (H) 20:09.49; 8, Zagst (J) 20:10.62; 9, Degenhard (J) 20:17.01; 10, Scott (SJA) 20:23.19; 11, Miller (W) 20:25.93; 12, Signorino (W) 20:34.63. | https://www.cantonrep.com/story/sports/high-school/2022/09/18/stark-championships-central-catholic-golf-kristen-belden-boardman-invitational-marlington-minerva/69501652007/ | 2022-09-18T06:15:50Z |
PETAH TIKVAH, Israel, July 18, 2022 /PRNewswire/ -- SaverOne 2014 Ltd. (NASDAQ: SVRE) (TASE: SVRE), a technology company engaged in transportation safety solutions, today announced a new collaboration with Universal Trucks Israel, Ltd. ("UTI"). UTI is the official Israeli importer for Isuzu vehicles, with over 13,000 trucks and buses in the country.
The collaboration with UTI equips the SaverOne protection systems into UTI trucks that are leased to its customers. In the current phase, the SaverOne system will be installed in around 100 UTI trucks.
Mr. Gilboa, CEO of SaverOne commented, "We are very pleased with this new collaboration with UTI, increasing our potential customer base and addressable market. UTI leases over 1,700 Isuzu trucks and buses to its customers, representing significant long-term potential for SaverOne. This new collaboration represents the important element in our strategy of cooperating with key players that will be able to lease vehicles to their business customers with a SaverOne system pre-installed. It is a demonstration of the growing market traction and acceptance for our accident protection and life-saving product, the SaverOne System. This new collaboration with UTI follows similar collaborations that we have implemented in recent months with most of the major rental car and leasing companies in Israel including Shlomo Sixt, Hertz, Eldan and Meir Leasing."
About the SaverOne System
SaverOne systems can be installed in private vehicles, trucks and buses and provide a solution to the problem of driver distraction away from the road, that results from drivers using specific distracting applications on the mobile device while driving, in a way that endangers their safety and the safety of passengers. This phenomenon is considered one of the main causes of road accidents in the world. According to the US National Highway Traffic Safety Administration, the annual cost of road accidents just in the United States, stands at about $870 billion each year, excluding the costs of serious injury or death, with a quarter of those accidents estimated to be related to the use of the mobile device while driving.
SaverOne's technology specifically recognizes the driver area in the vehicle and prevents the driver from accessing distracting applications such as messaging while allowing navigation, without user intervention or consent, creating a safer driving environment.
SaverOne's primary target markets include commercial and private vehicle fleets, as well as insurance and leasing companies that are very interested in reducing potential damages and significant costs. SaverOne is initially addressing car fleets with focus on the Israeli, European and US markets, as well as other markets around the world. SaverOne believes that ultimately increased focus on monitoring and prevention of cellular distraction systems in vehicles, in particular driven by upcoming expected EU regulation, will likely have a dramatic positive impact on the demand for its systems in the future. The Company's longer-term strategy is to address vehicle manufacturers, to install the Company's protection technologies in the vehicle manufacturing process as an OEM.
About SaverOne
SaverOne is a technology company engaged in the design, development and commercialization of transportation safety solutions designed to save lives by preventing car accidents resulting from distraction, by the use of mobile phones while driving. The SaverOne system provides an advanced driver safety solution that can identify and monitor mobile phones located in the driver's vicinity and selectively block use of distracting applications that may become life-threatening.
Learn more at https://saver.one/
Forward Looking Statements
This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act and other securities laws that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "target," "aim," "should," "will" "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on SaverOne's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Many factors could cause SaverOne's actual activities or results to differ materially from the activities and results anticipated in such forward-looking statements. Factors that could cause our actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to: the ability of our technology to substantially improve the safety of drivers; our planned level of revenues and capital expenditures; our ability to market and sell our products; our plans to continue to invest in research and development to develop technology for both existing and new products; our intention to advance our technologies and commercialization efforts; our intention to use local distributors in each country or region that we will conduct business to distribute our products or technology; our plan to seek patent, trademark and other intellectual property rights for our products and technologies in the United States and internationally, as well as our ability to maintain and protect the validity of our currently held intellectual property rights; our expectations regarding future changes in our cost of revenues and our operating expenses; our expectations regarding our tax classifications; interpretations of current laws and the passage of future laws; acceptance of our business model by investors; the ability to correctly identify and enter new markets; the impact of competition and new technologies; general market, political and economic conditions in the countries in which we operate; projected capital expenditures and liquidity; our intention to retain key employees, and our belief that we maintain good relations with all of our employees; the impact of the COVID-19 pandemic, and resulting government actions on us; and other risks and uncertainties, including those listed in the section titled "Risk Factors" in the final prospectus on Form 424b4 filed with the Securities and Exchange Commission on June 6, 2022. Forward-looking statements contained in this announcement are made as of this date, and SaverOne undertakes no duty to update such information except as required under applicable law.
View original content:
SOURCE SaverOne | https://www.mysuncoast.com/prnewswire/2022/07/18/new-collaboration-with-uti-israel-importer-isuzu-equip-isuzu-leased-trucks-with-saverone-protection-system/ | 2022-07-18T13:12:32Z |
MLS and Avant Announce MLS Co-Brand Credit Card
The "MLS Forward Credit Card powered by Avant" to feature pre-sale access to MLS special events, merchandise discounts, cash back, gift cards, and more
NEW YORK, Aug. 1, 2022 /PRNewswire/ -- As Major League Soccer (MLS) nears the mid-way mark of its exciting 27th season, MLS and Avant, a credit-first neobank* that gives consumers access to the financial solutions they deserve, announced today a multi-year partnership.
"This multi-year exclusive strategic partnership with MLS further expands upon Avant's offering to its customers," says Kevin Chin, Head of Business Development & Partnerships at Avant. "The agreement designates Avant as the Official Credit Card* Partner of Major League Soccer, the MLS All-Star Game, MLS Cup and eMLS, and will result in the creation of the fan affinity credit card."
Cardholders will have access to benefits including ticket pre-sales, express entry to select major events, and merchandise. Additionally, cardholders will earn rewards points on purchases, including increased rewards for certain categories of purchases such as MLS-related purchases. Points can be redeemed for cash back, tickets to MLS matches, and gift cards for MLS merchandise. Avant will also have the license to create specific credit card designs for 21 Major League Soccer clubs in the U.S. Among the additional highlights of the wide-ranging partnership, Avant will be featured at major MLS events including the MLS All-Star Game presented by Target, MLS Cup Playoffs, and MLS Cup. Avant also becomes a Presenting Sponsor of MLS matches on Univision during the second half of the current MLS regular season.
In the days leading up to the 2022 MLS All-Star Game in Minnesota, MLS and Avant will take to the streets of the Twin Cities to offer consumers compelling experiences to drive awareness of the new partnership. Prizes for the fans participating in fun-filled contests at the activations include a trip to MLS Cup.
"As Major League Soccer continues to experience a period of incredible growth and innovation focused on the fan experience, we are proud to partner with Avant to engage fans and reward them for their passion," said Carter Ladd, MLS EVP, Brand Alliances and Consumer Products. "We look forward to collaborating with Avant on offering access to an MLS-branded affinity credit card that will provide our fans with access to a series of experiences and a way to highlight their fandom through their everyday lives."
The partnership with MLS follows Avant's recent milestone of surpassing one million customers for the Avant Credit Card. The Avant Credit Card was named the third fastest-growing card business in the U.S. by Nilson - the number of Avant Credit Card holders grew 145% in 2021 and surpassed one million cardholders in January 2022.
"This is an exciting milestone in our company's journey," says Matt Bochenek, CEO of Avant. "The strategic partnership with Major League Soccer aligns with our vision and values. We're continually building our business in a way that brings value to underserved customers, providing them with solutions to own their financial journeys using the MLS Forward Credit Card powered by Avant, issued by WebBank."
Major League Soccer is the fastest-growing soccer league in the world, more than doubling in size to 29 clubs over the last 15 years. The momentum will continue as soccer will grow throughout North America on the road to the 2026 FIFA World Cup hosted by the US, Canada, and Mexico. With players representing 82 countries, MLS has the most global player pool in all sports, and its fan base is one of the youngest, most diverse audiences in North American sports.
Headquartered in New York City, Major League Soccer -- celebrating its 27th season in 2022 -- features 29 clubs throughout the United States and Canada, including 2022 expansion team Charlotte FC and St. Louis CITY SC, which debuts in 2023. Starting in 2023, the Apple TV app will be the exclusive destination to watch every single live MLS match. For more information about MLS, visit www.MLSsoccer.com.
Avant is a credit-first neobank that provides access to a full suite of digital financial solutions, including personal loans, credit cards, mobile banking and auto refinance, to everyday American consumers. Through a combination of technology, analytics, and superior customer service, Avant gives underserved consumers access to credit with innovative products that simplify and improve their financial journeys. Since 2012, Avant has connected almost 3 million customers to $8 billion in loans and over 1 million credit cards. A credit-first neobank, Avant has been featured in The Wall Street Journal, The New York Times, TechCrunch, Fortune and Bloomberg, and has raised over $650 million of equity capital. For more information on Avant, visit www.avant.com.
*Avant, LLC is a financial technology company, not a bank. Avant-branded credit products are issued by WebBank.
Media Contacts:
For Major League Soccer
Angela Alfano
MLS
646-682-5313
Angela.Alfano@MLSsoccer.com
For Avant
Fully Vested
avant@fullyvested.com
View original content to download multimedia:
SOURCE Major League Soccer | https://www.wibw.com/prnewswire/2022/08/01/major-league-soccer-avant-announce-multi-year-partnership/ | 2022-08-01T14:51:36Z |
ASHBURN, Va., July 20, 2022 /PRNewswire/ - DXC Technology (NYSE: DXC) today announced that it will release financial results for the first quarter of fiscal year 2023 on Wednesday, August 3, 2022, at approximately 4:15 p.m. Eastern Daylight Time (EDT).
DXC Technology senior management will host a conference call and webcast on the same day at 5:00 p.m. EDT. The dial-in number for domestic callers is 888-330-2455. Callers who reside outside of the United States should dial +1-240-789-2717. The passcode for all participants is 4164760. The webcast audio and any presentation slides will be available through a link posted on DXC Technology's Investor Relations website.
A replay of the conference call will be available until August 10, 2022, at 800-770-2030 for domestic callers and at +1-647-362-9199 for international callers. The replay passcode is 4164760. A transcript of the conference call will be posted on DXC Technology's Investor Relations website.
DXC Technology (NYSE: DXC) helps global companies run their mission critical systems and operations while modernizing IT, optimizing data architectures, and ensuring security and scalability across public, private and hybrid clouds. The world's largest companies and public sector organizations trust DXC to deploy services across our six offerings to drive new levels of performance, competitiveness, and customer experience. Learn more about how we deliver excellence for our customers and colleagues at DXC.com.
All statements in this press release that do not directly and exclusively relate to historical facts constitute "forward-looking statements." Forward-looking statements often include words such as "anticipates," "believes," "estimates," "expects," "forecast," "goal," "intends," "objective," "plans," "projects," "strategy," "target," and "will" and words and terms of similar substance in discussions of future operating or financial performance. Forward-looking statements include, among other things, statements with respect to our future financial condition, results of operations, cash flows, business strategies, operating efficiencies or synergies, divestitures, competitive position, growth opportunities, share repurchases, dividend payments, plans and objectives of management and other matters.
These statements represent current expectations and beliefs, and no assurance can be given that the results described in such statements will be achieved. Such statements are subject to numerous assumptions, risks, uncertainties and other factors that could cause actual results to differ materially from those described in such statements, many of which are outside of our control. Furthermore, many of these risks and uncertainties are currently amplified by and may continue to be amplified by or may, in the future, be amplified by, the ongoing coronavirus disease 2019 ("COVID-19") pandemic and the impact of varying private and governmental responses that affect our customers, employees, vendors and the economies and communities where they operate. For a written description of these factors, see the section titled "Risk Factors" in DXC's Annual Report on Form 10-K for the fiscal year ended March 31, 2022, and any updating information in subsequent SEC filings, including DXC's upcoming Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2022.
No assurance can be given that any goal or plan set forth in any forward-looking statement can or will be achieved, and readers are cautioned not to place undue reliance on such statements which speak only as of the date they are made. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date of this presentation or to reflect the occurrence of unanticipated events except as required by law.
View original content to download multimedia:
SOURCE DXC Technology Company | https://www.wibw.com/prnewswire/2022/07/20/dxc-technology-report-first-quarter-2023-results-wednesday-august-3-2022/ | 2022-07-20T21:39:34Z |
Jordan Spieth skips ball off water at PGA Championship
By Ben Morse, CNN
Jordan Spieth is not afraid of the spectacular.
And on Saturday, he added another shot to his long repertoire of unique and resourceful shots.
In what has been a relatively unforgettable few days at the 2022 PGA Championship in Tulsa, Oklahoma, the three-time produced a moment of magic during the third round.
After his drive on the par-4 12th hole drifted left and into the rough under some trees, Spieth needed to dig his ball out in tricky conditions with the green 120 yards away.
With trees overhanging the position, the option he chose was to punch the ball out in an attempt to salvage something from the hole.
What happened next was something no one expected.
His connection with the ball wasn’t what he hoped, and the ball flew toward the water between him and the green.
But, to everyone’s surprise, Spieth’s ball bounced off the water and back into the field of play.
Despite this extraordinary moment of skill or luck, he was unfortunately unable to avoid a bogey, something which was a common theme at the PGA Championship for Spieth.
The 28-year-old finished four-over for the major following a four-over par 74 in his final round on Sunday.
The-CNN-Wire
™ & © 2022 Cable News Network, Inc., a WarnerMedia Company. All rights reserved. | https://localnews8.com/sports/cnn-sports/2022/05/22/jordan-spieth-skips-ball-off-water-at-pga-championship/ | 2022-05-22T23:10:36Z |
TIFTON — The “G.I. Jobs” magazine has recognized Abraham Baldwin Agricultural College on its 2022-23 Military Friendly Schools list, making ABAC one of the seven University System of Georgia institutions designated as Military Friendly.
For more than 20 years, “G.I. Jobs” has committed to helping veterans connect to opportunities for education and employment. They evaluate schools for federal government accreditation and veteran satisfaction through the Military Friendly assessment survey.
A military-friendly school implements the best practices and policies to support student veterans, considering factors such as military student support and retention, graduation and career outcomes, and financial aid and loan repayment.
ABAC offers student veterans access to the Veteran Success Center, work-study opportunities, veteran-to-veteran tutoring programs, priority one registration for courses, and United States Veteran graduation stoles.
Veterans using G.I. Bill benefits have possible funding for college tuition, money for books, and a monthly housing allowance that is paid to eligible students by the Department of Veteran Affairs for attending ABAC.
Jessica Miller is the Veterans Affairs Certifying Official, assisting veterans applying for military educational benefits in the Office of Student Accounts located on the first floor of the college's Carlton Center. Interested persons can contact her at jmiller@abac.edu.
“ABAC is honored to receive the military-friendly designation once again,” Miller said in a news release. “Our military and veteran students have served our country, and now we are privileged to serve them through assisting in their educational success.”
All veterans, active-duty service members, members of the reserves, and dependents of disabled or deceased veterans, should contact the Office of Student Accounts immediately upon deciding to enroll in ABAC so that proper administrative procedures can be initiated.
Students who wish to use veterans benefits at ABAC must present a copy of their Form DD-214 to the Office of Student Accounts for evaluation.
Giggster scoured historical archives to compile a collection of photos that best illustrate what life was like in New York City 100 years ago. Click for more.
Keep it Clean. Please avoid obscene, vulgar, lewd,
racist or sexually-oriented language. PLEASE TURN OFF YOUR CAPS LOCK. Don't Threaten. Threats of harming another
person will not be tolerated. Be Truthful. Don't knowingly lie about anyone
or anything. Be Nice. No racism, sexism or any sort of -ism
that is degrading to another person. Be Proactive. Use the 'Report' link on
each comment to let us know of abusive posts. Share with Us. We'd love to hear eyewitness
accounts, the history behind an article. | https://www.albanyherald.com/news/abraham-baldwin-agricultural-college-named-to-military-friendly-college-list/article_2fd31e78-0c16-11ed-b479-731583bfec15.html | 2022-07-25T14:33:06Z |
BELTON — A Bell County judge approved a request for capital murder suspect Cedric Marks to spend $7,500 to hire forensic experts to help prepare his criminal defense.
Marks — who is defending himself with defense attorneys as standby counsel in the death penalty case — said the use of the forensic experts is “paramount” for his defense at a trial. The trial, initially set for Oct. 4, but is now delayed.
“I would like to have that available,” Marks said during a Tuesday hearing. “… They would provide assistance and maybe expert testimony.”
Marks said he was unhappy to learn that his trial would be delayed again. Upon hearing his forensic experts would need extra time to prepare, Marks argued with 426th District Court Judge Steve Duskie on the issue.
“My concern is that it will require disclosure that will further push away our trial date,” Duskie said. “The dilemma I have is having to work out a jury to be called.”
Duskie said the jury panel for Marks’ trial would be more significant than usual, and he had a deadline to meet before sending extra jury summons in a timely matter. About 1,000 people are expected to be summoned for jury selection, and then attorneys will whittle down that pool to about 100.
The extra cost of mailing additional jury summons was not an expense Duskie wanted to burden taxpayers with, he said.
“If I am going to spend money to appoint these experts, I need to move the trial,” Duskie said. “Would you like to turn around and confer with your standby counsel?”
“They know nothing about these experts, so they’re useless,” Marks responded, referring to attorney John Galligan and Gabrielle Greene, who were appointed as Marks’ standby counsel. “I am forced to represent myself. If I have to lose the experts to keep my trial date, I’d rather have that.”
“You’re not the one that has to sit on that cell,” Marks told Duskie. “I have been sitting on that cell for three years for something that I didn’t do.”
Marks is charged with capital murder of multiple persons in connection with the Jan. 3, 2019,deaths of Temple residents Jenna Scott, 28, and Michael Swearingin, 32. He is also charged with burglary of a habitation with intent to commit a felony, a first-degree felony; tampering with evidence, a third-degree felony, and various misdemeanor charges. He has been jailed in Bell County since Feb. 3, 2019.
Arrest affidavits in the case said both victims were killed in Killeen and the bodies buried in a shallow grave near Clearview, Okla.
Autopsy results listed Scott’s cause of death as homicidal violence due to multiple traumatic injuries while Swearingin was strangled and had cuts and abrasions on his body.
Standby counsel
Duskie continued asking Marks to talk to his standby counsel.
“If I needed to talk to them, I would be talking to them,” Marks responded.
Galligan and Greene joined a string of attorneys appointed to help Marks with his defense. His attorneys have experienced fierce opposition during court hearings from Marks when trying to assist him.
Duskie said he had already approved the experts and would reconvene at a later time for a status hearing in the case.
“I heard you this afternoon,” he said. “We will have a pretrial soon and decide where you’re at.”
Bell County Assistant District Attorney Stephanie Newell said the state had no objections about Marks having access to experts.
Fingerprint evidence
Marks’ antics began earlier in the hearing when the prosecution led by Bell County District Attorney Henry Garza filed a motion to require Marks to submit fingerprints from the edge of his fingers for further study.
“Here we are for the fourth time,” Marks said. “They ran those and came back negative. They have an item, and all fingerprints came back negative, that came back as inconclusive. They are hoping to put me in a place that I’ve never been.
“It is clear that there is an unconscious bias of putting me there,” Marks said. “This is a waste of time.”
Duskie asked what the issue was since he had ordered fingerprints before, and they were taken in the courtroom.
“What is the issue? Did the first time not work out?” Duskie asked Garza.
Garza responded that a Texas Department of Public Safety lab requested the additional prints and asked Duskie to not put too much weight on the defendant’s accusations about implied wrongdoing from the state.
“If you’re hearing it from (Marks’) mouth?” Garza said.
“This came out of your guy’s mouth,” Marks interrupted Garza, referring to the negative results. “Watch your mouth when you’re talking to me.”
Duskie asked both men not to talk to each other.
“I can either do something or do nothing,” Garza responded. “I am doing what the lab asked me to.”
Duskie said he would order the fingerprints and asked Marks to cooperate.
“I will cooperate if this is the man that takes those fingerprints personally,” Marks said, pointing at Garza.
Access to free phone calls
Marks also requested access to free-of-charge, non-recorded phone calls to coordinate with witnesses he plans to call in his defense.
“The issue is that I am in jail,” he said. “I can’t pay for all the phone calls. This trial keeps changing. I need to be able to coordinate that. Every time I call, the call is recorded, and I pay for the call. I’m asking to once, maybe twice a week, to be taken for this free phone call … to coordinate these witnesses.”
Newell opposed the petition, saying it would give Marks — jailed on bonds totaling more than $2 million — extra privileges not afforded to other inmates.
“This just gets into the issue of jail issues and safety,” Newell said. “Because he has access to standby council, there should not be special accommodations. He should not have free calls. We have nothing tailored to this request. We don’t have a list of witnesses. We ask that is denied at least in this form.”
At this point in the hearing, Marks began complaining about his standby counsel.
“Standby council won’t take my calls,” he said. “I have emails as evidence that say they won’t take my phone calls. I just talk to them here (in court).”
Duskie asked Marks how he intended to accomplish the phone calls from the jail.
Marks responded he just needed 30 minutes once a week and was not opposed to being shackled and having deputies present while he made the phone calls from a landline within the jail.
Duskie said he would take the information into advisement, seek more information from the Bell County Jail about safety issues, and decide at a later hearing. | https://www.tdtnews.com/news/central_texas_news/article_5ad214be-297e-11ed-b7bf-4ffd4d246c77.html | 2022-09-01T00:40:35Z |
DETROIT (AP) — A Detroit-area man who said he feared for his life when he fatally shot a young woman on his porch in 2013 was given the same 17-year prison sentence Wednesday at a new hearing ordered by the Michigan Supreme Court.
Ted Wafer was convicted of second-degree murder and involuntary manslaughter in the death of Renisha McBride in Dearborn Heights.
But about halfway through Wafer’s prison term, the Supreme Court in February unanimously threw out the manslaughter conviction, saying he couldn’t be punished twice for the same homicide.
Wayne County Judge Dana Hathaway said the prison sentence won’t change: 15 years for second-degree murder, plus two years for using a gun during a crime, which Wafer has already served. She noted that the murder sentence still was within the scoring guidelines.
Wafer, 63, gets credit for roughly eight years in custody, making him eligible for parole in 2031.
Wafer has been a “model prisoner” but the “facts remain the same,” the judge said.
“You cannot murder someone for simply knocking on your door in the middle of the night. You had choices,” Hathaway said.
Wafer opened his front door and shot McBride, 19, through a screen door before dawn. He said he was awakened by pounding and feared for his life, though he didn’t call police first. A jury rejected his self-defense claim.
Prosecutors speculated that McBride, who was drunk and had crashed her car hours earlier, might have been confused when she arrived on Wafer’s porch.
“I remain terribly sorry,” Wafer said Wednesday.
Wafer is white and McBride was Black; some people wondered in the aftermath of the shooting whether race was a factor, likening it to the 2012 shooting of Florida teenager Trayvon Martin. But race was hardly mentioned during Wafer’s trial in 2014.
“Holidays are no longer holidays because we have no joy,” McBride’s mother, Monica McBride, said in court. “Every day is a living nightmare that we can’t and won’t wake up from.”
___
Follow Ed White at https://twitter.com/edwritez | https://cw33.com/news/u-s-news/ap-us-headlines/17-year-sentence-sticks-for-man-who-killed-woman-on-porch/ | 2022-06-23T00:14:34Z |
Raptor's new school safety software is built on a proven safeguarding solution used in the United Kingdom, providing a holistic picture of student wellbeing
HOUSTON, June 21, 2022 /PRNewswire/ -- Raptor Technologies ("Raptor"), the U.S. leader in school safety software, announces Raptor StudentSafe™, a revolutionary new software platform designed to help schools recognize, document, support, and manage the wellbeing of individual students. The patent-pending software ultimately helps schools create and maintain a student-focused culture that emphasizes early intervention and the application of services to drive improved outcomes for the child.
In the wake of the 2021-22 school year that saw unprecedented student mental health challenges and violence, many school districts want solutions to proactively identify concerning student behaviors earlier. Built on a proven and advanced safeguarding technology in use in the United Kingdom for the last decade, Raptor StudentSafe enables schools to document and address low-level concerns before they evolve into more significant issues or risks. The software also integrates an easy-to-use behavioral threat assessment (BTA) case management workflow for school Threat Assessment Teams.
"As the leader in school safety software, our customers have asked us to help them respond to the growing need to identify students who may be in distress or at risk for harm or abuse," said Gray Hall, chief executive officer, Raptor Technologies. "By providing schools with a proven safeguarding solution integrated with an advanced behavioral threat assessment workflow, schools now have the tools to proactively manage the wellbeing of every student."
From alerts and reminders to security and privacy, Raptor StudentSafe assists school staff with proactively safeguarding each student from harm, abuse, and distress. StudentSafe gives both schools and districts rapid insight into students' needs, centralized communications, robust reporting, and a complete chronology of concerns, cases, and intervention plans for each student in need of support. When school and district staff have a holistic view, they are better positioned for decision-making and directing resources in the best interest of students.
"Safeguarding has become a critical tool in how UK schools address the needs of pupils, and we have seen a significant and positive impact on outcomes," said Ann Marie Christian, UK-based safeguarding expert, speaker, and author. "Additionally, U.S. teachers and staff will feel confident that the information they report is available to the relevant professionals immediately and securely through StudentSafe."
With almost half of the U.S. states mandating schools have Threat Assessment Teams in place, Raptor StudentSafe features a robust BTA workflow supporting the leading BTA methodologies and is configurable to support any custom workflows. The advantage of providing safeguarding and BTA together in one product is that if a student crosses certain behavioral thresholds, the Threat Assessment Team is provided a well-documented chronology of concerns, including any prior interventions and results. This critical information can lead to better outcomes for the student.
"Schools cannot wait until a small problem has grown into a crisis before they take action," stated Dr. Dewey Cornell, professor of education at the University of Virginia. "With a comprehensive approach like StudentSafe, our school counselors, psychologists, nurses, and social workers are better equipped to identify needs for support services, taking a truly proactive approach to student safety and wellbeing."
Raptor StudentSafe will be available for schools and districts across the country for the 2022-2023 school year. For more information on Raptor StudentSafe, visit www.raptortech.com/studentsafe.
Founded in 2002, Raptor has partnered with over 50,000 schools globally, including over 5,000 K-12 US school districts, to provide integrated visitor, volunteer, emergency management, safeguarding, and behavioral threat assessment software and services that cover the complete spectrum of school and student safety. To learn more about Raptor Technologies, visit www.raptortech.com.
Media Contact:
Matt Maurel
512.387.3440
matt.maurel@anthonybarnum.com
View original content to download multimedia:
SOURCE Raptor Technologies | https://www.wibw.com/prnewswire/2022/06/21/new-raptor-studentsafe-software-brings-student-safeguarding-earlier-interventions-violence-reduction-us-schools/ | 2022-06-21T13:41:36Z |
NEW ORLEANS, June 10, 2022 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF continues its investigation into ATI Physical Therapy, Inc. (NYSE: ATIP; ATIP WS) f/k/a Fortress Value Acquisition Corp. II. (NYSE: FAII; FAII WS).
On February 22, 2021, ATI and Fortress Value Acquisition Corp. II announced a proposed merger that would take ATI public. On June 17, 2021, the Company announced that it had completed its Business Combination with Fortress. Then, on July 26, 2021, the Company reported its financial results for 2Q2021, the period in which the Business Combination was completed, disclosing that "the acceleration of attrition among [its] therapists in the second quarter and continuing into the third quarter, combined with the intensifying competition for clinicians in the labor market, prevented us from being able to meet the demand we have and increased our labor costs" and reduced its fiscal 2021 forecast due to the foregoing factors.
Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information in violation of federal securities laws, which remains ongoing.
KSF's investigation is focusing on whether ATI's officers and/or directors breached their fiduciary duties to the Company's shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of ATI Physical Therapy shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-877-515-1850 or email KSF Managing Partner Lewis Kahn (lewis.kahn@ksfcounsel.com), or visit https://www.ksfcounsel.com/cases/nyse-atip/ to learn more.
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. KSF serves a variety of clients – including public institutional investors, hedge funds, money managers and retail investors – in seeking to recover investment losses due to corporate fraud and malfeasance by publicly traded companies. KSF has offices in New York, California, Louisiana and New Jersey.
To learn more about KSF, you may visit www.ksfcounsel.com.
Contact:
Kahn Swick & Foti, LLC
Lewis Kahn, Managing Partner
lewis.kahn@ksfcounsel.com
1-877-515-1850
1100 Poydras St., Suite 3200
New Orleans, LA 70163
View original content to download multimedia:
SOURCE Kahn Swick & Foti, LLC | https://www.kxii.com/prnewswire/2022/06/11/ati-physical-therapy-investigation-continued-by-former-louisiana-attorney-general-kahn-swick-amp-foti-llc-continues-investigate-officers-directors-ati-physical-therapy-inc-fka-fortress-value-acquisition-corp-ii-atip/ | 2022-06-11T04:02:37Z |
NAVASOTA – Coaches say it often. “That’s why we play a series.” Or something along those lines. Well, the adage showed up uninvited as far as Lake Belton’s baseball team was concerned. Lufkin Hudson, meanwhile, wouldn’t mind if it tagged along a few more rounds.
The Broncos couldn’t maximize the 1-0 Class 4A area round best-of-three series lead it earned in come-from-behind fashion Thursday night and dropped games of 9-4 and 7-2 to the Hornets at sweltering Boenker Field on Friday night.
Hudson (25-11-1), which eliminated Lake Belton in the regional quarterfinals a year ago with results of 2-1 and 1-0, booked a return trip to the third round. The Hornets face Carthage or Giddings.
The Broncos (23-9-1) headed into the offseason with a second straight District 19-4A title, a bi-district crown, the prospects of their entire roster returning for a third year and an anticipation of moving up to 5A.
Nolan Larsen pitched 6 2/3 innings in Game 3 to pick up the win, scattering nine hits while allowing two runs and striking out four.
Hudson’s four-run second inning was about all the run support the lefty needed and was one of five innings during the two Friday contests in which the Hornets scored at least two runs.
Mason Law took the loss in Game 3, though the right-hander finished with seven strikeouts, including a stretch of five in a row, in four innings of work.
Kanaan Holder had a two-run single, and Blake Slaga and Collin Ross had an RBI each to stake Hudson to its 4-0 lead in the second.
Lake Belton got on the board in the third with Mason Gerrard’s RBI single to make it 4-1. The Hornets tacked on two in the fourth with an RBI double by Holder and Tyler Dickerson’s run-scoring single for 6-1.
It was 7-1 after Diesel Gonzalez drew a bases-loaded walk off Lake Belton reliever Clint Beck in the fifth. The Broncos scratched across a run in the seventh when Jaydon Leza tagged up from third on Gerrard’s fly out to center. Mathew Gardner relieved Larsen with two outs in the frame and recorded the final out.
Ty Jackson was 2-for-3 with a walk in Game 3 for the Broncos, who also got two hits from Leza and Connor Bartz.
The Hornets forced the winner-take-all Game 3 by scoring three runs in three innings of Game 2, backing Carson Courtney’s 6 2/3-inning performance on the mound.
Courtney gave up seven hits and allowed four runs while striking out six. Counterpart Bartz took the loss, surrendering six runs on six hits in four innings.
Hudson took a 3-0 lead in the second inning with an RBI double from Larsen and back-to-back RBI groundouts from Chandler Spencer and Holder.
The Broncos got one back in the bottom of the third through Mason Trovinger’s RBI triple to the wall in right-center field that chased home Tanner Jones.
Ross’ two-out, two-run triple one batter after an error kept alive the fourth, highlighted the Hornets’ three-run frame that made it 6-1.
Brandon Bell’s RBI sacrifice fly got Lake Belton within 6-2 in the bottom of the fourth before the Hornets tallied a trio in the sixth. Run-scoring singles by the Broncos' Bryce Davis and Beck in the seventh went toward the final margin.
Beck was 3-for-4 in Game 2 and Malaki McGehee was 2-for-4.
NOTE: Lake Belton scored twice in the top of the seventh of Game 1 on Thursday to win 3-1. Logan Flores pitched a complete game in the victory.
Game 2
Lufkin Hudson 9, Lake Belton 4
Hudson 030 303 0 9 8 2
Lake Belton 001 100 2 4 8 2
Courtney, Salas (7) and Roff. Bartz, Flanagan (5), Stanford (6) and Jackson, Jones (3).
W—Courtney. L—Bartz.
3B—H: Ross; LB: Trovinger. 2B—H:Larsen; LB: Beck.
Game 3
Lufkin Hudson 7, Lake Belton 2
Lake Belton 001 000 1 2 9 1
Hudson 040 210 x 7 10 0
Law, Beck (5) and Jackson. Larsen, Gardner (7) and Roff.
W—Larsen. L—Law.
2B—LB: Jackson; H: Slaga, Spencer.
Records: Lake Belton 23-9-1; Hudson 25-11-1 | https://www.tdtnews.com/sports/article_4921023c-d336-11ec-89ef-ff1dc27de4c6.html | 2022-05-14T06:05:30Z |
– Pro and college stars will create NFTs on Momento NFT's social network; fans can buy and collect the social NFTs and receive autographed merchandise, and exclusive one-on-one livestreams with the athletes –
NEW YORK, May 17, 2022 /PRNewswire/ -- JuJu Smith-Schuster, Monique Billings, Jalen Suggs, Cameron Brink and Zaire Wade are among the popular athlete-creators to join direct-to-fan social network Momento NFT and mint exclusive NFTs on the app for their fans and other collectors. The first collections will launch today.
In partnering with Momento NFT, the five new athlete-creators can turn their own experiences into limited-edition social NFTs and monetize them, allowing legions of fans to own and collect NFTs directly from their favorite players and receive autographed merchandise and personal livestreams with them. Before Momento NFT's launch, creators had to rely on traditional social media channels to monetize their work through paid advertising and growing their likes and shares. Momento NFT removes these challenges and saves creators time by giving them a consolidated platform through which they can own, control, and monetize their own content.
The Momento NFT athlete-creators are:
- JuJu Smith-Schuster: Star receiver of the Kansas City Chiefs, gamer and social media creator.
- Monique Billings: Veteran forward with the Atlanta Dream, sports broadcaster, and fashion model.
- Jalen Suggs: Rising star of the Orlando Magic.
- Cameron Brink: All-American championship forward with the Stanford Women's Basketball team and social media influencer.
- Zaire Wade: NBA G-League guard with Salt Lake City Stars and entrepreneur.
"I can't wait to share my experiences with fans in ways I never even imagined. Momento NFT is bringing athletes and fans together in a game changing new way so that we all can be part of this exciting world of NFTs," said Billings.
"NFTs are revolutionizing the player-fan experience, and I'm hyped to create some limited-edition moments through Momento's app that reward my fans for being so loyal and passionate," said Suggs.
"I love interacting with fans which is why I'm thrilled to be partnering with the crew at Momento NFT to create exclusive NFT content so that my fans feel closer and can share in my own incredible experiences," said Wade.
Fans are at the heart of the NFT experience, and as the athletes create content through the app, it will be promoted across fan groups. For those fans who buy the NFTs, they will also receive autographed merchandise and exclusive one-on-one livestreams with the athletes. For this launch, Momento NFT partnered with OneTeam Partners, a licensing, marketing and multimedia company that specializes in commercializing the group rights of athletes.
As Momento NFT expands its global reach and builds its network of creators, it is committed to offering fans greater access to moments they may otherwise not be able to experience while giving creators more opportunities to transition into the metaverse.
To learn more about Momento NFT, visit https://momentonft.com/
About Momento NFT
Led by CEO Julian Rodriguez, CTO Sudesh Banskota, and CMO Nelson Sarco, Momento NFT is a direct-to-fan social NFT App that allows fans to own viral moments from their favorite creators and unlock perks like meet & greets, autographed merchandise, and more. Be among the first to create or own your own NFT moment by downloading the app here: https://www.momentonft.com.
View original content to download multimedia:
SOURCE OneTeam Partners | https://www.kxii.com/prnewswire/2022/05/17/momento-nft-adds-star-athletes-smith-schuster-billings-suggs-brink-wade/ | 2022-05-17T14:54:38Z |
High-speed data cards leverage Verizon's network to enable high-performance industrial and consumer applications including enterprise routers, industrial gateways, public safety, private networks and mobile computing
IRVINE, Calif., Aug. 22, 2022 /PRNewswire/ -- Telit, a global leader in the Internet of Things (IoT), today announces that Verizon certified its LN920 global M.2 modules for use on its mobile broadband network. Powered by the Snapdragon® X12 LTE Modem, the LN920 quickly leverages Verizon's network to enable high-throughput connectivity for industrial and consumer applications including enterprise routers, industrial gateways, public safety, private networks and mobile computing. With certification from Verizon, original equipment manufacturers (OEMs), system integrators and end users gain verification and assurance that their LN920-based devices will achieve optimal performance on Verizon's network. For more information on the LN920 visit: https://www.telit.com/ln920/.
The high-speed LN920 compact M.2 (NGFF) data card is available in LTE Cat 6 and Cat 12 versions, with a smooth evolution path toward 5G technology, and supports global cellular bands between 600 MHz and 3.7 GHz, including CBRS (band 48). Ideal for both public and private LTE applications worldwide, the LN920 is certified by major regulators and Tier 1 operators in the U.S., Canada, Japan, Australia and Europe — enabling rapid development of global SKU devices.
"Verizon's nationwide LTE and 5G networks deliver reliable high-speed connectivity, critical for all IoT devices," said Shamik Basu, executive director & product head, IoT and automotive at Verizon. "Certifying Telit's LN920 data card provides our business customers the confidence that their IoT devices will achieve their performance requirements in both industrial and consumer applications."
"Designed in M.2 (NGFF) form factor, the LN920 global data cards are the natural evolution toward 5G technology," said Jitender Vohra, senior director of carrier relations, Telit. "By supporting several next-generation features such as LTE Advanced Carrier Aggregation and CBRS, the Snapdragon X12 LTE Modem-based LN920 represents the ultimate in LTE connectivity—and our collective and longstanding commitment to provide solutions that give vendors and systems designers a competitive and financial edge."
"Innovation is at the heart of Qualcomm Technologies, Inc. By equipping operators and OEMs with industry leading technologies, end consumers are able to reap the benefits of best-in-class cellular connectivity," said Gautam Sheoran, vice president, product management, Qualcomm Technologies, Inc. "We are excited to collaborate with Telit to power their LN920 with the Snapdragon X12 LTE Modem to give IoT devices the ability to utilize Verizon's mobile broadband network."
Both versions of the LN920 include global bands, WCDMA fallback, on-board GNSS receiver, industrial-grade operating temperature durability (-40 to +85°C) and support for Telit AppZone embedded application development environment. It also supports enhanced security features suitable for enterprise applications including secure boot and secure environment SE Linux with latest kernel 5.4 security updates.
About Telit
Telit simplifies onboarding of connected 'things' with a portfolio of enterprise-grade wireless communication and positioning modules; cellular MVNO connectivity plans and management services; edge and cloud software; and data orchestration, IoT and Industrial IoT platforms. With over two decades of pioneering IoT innovation experience, Telit delivers award-winning, secure, integrated IoT solutions for many of the world's largest enterprises, OEMs, system integrators and service providers, so they can connect and manage IoT at any scale.
For more information, follow us on Twitter, LinkedIn and Facebook or visit www.Telit.com.
Copyright © 2022 Telit Communications LTD. All rights reserved. Telit, Telit OneEdge and all associated logos are trademarks of Telit Communications LTD and its affiliated companies in the United States and other countries. Other names used herein may be trademarks of their respective owners.
Snapdragon is a trademark or registered trademark of Qualcomm Incorporated.
Snapdragon is a product of Qualcomm Technologies, Inc. and/or its subsidiaries
Media Contacts
Leslie Hart
Telit
+1 919-415-1510
Leslie.Hart@Telit.com
Lora Wilson
Valerie Christopherson
GRC for Telit
+1 949-608-0276
telit@globalresultspr.com
View original content to download multimedia:
SOURCE Telit | https://www.mysuncoast.com/prnewswire/2022/08/22/telit-ln920-m2-global-modules-certified-use-verizons-mobile-broadband-network/ | 2022-08-22T15:51:34Z |
BOSTON, July 18, 2022 /PRNewswire/ -- Today, the Digital Medicine Society (DiMe) released the Sensor Data Integrations Toolkits, four comprehensive toolkits to guide data producers, processors, and consumers to use the influx of data from the increased use of wearables and digital sensing products at scale. These resources are based on the Sensor Data Integrations project, comprised of healthcare leaders from Amazon Web Services (AWS), Oracle, the Moffitt Cancer Center, Takeda, the US Department of Veterans Affairs (VA), and more. These toolkits will help realize the promise of sensor generated data to drive better decisions, faster, to improve healthcare delivery and research. The project team will conduct a demo of the toolkits during a live launch event on July 18 at 10:30 am ET, featuring Micky Tripathi, the National Coordinator for Health Information Technology at the US Department of Health and Human Services.
The surge of data from sensor technologies is far outpacing the industry's ability to collect, store, analyze, protect, and use this data effectively for patient care and research. The number of US patients using remote patient monitoring devices is expected to surpass 70 million by 2025. Between 2022 and 2028, the global market for wearable technology is expected to grow around 18.5 percent, reaching $380.5 billion. The number of unique digital endpoints being used in industry sponsored trials of new medical products increased by over 950% between October 2019 and May 2022. The number of sponsors using these products in medical product development increased from 12 to 96 in the same timespan. And while the ability to discern high-quality sensor data suitable for clinical decision making is increasing rapidly, the ability to access these data is constrained by a current dependence on individual point solutions.
"Sensor generated data, captured during people's daily lives, offer the opportunity to redefine how we measure health and disease. This opportunity powers the possibility of using high quality, high resolution flows of data to reimagine our approach to healthcare and research, leveraging more complete information to improve individual clinical decisions, decisions about the effectiveness of new medical products, and broader policy and public health decisions," said DiMe CEO Jennifer Goldsack. "DiMe's new Sensor Data Integrations Toolkits provide action-oriented resources to help data producers, processors, and consumers come together to create a sensor data ecosystem suitable for scale."
AWS has contributed customer feedback and technical expertise to ensure the toolkit meets the needs of today's modern healthcare system. "Across every industry, we see companies trying to accelerate their path to the cloud," said Lita Sands, Head of Solutions Life Sciences at AWS. "Timelines are getting quicker while the data collected is increasing exponentially – there is a clear and significant need for how to effectively and securely collect and use this information at scale. DiMe's new toolkits are a lifeline to organizations working with sensor data. They offer a comprehensive starting point for data producers, processors, and consumers to help build an integrated pipeline to support better and faster decision making."
The development of these toolkits builds on DiMe's previous pre-competitive initiatives, such as The Playbook, the essential guide for developing and deploying digital clinical measures to advance patient care, clinical research, and public health. The Sensor Data Integrations Toolkits go further to ensure that high quality sensor data can be used at scale to improve patient care and speed efficient medical product development.
The DiMe community is currently working on additional projects related to taking digitally generated data to scale and will be releasing additional resources over the coming months. DiMe is not only committed to creating and disseminating new digital health approaches and tools, but also sharing user experiences with the broader community. We encourage Sensor Data Integrations Toolkits users to contribute to Dime's "Resources in Action" case study hub by sharing how you are using resources to further the safe, effective, equitable, and ethical use of digital medicine to redefine healthcare and improve human health.
The leading organizations from across the global healthcare, research, and digital health innovation sectors that collaborated with DiMe to create these open-access resources are AWS, Elevance Health, Evidation, US Food and Drug Administration (FDA), Human First, Institute of Electrical and Electronics Engineers, Medable, Moffitt Cancer Center, Open mHealth, Oracle, Savvy, Takeda, and US Department of Veterans Affairs (VA).
About the Digital Medicine Society: DiMe is a global non-profit and the professional home for all members of the digital medicine community. Together, we tackle the toughest digital medicine challenges, develop clinical-quality resources on a technology timeline, and deliver these actionable resources to the field via open-source channels and educational programs. Join us to advance the ethical, effective, equitable, and safe use of digital medicine to redefine healthcare and improve lives.
Media Contact: Carla English, press@dimesociety.org
View original content to download multimedia:
SOURCE Digital Medicine Society (DiMe) | https://www.mysuncoast.com/prnewswire/2022/07/18/dime-releases-toolkits-improve-sensor-data-integration-power-better-faster-global-healthcare-research/ | 2022-07-18T05:27:39Z |
NEW YORK, Sept. 6, 2022 /PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN)'s sale to Pfizer Inc. for $148.50 per share in cash. Biohaven common shareholders, including Pfizer, will also receive 0.5 of a share of New Biohaven, a new publicly traded company that will retain Biohaven's non-CGRP development stage pipeline compounds, per Biohaven common share. If you are a Biohaven shareholder, click here to learn more about your rights and options.
Duke Realty Corporation (NYSE: DRE)'s sale to Prologis, Inc. for 0.475x of a Prologis share for each Duke Realty share. If you are a Duke Realty shareholder, click here to learn more about your rights and options.
Prologis, Inc. (NYSE: PLD)'s merger with Duke Realty Corporation. If you are a Prologis shareholder, click here to learn more about your rights and options.
Gemini Therapeutics, Inc. (NASDAQ: GMTX)'s merger with Disc Medicine, Inc. Pre-merger Gemini shareholders are expected to own approximately 28% of the combined company. If you are a Gemini shareholder, click here to learn more about your rights and options.
Safehold Inc. (NYSE: SAFE)'s merger with iStar Inc. If you are a Safehold shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com
View original content to download multimedia:
SOURCE Halper Sadeh LLP | https://www.kxii.com/prnewswire/2022/09/06/shareholder-notice-halper-sadeh-llp-investigates-bhvn-dre-pld-gmtx-safe/ | 2022-09-06T14:34:30Z |
BOULDER, Colo., June 8, 2022 /PRNewswire/ -- LongPath Technologies co-founder and CTO Greg Rieker testified today before a House Science Committee hearing focused on efforts to monitor methane emissions from the oil and gas sector.
"You can't improve what you don't measure," said Rieker, offering the committee a key and unique perspective as LongPath is the only independent blind-tested and proven true-continuous leak monitoring platform.
"The action of emissions mitigation happens at the local level," said Reiker, "so continuous, specific-facility monitoring with instantaneous feedback directly to the oil and gas companies is critical."
LongPath provides multiple per day full-site-coverage (facility-wide) emissions measurements to operators, catching large leaks in real-time. LongPath's large-scale networks of laser sensors (akin to a methane radar) provide scalable and accurate data for rapid emissions mitigation and ESG/RSG accounting.
Rieker highlighted three key points for the committee: First, the savings realized when operators opt for continuous emissions monitoring systems like LongPath's more than pay for themselves in improved operational efficiency and rapid repair of leaks. Second, new policies and legislation (e.g. EPA's proposed methane rule and the SEC's proposed climate-related disclosures rule) must recognize that evolving technologies provide more and better information than older leak survey methods and calculation-based inventory values. And, Third, the cost of new methane technologies are well within reach, not only for operator adoption but for public good and public infrastructure considerations.
"LongPath can cover the Permian, one of the US' largest oil and gas basins, for less than the cost of the last James Bond Movie… or, in infrastructure terms, for less than the cost of 20 miles of interstate highway," said Reiker.
LongPath's foundational laser technology combines low system cost and field robustness with continuous long-distance emissions detection. LongPath is based in Boulder, CO. Learn more at www.LongPathTech.com.
View original content to download multimedia:
SOURCE LongPath Technologies, Inc. | https://www.mysuncoast.com/prnewswire/2022/06/08/longpath-testifies-methane-monitoring-house-science-committee/ | 2022-06-08T16:50:23Z |
PLYMOUTH, Mass. (AP) — Boaters and whale watchers off Massachusetts got a surprise over the weekend when a humpback whale breached and landed on the bow of a 19-foot vessel.
The boat operator reported no injuries and no damage that affected the seaworthiness of the vessel, according to officials in Plymouth, on Cape Cod Bay.
Several boats were around the whale Sunday when it made the jump. Video footage shows it launching its body out of the water and its head slamming onto the front of a boat, tipping the rear of the vessel out of the water as it slid back into the ocean.
Humpback whales can grow up to 62 feet long and weight up to 53 tons. They are popular with whale watchers because of their acrobatic displays — including spectacular breachings in which they launch their school-bus-size bodies entirely out of the water and slap the surface with their pectoral fins or tails.
The Plymouth harbormaster said collisions like that off Plymouth are rare and can be dangerous for both boaters and whales. The harbormaster recommends that boaters stay at least 100 yards from humpbacks to minimize such meetings. | https://cw33.com/strange-news/ap-strange-news/whale-whomping-jumping-humpback-lands-on-boat-no-one-hurt/ | 2022-07-26T11:00:44Z |
Editor's Note: This story is part of a series called "Georgia Groundbreakers" that celebrates innovative and visionary faculty, students, alumni and leaders throughout the history of the University of Georgia – and their profound, enduring impact on our state, our nation and the world.
ATHENS -- The football programs at the University of Georgia and Iowa State University don’t share a lot in common. They’ve never played each other in the 130 years since they each started formal football programs in 1892. Their campuses in Athens and Ames, Iowa, are separated by 800 miles. They don’t even compete in the same recruiting pool for players.
Yet in 1895, Georgia and what was then called Iowa Agricultural College and Model Farm shared the same first-time head football coach – Glenn Scobey “Pop” Warner. Before becoming the first man to exceed 300 coaching victories, to innovate everything from formations to techniques to equipment and whose name for nearly a century has been synonymous with youth football in America – before all of that, Pop Warner quit his law practice in Buffalo, N.Y., to moonlight as head coach of two colleges at the same time.
“Things were a free-for-all then,” Jon Butler, the executive director of Pop Warner Little Scholars, the largest youth football and cheerleading program in America for 93 years, said.
It’s safe to say that neither Georgia nor Iowa State knew who they were getting when they signed him to coach. Glenn Warner had never even seen a football game when he set off to Cornell in 1892 at age 21. He only went to college because he’d lost all of his money betting and figured the only way to secure more funding from his father, a former Civil War cavalry officer, was to commit to studying law.
On the train to Ithaca, N.Y., he ran into Cornell’s football coach, Carl Johanson, who took one look at the 200-pound Warner and ordered him to attend practice. Warner – quickly nicknamed “Pop” because he was older than most of the college kids at Cornell – was a gifted athlete. His first love was baseball, and he also participated in track and field, and was Cornell’s heavyweight boxing champion for two years. Despite his lack of football experience or knowledge, he proved to be a standout at guard and a natural leader. After graduating, he hung around another season in 1894 and served as Cornell’s captain.
When that season finished, Warner had no option but to put his law studies to use as an attorney in Buffalo. That lasted only a few months. In the spring of 1895, the folks at Iowa Agricultural College wrote Cornell asking for references to fill its vacant head coaching position. Warner applied himself and accepted an offer for $25 per week. He simultaneously applied for a similar position at Georgia and got an offer of $34 a week to come coach in Athens.
Instead of making a choice, the ambitious Warner got creative. Since Iowa State began its season in August, six weeks before Georgia, he worked out a deal to coach in Iowa until mid-September and then head to Georgia to begin coaching there while continuing to advise the team in Iowa via long-distance correspondence.
It wasn’t until after Warner left for Athens that Iowa State played its first official game of the season at Northwestern, winning 36-0. The Chicago Tribune headline said “Struck by a Cyclone,” earning Iowa State its Cyclones nickname.
At Georgia, Warner found conditions that were far from ideal. With no athletic facilities, bleachers that held only about 150 people (the student body was only 248) and a bare field behind the New College that wasn’t level and had rocks sticking out of the red clay. Only 13 students showed up for the team.
At Georgia, Warner made his official debut as a sideline head coach on Oct. 19, 1895, against Wofford at Herty Field (UGA won 34-0). The team went 3-4 – its first losing season but good enough for Georgia to make the uncommon step of hiring him back the next season for $40 a week. (Iowa State retained him as well for five seasons, even though he never was present for a game there.) One of those losses included what is considered football’s first (not-yet-legal) forward pass when North Carolina’s quarterback, instead of punting, threw the ball out of desperation and it was caught by another UNC player who went 70 yards for a decisive touchdown. Warner objected vociferously but the refs claimed they didn’t see it and the play stood.
Warner’s 1896 squad was considered Georgia’s first great team, going undefeated at 4-0, 3-0 in the Southern Intercollegiate Athletic Association, to win its first conference title. The finale pitted Pop Warner against Auburn coach John Heisman – two future coaching legends who at the time were unknown outside their own campuses. The Bulldogs won the Thanksgiving encounter, and thus the SIAA title, 12-6 thanks to a couple of Warner innovations.
The first touchdown came thanks to what some have regarded as football’s first “huddle,” when quarterback Richard Von Albade Gammon gathered his offense out of earshot to script four plays called without signals to keep Auburn’s defense guessing. The second came after the first onsides kick ever deployed in the South fooled the unsuspecting Tigers.
“They were just young bucks coming up but there were no nationally famous coaches at that time,” said Miller of the Warner-Heisman matchup. “Walter Camp and Amos Alonzo Stagg were first and then came Warner, Heisman, Fielding Yost and Knute Rockne. These guys were the originals – like the founding fathers. They were the first ones who had the chance to rise to prominence.”
Warner’s success at Georgia led him back home to Cornell in 1897 for twice his salary in Athens. Georgia’s program, meanwhile, was discontinued that same year after Gammon died from injuries suffered in a game against Virginia. The legislature passed a bill that would have banned football in the state of Georgia, but the governor vetoed the bill at the request of Gammon’s mother. The Bulldogs, did not win another conference title until 1920. By then, Warner had three national championships.
Warner pushed college football’s evolution with his innovative ideas that included everything from creative substitutions, hidden-ball tricks, sewing football-shaped leather patches on uniforms to confuse defenders or drawing receiving routes that went out of bounds to sneak behind the secondary.
“Nothing was illegal until somebody did it and they made a rule against it,” said Butler.
After Georgia, Warner spent 1897-1914 bouncing between two stints – one at his alma mater and the other at the Carlisle Indian Industrial School, a boarding school founded to teach Native American children and young adults skills to advance in U.S. society. His 13 combined seasons with Carlisle were the most he spent at any school in his 45 years as head coach.
After two winning seasons with Cornell, Warner resigned in 1898 after tensions among the team led to a small uprising against his leadership style. The next year he took the helm at the Carlisle School. It was here where Warner gained national prominence for his coaching and innovations to take advantage of speed and athleticism instead of raw strength.
“When he was at Cornell, he was gaining prominence,” Miller said. “But when he went to Carlisle, he turned a good team into a great one playing against Army and Harvard. He really made his bones there.”
At Carlisle, he started using double laterals and teaching his backs to launch themselves like sprinters from a three-point stance in the backfield.
“Carlisle guys all ran track and they took off like a shot,” Miller said of Warner’s innovative technique that became a norm after the Indians clobbered Columbia using it.
He created the single-wing and later the double-wing formations – precursors to modern spread and shotgun offenses – opening up all sorts of offensive possibilities that kept defenses off-balance. He developed the modern body blocking technique instead of leading with the shoulder. He taught his backs to use the spiral throwing method, weaponizing the downfield passing game after it was legalized in 1906. His punters learned to kick longer spirals as well.
His most famous player at Carlisle was Jim Thorpe, considered one of the greatest all-around athletes of all time. Warner’s Carlisle teams won 114 games and in four seasons between 1907 and 1913 lost only one game – three of those seasons with Thorpe on the roster (1907, 1911-12), the last two earning all-American honors. Warner traveled to Stockholm, Sweden, to coach Thorpe to gold medals in the pentathlon and decathlon in the 1912 Olympic Games.
In 1915, Warner took over an already quality Pitt program that was moving to a new campus. He immediately elevated the Panthers to the next level, winning the first 29 games as head coach there and claiming three national titles in 1915, 1916 and the WWI/Spanish flu-shortened 1918 season. His 1917 team went 10-0 but didn’t get credited with the national championship that was instead presented to his old rival John Heisman’s Georgia Tech team. Heisman challenged Pop’s Pitt team to a decisive postseason matchup to determine a champion, but faculty thwarted the game amidst the war and flu epidemic. The matchup didn’t materialize until November of the 1918 season in Pittsburgh, with the Panthers throttling Heisman’s Georgia Tech 32-0.
Before leaving Pitt, Warner once again double-booked himself with a rising Stanford program, sending his own associate Andrew Kerr west for two seasons before leaving the “disagreeable” weather of Pittsburgh for sunny California himself to take over in 1924. His 1926 Cardinal team earned him his fourth and final national championship with a 10-0-1 season that ended with a Rose Bowl tie against Alabama.
His head coaching career wrapped up back East with his final stint at Temple from 1933-38 for $75,000 annually. It was in Philadelphia that serendipity led to his name being forever associated with youth football.
In 1929, factories in northeast Philly were plagued by young vandals throwing rocks through their windows. A young athlete turned stockbroker named Joe Tomlin suggested the building owners band together to fund a youth athletic program to keep idle kids occupied. By 1933, Tomlin’s Junior Football Conference had expanded to 16 teams representing neighborhoods and suburbs, and he invited dozens of prominent local coaches to speak at a spring banquet and clinic. Temple’s Warner was the only one to brave a freak snowstorm and show up to speak to the 800 kids in attendance.
“He regaled the boys with stories of Jim Thorpe and (fellow Hall of Famer) Ernie Nevers and other great players and stayed for hours signing autographs for every kid and they just adored him,” Miller said. “At the end, the powers that be thought it would be great to have him endorse it and be associated with them. He was willing to let them use his name, though he never coached little league football.”
Pop Warner’s name affiliation helped the program rapidly expand. In 1959, Pop Warner Little Scholars was officially incorporated as a national nonprofit organization and spread from coast to coast. During the 1970s, cheerleading was added to the program to include girls. It remains the only youth football program that requires its participants to maintain academic standards in order to participate and currently serves more than 300,000 boys and girls ages 5-16 in the United States and Japan.
“There’s an awful lot of people who don’t realize there was a person named Pop Warner,” Butler, the executive director of Pop Warner Little Scholars, said of its young participants. “It’s been great for his legacy, for sure, because it is so well-known and it’s been around for 93 years.”
Warner was the most prolific winning coach of his era, retiring with a record 319 career head coaching victories. (His totals do not include the 18 wins Iowa State collected under his long-distance leadership as he coached three other teams simultaneously.) His record stood for nearly 50 years before Bear Bryant surpassed him, and Warner still ranks ninth all-time and, along with Vince Dooley, is among 23 coaches to surpass 200 victories at the Division I level.
He was inducted as a coach into the College Football Hall of Fame as part of its inaugural class in 1951.
Pop Warner’s legacy, however, goes beyond the wins and losses. His innovations in equipment (thigh and shoulder pads and lightweight uniforms designed for speed), practice tools (tackling dummies and blocking sleds) as well as game strategies laid the groundwork for football as we recognize it today. While it’s hard to confirm the veracity of everything Warner is credited for introducing to the game – the trap run, bootleg, end arounds, naked reverse, reverse handoffs on kickoffs, screen pass, spiral passes and punts, etc. – his reputation as an innovator is unquestioned.
“I consider Warner to be the greatest creative genius in American football,” Andy Kerr, a Hall of Fame coach who served as assistant to Warner at Pitt and Stanford before becoming a legend himself at Colgate, once said. “Most of us coaches are imitators, but Pop Warner was an inventor.”
In his book “History of Cornell,” professor of history Morris Bishop wrote that Warner “caused more rule changes than all the other coaches combined.”
What started humbly with his first win on Herty Field at Georgia grew into collegiate football legend.
“His biggest legacy is being one of the first,” said Miller, his biographer. “The idea that someone with no formal training could come into this game and dominate with his ideas and beat these guys at their own game with different ideas. He was just that innovative guy and a thinker who refused to go with the status quo.”
Success! An email has been sent to with a link to confirm list signup.
Error! There was an error processing your request. | https://www.albanyherald.com/features/georgia-groundbreakers-ugas-pop-warner-a-football-innovator/article_25363884-2b0a-11ed-8e0d-fb3210ae79d0.html | 2022-09-03T12:33:23Z |
HOUSTON, Sept. 7, 2022 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting highly resistant tumors and viruses, today announced that Walter Klemp, President and Chief Executive Officer of Moleculin, will present at the H.C. Wainwright 24th Annual Global Investment Conference being held in New York, NY and virtually on September 12-14, 2022.
In addition to the presentation, management will be available to participate in virtual one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information about the conference, please visit the conference website.
A video webcast of the presentation will be available for viewing on-demand through the H.C. Wainwright conference platform beginning Monday, September 12 at 7:00 AM ET for 30-days to those registered for the event.
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The Company's lead program, Annamycin, is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity. Annamycin is currently in development for the treatment of relapsed or refractory acute myeloid leukemia (AML) and soft tissue sarcoma (STS) lung metastases.
Additionally, the Company is developing WP1066, an Immune/Transcription Modulator designed to be capable of inhibiting p-STAT3 and other oncogenic transcription factors while also stimulating a natural immune response, targeting brain tumors, pancreatic and other cancers; and WP1220, an analog to WP1066, for the topical treatment of cutaneous T-cell lymphoma. Moleculin is also engaged in the development of a portfolio of antimetabolites, including WP1122, for the potential treatment of COVID-19 and other viruses, as well as cancer indications including brain tumors, pancreatic and other cancers.
For more information about the Company, please visit www.moleculin.com and connect on Twitter, LinkedIn and Facebook.
Investor Contact:
JTC Team, LLC
Jenene Thomas
(833) 475-8247
MBRX@jtcir.com
View original content to download multimedia:
SOURCE Moleculin Biotech, Inc. | https://www.kxii.com/prnewswire/2022/09/07/moleculin-present-hc-wainwright-24th-annual-global-investment-conference/ | 2022-09-07T13:24:53Z |
Officer’s job offer with police department revoked due to HIV diagnosis, DOJ says
CLARKSVILLE, Ind. (Gray News) – The Justice Department filed a lawsuit against a town in Indiana for discriminating against a police officer diagnosed with HIV.
According to the Department of Justice, the lawsuit alleges the police department in the town of Clarksville revoked a job officer to a qualified person based on his diagnosis.
The DOJ said the officer had been successfully working for the police department as a volunteer for over a year and was fully qualified for the position.
“Every day, we depend on law enforcement officers who put themselves in harm’s way to keep us safe,” said U.S. Attorney Zachary A. Myers for the Southern District of Indiana. “Those who are qualified and seek to serve their communities should not be subjected to unlawful discrimination.”
Title I of the Americans with Disabilities Act prohibits employers from discriminating against anyone skilled for the position on the basis of disability.
“No qualified individual should lose a hard-earned career opportunity because of misguided views about their disability that are not supported by medicine or science,” said Assistant Attorney General Kristen Clarke of the Justice Department’s Civil Rights Division. “This lawsuit reflects the Justice Department’s firm commitment to protecting qualified workers, including those with HIV, from unlawful employment discrimination.”
Copyright 2022 Gray Media Group, Inc. All rights reserved. | https://www.kxii.com/2022/04/26/officers-job-offer-with-police-department-revoked-due-hiv-diagnosis-doj-says/ | 2022-04-26T19:54:50Z |
TOKYO, Aug. 22, 2022 /PRNewswire/ -- A recent research result has been released by ITANDI Co., Ltd (Headquarters: Tokyo, Japan; Representative: Shinpei Noguchi "The Company") about how real estate companies are reacting to the digital transformation movement that has been taking place in the real estate industry in Japan. ITANDI Co.,Ltd is a technology focus company. The Company is part of the GA technologies Co.,Ltd (Headquarters: Minato-Ku, Tokyo, Japan; CEO: Ryo Higuchi; Securities code: 3491) group providing services in the real estate industry with advanced technology applied. The research released this time was conducted among 766 real estate companies asking about how they feel about the digital transformation development in the industry.
【Proptech (property technology) business companies】
- ITANDI Co .,Ltd (Headquarters: Minato-Ku, Tokyo, Japan; Representative: Shinpei Noguchi)
- WealthPark Co.,Ltd (Headquarters: Shibuya-Ku, Tokyo, Japan; Representative: Ryuta Kwada)
- Spacely Inc. (Headquarters: Shibuya-Ku, Tokyo, Japan; Representative: Hirokazu Morita)
- Sumasate Co.,LTd (Headquarters: Shinagawa-Ku, Tokyo, Japan; Representative: Nobuyoshi Yamagishi)
【Real estate specialized media】
SUMAVE (Proptech specialized online media / 2017~)
Zenchin (Press media specialized in real estate for rental & lease purpose / 1989~)
The definition of "digital transformation" in this article refers to "how companies in the real estate industry apply technology in order to improve work efficiency."
◆ Key Highlights
- 98.4% of the companies believe that digital transformation must be done. 71% have taken certain measures before or are planning on doing so.
- Companies those had been implemented with such measures in the past, 44.1% only involved for less than one year while 70.7% of the companies gave a positive feedback about digital transformation and the measures they have been taken
- When it comes to the annual budget, small companies with fewer than 10 employees are willing to spend less than one million yen for implementing digital transformation. Companies with more than 501 staff are willing to spend more than 10,010,000 yen.
- 3 major obstacles for companies to proceed with digital transformation are as follows: budget, right people, know-how
- 98.2% of the companies do know that online contract and online documentation are available along with the law revision in May 2022.
- The "online contract system" is the system (software) that has been discussed the most among companies currently
- More than 50% of the companies answered that they are satisfied with the software they have been using, especially for the "online meeting software", "appointment reservation software", "price assessment software", "software for important matters documentation" and the "online application software".
- The software that has been installed the most by companies is the "online contract software" in 2022. Other software such as "online meeting software", "software for important matters documentation" and "VR, online house tour software" are also popular among companies in 2021 to 2022.
◆ 98.4% of the companies participated in this research support with the digital transformation wave in the industry; 71% had been or is underway of taking actions
A total of 98.4% of the companies do support this digital transformation movement that has been taking place in the real estate industry either with strong agreement or somewhat positive reactions. When it comes to the question of how your company has been doing on the matter, 71% of them have taken or are taking some actions to make the change. 93.4% of the companies answered that the purpose for such action is to improve productivity and work efficiency. While to improve customer satisfaction and to attract more customers followed with 53.4% and 35.1%.
The companies that have been participating in the research this time, nearly 50% are small companies with staff fewer than 10 people. Many small to medium size companies also believe that digital transformation is necessary and are planning on taking some strategy for that or had such experience before.
◆ Almost half of the companies have less than one year of experience regarding DX, while more than 70% feel satisfied about the change
44.1% of the companies replied that they had less than one year of actual experience working on digital transformation. Only 0.7% of companies answered that they already have the related measures, or the DX system organized in the company. The companies that have started such actions have increased in the past one year. 70.6% of the companies have the system/ know-how ready in less than two years. And 70.7% of them gave positive feedback regarding such a change. When being asked about which part do you feel that has been improved the most, 93.2% answered with better efficiency and productivity. 29% answered with higher customer satisfaction while 25.6% said that the percentage of deals made has gone up.
◆ Companies are willing to spend from one million yen to more than 10,010,000 yen annually depending on the size of a company
When being asked about how much budget you are willing to spend on making the digital transformation a year, companies' answers vary from less than one million yen to more than 10,010,000 yen depending on the size of a company. 85.4% of the companies with 5 to 10 employees are willing to spend no more than one million yen annually to make the DX change. This percentage jumps to 93.1% for companies with only 1~4 people. On the other hand, companies with number of employees more than 501 people are willing to spend more than 10,010,000 yen per year to make the transformation. As we could see, the annual budget for companies to make the change increases along with the size of a company.
When it comes to the question "which department is responsible for the DX project?"21.3% of the companies answered with "the executive board" followed by "the sales (planning) department" with 20.6%. "Business strategy, the CEO office" comes in third with 16.7%. Finally, 9.7% of the companies being researched answered that there is a department specialized in such projects in their companies.
◆ "Budget", "Right people", "Know-how" are the biggest obstacles for companies
The Top 3 obstacles that prevent companies from making the digital transformation are: "budget", "right people", "know-how".40% answered that the lack of all three or either one of the resources makes the companies hesitate to make the change. All three factors are selected as the top 3 obstacles by companies which is almost the same as last year's research result (※1). Companies that have no plan for making the shift also pointed out "budget", "human resource", and "know-how" are the major concerns for them as well.
◆ 98.2% are aware of the law revisions about electronification of documentations
57.7% of the companies are aware of the electronification of the documentation process along with the law revisions enacted on May 18th, 2022; 40.5% are somewhat familiar with the News. Still 1.8% of the companies replied that they do not know about such a change. In conclusion, almost most companies working in the real estate industry are aware of such information.
◆ "Online contract software" is the most popular software among companies
70% of the companies answered that they have the online meeting software installed or are planning to do so. The second most popular software is the rental & lease application management software with 52.3% of the companies installed already or plan to do so. 39.1% answered with "online application software". Finally, 31.8% answered with the "customer relationship management software".
When it comes to the question of which software are you considering installing, 18.7% choose the "online contract software", 15.8% choose the "important matters documentation software", and 14% choose the "online application software". 11.5% choose the "App. for property owner". As we could see, the influence of the law revision has been pushing the process moves faster.
◆ More than 50% are satisfied with the changes DX brings
More than half of the companies researched say that they are satisfied with the strategies being taken to make the transformation. The satisfaction is especially high about the following software: "online meeting software", "appointment reservation software", "AI assessment software", "important matters documentation software" and the "online application software".
◆ "Online contract software" is the most popular software installed among companies in 2022
When we look at the percentage of installation of individual software, both the "online meeting software" and the "important matters documentation software" receive more than 70% popularity in 2020 ~ 2021. The installation rate is 61% for the "VR / online tour software" because of the increasing needs during the pandemic. In 2022, the software those receive high popularity are "online contract software" (31.7%), "AI price assessment software" (24.3%), "appointment reservation software" (20.9%), and the "online application software" (20.5%). For the times before the pandemic broke out, the software those were popular among real estate companies are "rental & lease application management software", "contract management software (for contract renewal & move-out)", and "CRM (customer relationship management) software".
◆ Conclusion
The real estate industry is experiencing a huge change in the digital technology aspect and how the real estate transaction process is going to be along with the related law revisions enactment, and the change in lifestyle because of the pandemic. All these have a huge impact on the industry, and indeed about 70% of the companies are starting or have been taking measures to ride on this digital transformation wave that is happening in the industry. No doubt, the so-called DX movement is certainly taking place in the real estate industry.
◆ Result Summary
- Research time period:June 16th, 2022 ~ July 7th, 2022
- Practical answers received: 776
- Targets for research: real estate management companies and companies provide related services
- Research method: online questionnaire
- Companies participated in the research are as follow:
*The percentage is round up, so it might not be 100% exactly when added up
◆ ITANDI Co.,Ltd
Company name: ITANDI Co.,Ltd
Representative: Shinpei Noguchi
Website: https://www.itandi.co.jp/
Headquarters: 40F of Sumitomo real estate Roppongi Grand Tower, Roppongi 3-2-1, Minato-Ku, Tokyo
Year of founding: June 2012
Capital fund: 36,000,000 yen
Services:
- Development, operation of SaaS for real estate companies : ITANDI BB
- Development, operation of SaaS for rental & lease management companies: ITANDI BB +
- Development, operation of self-tour house hunting platform: OHEYAGO
◆ WealthPark Co.,Ltd
Company name: WealthPark Co.,Ltd
Representative: Ryuta Kwada
Website: https://wealth-park.com/ja/
Headquarters: 3F of New mitomi building, Ebisu 1-20-18, Shibuya-Ku, Tokyo
Capital fund: 100,000,000 yen
Services:
- SaaS business (WealthPark Business)
- Vertical business (WealthPark Asset management)
- Fintech business (WealthPark Alternative)
◆ Spacely, Inc
Company name: Spacely, Inc
Representative: Hirokazu Morita
Website: https://corp.spacely.co.jp
Headquarters: 3F of Yagi building (second building), Shibuya 3-6-2, Shibuya-Ku, Tokyo
Year of founding: August 2013
Capital fund: 510,000,000 yen
Services:
- 360°VR & space utilization platform : Spacely
- Web media: Spacely Tips (Tips & contents about VR technology)
- AI x VR research lab: Spacely Lab
◆ Sumasate Co.,Ltd
Company name: Sumasate Co.,Ltd
Representative: Nobuyoshi Yamagishi
Website: https://sumasate.jp/
Headquarters: 8F of Noda building, Kamiozaki 2-12-1, Shinagawa-Ku, Tokyo
Year of founding: July, 2015
Capital fund: 10,000,000 yen
Services:
- Development & operation of AI rent price assessment software
- Development & operation of street guide software: Town Navi
◆SUMAVE
Website: https://www.sumave.com/
Year of founding: 2017
A News site specialized in real estate technology (property technology) both nationally and Internationally
◆ Zenchin Co.,Ltd
Website: https://www.zenchin.com/
Year of founding: 1989
One of the prestigious News media focuses on the rental and lease area, covers the newest information and trends in the real estate industry. The readership covers more than 80% of the real estate companies in Japan. It is one of the major resources for managerial positions in the industry to gather necessary information.
◆ GA technologies Co.,Ltd
Company name: GA technologies Co.,Ltd
Representative: Ryo Higuchi
Website: https://www.ga-tech.co.jp/
Headquarters: 40F of Sumitomo real estate Roppongi Grand Tower, Roppongi 3-2-1, Minato-Ku, Tokyo
Year of founding: March, 2013
Capital fund: 7224,816,203 yen (by July 2022)
Services:
- Internet real estate marketplace business: RENOSY
- BtoB PropTech SaaS development
- GA technologies group: ITANDI, RENOSY PLUS, Shenjumiausuan and 10 other group companies
Reference:
(*1) The research result for 2021 please refer to the following link: https://www.itandi.co.jp/news_posts/709 (July, 2021)
For this release, please contact below:
Nami (+81-90-1503-9158), Judy, GA technologies Co., Ltd. MAIL: pr@ga-tech.co.jp
View original content to download multimedia:
SOURCE GA technologies Co., Ltd. | https://www.mysuncoast.com/prnewswire/2022/08/22/japan-insights-2022-research-shows-that-984-real-estate-companies-believe-digital-transformation-is-necessary/ | 2022-08-22T17:20:00Z |
NEW YORK, April 13, 2022 /PRNewswire/ -- Oliver Wyman, a global management consulting firm and business of Marsh McLennan (NYSE: MMC) today announced it has acquired a minority stake in Blue Orange Digital, a data science, machine learning, and data visualization firm.
"We have worked with Blue Orange Digital on several projects and have been very impressed with their technical abilities," said Vivek Sen, a Partner with Oliver Wyman and Americas Head of Digital. "Our Digital practice is rapidly growing and investing in Blue Orange Digital will allow us to help our clients optimize and automate their businesses faster and more efficiently."
Josh Miramant, CEO and founder of Blue Orange Digital said, "Oliver Wyman is a leader in the consulting world and we are proud to partner with them and help deliver data science solutions to their clients."
Working together, Oliver Wyman and Blue Orange Digital will help clients unlock the power of data and advanced analytics to generate new sources of value and modernize their data environments.
In the past six months, Oliver Wyman has made several strategic investments. The firm acquired Huron's life sciences strategy consulting practice in November. In February Oliver Wyman acquired Azure Consulting, a premium boutique management consulting firm with offices in Perth and Melbourne. Earlier this month, the firm entered into an agreement to acquire Booz Allen Hamilton's management consulting business serving the Middle East and North Africa (MENA) region.
About Blue Orange Digital
Blue Orange Digital is a data science, machine learning, and data visualization firm that works with businesses to implement data-driven analytic techniques derived from statistical modeling and data science. Blue Orange Digital has a team of passionate data engineers, PhDs, data scientists, and visualization experts.
About Oliver Wyman
Oliver Wyman is a global leader in management consulting. With offices in more than 70 cities across 29 countries, Oliver Wyman combines deep industry knowledge with specialized expertise in strategy, operations, risk management, and organization transformation. The firm has more than 5,000 professionals around the world who work with clients to optimize their business, improve their operations and risk profile, and accelerate their organizational performance to seize the most attractive opportunities. Oliver Wyman is a business of Marsh McLennan [NYSE: MMC]. For more information, visit www.oliverwyman.com. Follow Oliver Wyman on Twitter @OliverWyman.
View original content to download multimedia:
SOURCE Oliver Wyman | https://www.kxii.com/prnewswire/2022/04/13/oliver-wyman-announces-strategic-investment-blue-orange-digital/ | 2022-04-13T12:33:53Z |
MIAMI, Aug. 16, 2022 /PRNewswire/ -- After announcing last Friday that it was revising pre-cruise vaccination and testing requirements that will allow more guests to sail, Carnival Cruise Line said today that its booking activity for Monday, Aug. 15 was nearly double the level for the equivalent day in 2019.
Carnival announced simplified protocols last Friday that eliminated pre-cruise testing requirements for vaccinated guests, and eliminated the exemption request process for unvaccinated guests, who now will only need to show a negative test result at embarkation – effective for cruises departing on Tuesday, Sept. 6, 2022 or later on voyages less than 16 nights. (The full announcement is available here.)
"We have previously disclosed strong occupancy projections for the summer, and our bookings through the end of 2022 have also been very solid," said Christine Duffy, president of Carnival Cruise Line. "With the further alignment of protocols to other vacation choices, our guests are booking the remaining 2022 inventory, and getting a head start planning for 2023. Mid-August is typically not a busy month for cruise bookings, but it's clear that pent-up demand for Carnival has not been satisfied and guests are responding very favorably to our updated protocols."
Duffy reiterated that Carnival remains committed to the health and safety of guests, crew, and the communities it visits, and will continue to work with medical experts and public health officials to refine its protocols responsibly.
For additional information on Carnival Cruise Line and to book a cruise vacation, call 1-800-CARNIVAL, visit www.carnival.com, or contact your favorite travel advisor or online travel site.
ABOUT CARNIVAL CRUISE LINE
Carnival Cruise Line, part of Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK), is proud to be known as America's Cruise Line. Since its founding in 1972, Carnival has continually revolutionized the cruise sector, making a cruise vacation an affordable and popular option for millions of guests. Carnival operates from 14 U.S. homeports and employs more than 40,000 team members representing 120 nationalities. Carnival's newest ship, Mardi Gras, featuring the first roller coaster at sea, is the first cruise ship in the Americas powered by eco-friendly Liquefied Natural Gas (LNG). Carnival returns to Australia in October 2022 and will welcome four additional ships over the next two years, including Carnival Celebration, which arrives to Miami in November to close out Carnival's 50th birthday festivities.
View original content to download multimedia:
SOURCE Carnival Cruise Line | https://www.kxii.com/prnewswire/2022/08/16/carnival-cruise-line-says-booking-activity-nearly-doubles-2019-comparison-after-covid-protocols-simplified/ | 2022-08-16T17:08:34Z |
(NEXSTAR) – Lyme disease cases have jumped across the United States over the past 15 years, but especially in rural areas, a new study found.
Humans can get Lyme disease from the bite of an infected tick, according to the Centers for Disease Control and Prevention. Milder symptoms include fever headache, fever, fatigue and skin rash. Left untreated, however, Lyme disease can spread to joints, the heart and the nervous system.
From 2007 to 2021, private insurance claim lines involving Lyme disease diagnoses rose 357 percent in rural areas and 65 percent in urban areas, according to a recent study FAIR Health, a national nonprofit that tracks health care claims. A claim line is an individual service or procedure listed on an insurance claim.
In just the past five years, those numbers are 60 percent for rural areas and 19 percent for urban areas, the study found. There was a seasonal pattern as well, the study found, with rural diagnoses jumping during the summer months, while claim lines from November to April happened more often in urban areas.
“The top states in 2021, from highest to lowest, were New Jersey, Vermont, Maine, Rhode Island and Connecticut,” the study’s authors wrote. “Maine, which was not previously on the list of top five states for Lyme disease claim lines, assumed third place in 2021, suggesting a growing presence of the tick-borne illness in the state.”
Rounding out the top twenty, from highest to lowest, were Pennsylvania, New York, New Hampshire, North Carolina, Massachusetts, Virginia, Hawaii, Wisconsin, West Virginia, Delaware, Alaska, Washington D.C., Indiana, Maryland and Iowa.
FAIR Health President Robin Gelburd stated, “Lyme disease remains a growing public health concern. FAIR Health will continue to use its repository of claims data to provide actionable and relevant insights to healthcare stakeholders seeking to better understand the ongoing rise of Lyme disease cases.”
Most cases of Lyme disease can be treated successfully with a few weeks of antibiotics, according to the CDC. Insect repellent, prompt tick removal, using pesticides and reducing the tick habitat are all ways to decrease the chance of contracting the disease. | https://cw33.com/news/nexstar-media-wire/lyme-disease-cases-are-growing-in-the-us-these-5-states-led-the-rest-in-2021-study/ | 2022-08-06T14:32:38Z |
GREENSBORO, N.C. (WGHP) — A 46-year-old woman has died after being attacked by two pit bulls she was dogsitting on Thursday morning.
Trena Peed was dogsitting for the dogs when she let them out of the backyard of her home in Greensboro around 2:00 a.m. But moments after she let the dogs outside, neighbors heard her crying loudly for help and witnessed the attack.
Their shock and horror could be heard in 911 calls.
“It’s dark. All I hear is her yelling and her dogs over there attacking her,” the caller said.
Peed’s son was asleep inside the home. He woke to the news of his mother’s passing.
“It’s terrible,” said Mr. Johnson, a neighbor and close friend of over 15 years. “She got mauled to death. That’s terrible.”
Peed’s daughter Waynesha has since set up a GoFundMe fundraiser to cover her mother’s funeral expenses. She also explained that Peed herself had lost two sons a few years apart, both in “tragic car accidents.”
“My mom has always been a true example of strength, love, and determination,” Waynesha Peed wrote. “My siblings, grandmother, family, & I are heartbroken at her sudden passing.”
After the attack, Peed’s friend Johnson sat on her porch, his head sunk low and his heart heavy.
“We were real good friends. Her and my wife talked together a lot. We were just friends,” he said. “It’s terrible.”
Greensboro Police and Guilford County Animal Control were the first to respond to the scene on Thursday morning, to try and get a handle on the situation. Police told WGHP the only way they could stop the attack was to shoot one of the dogs.
“I heard some shots,” Johnson recalled. “I looked out the window, and the ambulance trucks, and fire trucks, everybody was there before I even heard the shots.”
The other dog is under quarantine at Guilford County Animal Services.
Police are still investigating, and have not informed WGHP of any possible charges in connection with Thursday’s mauling.
Friends, family and neighbors, meanwhile, are still trying to process that morning’s events.
“It’s a terrible way to go. I wish the family the best,” said Johnson, who claimed he hasn’t witnessed anything this heartbreaking during his 40 years in the neighborhood. “She was doing something good and died behind it, and died a tragic death.” | https://cw33.com/news/nexstar-media-wire/terrible-way-to-go-nc-woman-dies-after-vicious-dog-attack/ | 2022-07-08T22:36:07Z |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.